Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"
ADAMTS4	"ADAMTS-2, ADMP-1, KIAA0688"	ENSG00000158859	"ADAM metallopeptidase with thrombospondin type 1 motif 4"	O75173	1	161184308-161199056	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 58.0"	"Cell line enhanced"	"Detected in some"		"hTEC/SVTERT24-B: 10.7;HUVEC TERT2: 12.9;SH-SY5Y: 7.2;TIME: 10.8;U-251 MG: 9.6"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basal ganglia: 20.7;cerebral cortex: 10.0;midbrain: 28.6;pons and medulla: 20.5;thalamus: 15.7"	"Cell type enriched"	"Detected in some"	8	"plasmacytoid DC: 8.0"	"Lineage enriched"	"Detected in many"	8	"dendritic cells: 8.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB025876, HPA051296, HPA068374"	Uncertain		Supported	"Nuclear speckles"	"Secreted to extracellular matrix"			"Nuclear speckles"		"CAB025876: , HPA051296: , HPA068374: "	"unprognostic (2.70e-2)"	"unprognostic (8.10e-3)"	"unprognostic (3.00e-3)"	"unprognostic (2.75e-1)"	"unprognostic (9.95e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.07e-1)"	"prognostic unfavourable (5.00e-4)"	"unprognostic (1.20e-2)"	"unprognostic (9.59e-3)"	"unprognostic (2.48e-2)"	"unprognostic (1.59e-1)"	"prognostic unfavourable (7.27e-7)"	"unprognostic (1.10e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.44e-3)"	"unprognostic (3.13e-2)"	58.0	9.7	2.6	18.1	20.7	1.8	14.6	1.5	10.7	7.8	6.3	33.4	0.0	1.9	5.8	2.0	7.7	14.2	16.4	19.5	3.4	2.3	3.1	11.0	15.7	2.7	28.6	3.5	35.7	10.6	4.7	4.9	4.4	20.5	5.8	3.4	0.0	1.7	1.7	7.7	1.7	3.0	12.0	15.5	1.9	8.1	1.7	15.7	0.0	7.5	1.2	1.4	8.7	4.0	0.5	8.0	1.0	0.2	0.4	0.6	0.2	0.0	0.0	0.2	0.1	6.0	3.8	0.5	4.8	0.2	0.4	2.8	0.1	0.1	0.2	4.1	1.5	0.1	0.0	0.0	1.7	0.1	0.3	0.1	0.4	1.2	0.6	0.0	0.1	4.2	0.0	10.7	0.1	12.9	0.1	0.3	0.3	0.1	0.0	0.2	4.8	0.0	0.1	4.7	0.1	0.0	0.1	0.1	7.2	0.0	0.1	0.1	0.2	0.5	10.8	6.8	0.1	0.3	9.6	0.2	0.1	0.1	2.1	0.1	0.1	0.7	0.2	0.2	0.6	0.1	0.3	0.3	0.3	0.3	0.1	0.5	0.4	0.4	1.0	0.4	0.1	8.0	0.3	0.2	2.6	20.7	1.5	10.0	3.4	2.3	28.6	3.5	20.5	15.7
AK6	CINAP	ENSG00000085231	"Adenylate kinase 6"	Q9Y3D8	5	69350984-69370013	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB005361, HPA070217"	Supported		Supported	"Nuclear speckles,Centrosome,Cytosol"				"Nuclear speckles"	"Centrosome, Cytosol"	"CAB005361: AB_2302969, HPA070217: "	"unprognostic (5.47e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.48e-1)"	"unprognostic (8.58e-2)"	"unprognostic (8.73e-2)"	"unprognostic (4.09e-2)"	"prognostic unfavourable (9.54e-4)"	"unprognostic (1.79e-1)"	"unprognostic (3.41e-2)"	"unprognostic (6.21e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.55e-2)"	27.6	27.7	25.1	16.9	25.4	14.8	23.3	21.5	23.6	17.6	22.7	11.3	16.4	18.3	18.3	30.4	26.7	15.4	15.1	17.9	23.2	22.2	30.2	42.3	17.0	18.7	20.9	16.2	18.8	17.2	15.8	26.3	21.5	23.3	18.2	20.6	12.3	14.5	14.6	41.4	11.9	24.0	16.7	19.6	21.8	17.0	46.1	17.5	25.2	24.3	24.2	18.8	19.7	13.7	22.2	22.0	14.3	15.9	16.6	21.2	10.0	17.2	9.6	12.6	16.8	20.7	13.8	23.7	26.0	9.8	12.8	15.9	26.8	14.9	37.0	24.6	11.8	5.8	19.7	12.4	19.6	15.1	9.5	18.2	20.5	20.4	16.9	21.6	7.9	8.0	16.4	12.7	18.3	8.3	17.0	12.2	16.4	20.0	19.9	14.6	10.5	6.4	23.4	15.7	20.5	20.1	14.1	6.5	6.4	13.4	10.8	18.6	11.5	24.4	10.9	9.6	15.4	17.9	21.5	14.7	30.6	32.8	12.4	31.8	12.4	13.7	13.0	14.3	15.5	15.9	16.1	22.2	18.4	19.3	18.0	18.1	20.1	21.2	2.1	16.6	14.2	22.0	18.1	10.0	25.1	25.4	21.5	23.6	23.2	22.2	20.9	16.2	23.3	17.5
AKAP17A	"721P, CCDC133, CXYorf3, DXYS155E, MGC39904, SFRS17A, XE7, XE7Y"	ENSG00000197976	"A-kinase anchoring protein 17A"	Q02040	X	1591593-1602514	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 7.0"	"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA043247, HPA051020"	Supported		Supported	"Nuclear speckles,Cytosol"				"Nuclear speckles"	Cytosol	"HPA043247: AB_10964776, HPA051020: "	"unprognostic (4.55e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.74e-1)"	"prognostic favourable (3.40e-4)"	"unprognostic (5.38e-2)"	"unprognostic (1.59e-2)"	"unprognostic (9.73e-3)"	"unprognostic (6.25e-2)"	"unprognostic (2.09e-1)"	"unprognostic (7.91e-3)"	"prognostic favourable (2.42e-4)"	"unprognostic (1.55e-3)"	"prognostic unfavourable (3.52e-7)"	"unprognostic (1.86e-2)"	"unprognostic (2.71e-1)"	"unprognostic (4.03e-2)"	"prognostic favourable (1.11e-5)"	7.4	10.3	28.1	14.5	42.3	18.0	24.5	27.5	25.2	32.8	7.2	2.5	2.5	14.2	40.9	9.7	9.2	9.1	7.4	12.5	27.1	3.4	20.3	16.4	12.2	15.4	37.6	27.1	38.0	15.6	5.2	31.0	42.7	33.7	12.6	4.3	2.5	17.0	7.8	6.9	12.3	11.6	3.2	27.8	21.4	14.2	7.0	37.2	2.5	16.1	2.5	8.9	6.8	47.6	1.8	1.8	7.0	1.0	1.3	1.6	0.4	9.5	12.3	9.8	11.1	4.8	6.2	24.1	10.4	4.2	8.4	7.1	13.6	8.8	14.4	6.7	5.1	8.4	6.0	5.2	5.0	11.8	20.5	17.9	11.8	12.6	10.4	6.9	30.1	5.5	9.6	6.2	6.9	5.7	11.2	9.1	4.9	6.3	15.3	30.0	14.7	10.7	11.6	11.7	12.0	5.6	6.6	11.0	16.1	8.1	13.2	12.5	8.6	12.7	11.0	13.1	6.0	11.3	8.9	39.6	6.6	20.0	5.3	11.3	3.4	7.0	1.0	1.9	0.8	0.5	0.9	1.8	1.0	1.6	0.6	1.2	0.8	0.8	4.1	1.3	0.8	1.8	0.5	0.4	28.1	42.3	27.5	25.2	27.1	3.4	37.6	27.1	33.7	37.2
AKAP8L	"HAP95, NAKAP95"	ENSG00000011243	"A-kinase anchoring protein 8 like"	Q9ULX6	19	15380048-15419141	"Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042485, HPA042546"	Enhanced		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA042485: AB_2678019, HPA042546: AB_2678046"	"unprognostic (9.52e-3)"	"unprognostic (5.23e-2)"	"prognostic unfavourable (3.49e-4)"	"unprognostic (1.08e-2)"	"unprognostic (3.25e-1)"	"unprognostic (3.53e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.57e-2)"	"prognostic favourable (8.04e-4)"	"unprognostic (1.01e-2)"	"prognostic unfavourable (1.08e-7)"	"unprognostic (2.77e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.80e-2)"	"unprognostic (2.34e-3)"	13.9	20.6	25.6	12.1	35.8	55.1	14.3	51.0	30.3	17.9	15.9	20.6	20.0	10.7	15.3	26.8	13.6	18.7	13.4	23.4	24.6	17.9	14.8	16.3	17.0	17.3	25.4	22.3	23.9	10.7	23.6	25.6	18.8	23.9	17.6	13.0	19.7	13.7	17.8	31.9	17.8	12.0	14.6	19.5	16.4	13.7	28.5	30.0	15.5	18.0	13.8	18.7	15.1	16.6	4.2	3.0	5.9	2.7	0.7	3.6	1.3	12.6	13.3	20.1	9.3	17.5	20.4	10.5	11.6	13.0	19.4	17.2	22.6	18.7	11.5	19.7	13.7	14.5	27.8	15.9	15.9	19.6	22.8	22.3	14.1	16.9	31.2	19.8	14.6	18.0	27.0	15.9	20.0	13.9	25.3	23.1	11.7	18.4	20.4	18.8	15.7	23.5	24.2	11.3	13.8	14.6	9.2	18.3	12.1	13.8	15.5	18.0	11.3	19.2	17.2	12.0	8.4	18.5	18.7	35.4	20.8	24.0	10.0	20.9	11.6	0.1	2.7	2.2	1.2	1.4	3.4	1.4	1.5	1.9	3.0	4.2	1.7	2.6	5.9	0.7	1.8	1.9	3.6	1.3	25.6	35.8	51.0	30.3	24.6	17.9	25.4	22.3	23.9	30.0
AP5Z1	"KIAA0415, SPG48, zeta"	ENSG00000242802	"Adaptor related protein complex 5 zeta 1 subunit"	O43299	7	4775622-4794312	"Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair, Protein transport, Transport"		"Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035693	Supported		Supported	"Nucleoplasm,Nuclear speckles"				"Nuclear speckles"	Nucleoplasm	"HPA035693: AB_10960687"	"unprognostic (1.64e-1)"	"unprognostic (5.22e-2)"	"unprognostic (3.01e-3)"	"unprognostic (4.24e-2)"	"unprognostic (2.43e-3)"	"unprognostic (5.19e-1)"	"prognostic unfavourable (1.35e-5)"	"unprognostic (1.50e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.26e-2)"	"unprognostic (5.32e-3)"	"unprognostic (8.28e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.22e-1)"	15.2	18.6	9.5	19.2	11.1	20.8	11.3	14.3	14.9	10.7	12.6	13.5	6.3	22.2	14.0	11.0	10.8	10.6	9.9	8.0	8.6	6.8	9.9	9.2	12.6	18.6	10.9	9.7	12.6	16.9	5.6	11.5	9.6	10.3	11.6	4.6	13.1	15.0	12.8	8.4	21.8	19.1	13.0	8.5	23.4	17.1	10.1	12.6	18.2	11.3	6.6	16.9	13.2	10.6	11.7	11.3	15.7	17.0	12.3	13.4	9.8	11.2	5.0	1.3	8.9	5.7	4.0	12.4	8.9	5.1	7.0	5.7	9.7	10.4	7.7	5.4	5.8	13.5	1.2	5.5	0.7	5.8	5.4	5.7	11.9	7.0	18.7	9.9	16.3	8.2	4.3	5.8	2.3	4.6	9.8	8.5	2.9	12.0	2.9	22.6	8.4	12.3	7.3	4.4	7.1	2.2	10.7	5.1	9.5	7.5	11.9	8.5	10.5	16.1	11.5	7.3	8.6	14.7	6.6	17.8	11.4	4.6	10.9	12.4	14.7	1.7	12.9	15.7	13.4	17.0	10.7	10.5	9.2	11.8	11.3	11.7	10.1	8.4	13.5	12.3	14.2	10.2	8.6	9.8	9.5	11.1	14.3	14.9	8.6	6.8	10.9	9.7	10.3	12.6
BARD1		ENSG00000138376	"BRCA1 associated RING domain 1"	Q99728	2	214725646-214809711	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB034106, HPA035354, HPA044864"	Enhanced		Supported	"Nuclear speckles,Cytoplasmic bodies"				"Nuclear speckles"	"Cytoplasmic bodies"	"CAB034106: AB_2061237, HPA035354: , HPA044864: "	"unprognostic (4.85e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.74e-2)"	"unprognostic (8.37e-3)"	"unprognostic (2.57e-2)"	"unprognostic (1.03e-2)"	"unprognostic (6.25e-4)"	"unprognostic (1.99e-1)"	"unprognostic (2.16e-2)"	"unprognostic (3.92e-3)"	"unprognostic (2.80e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.94e-8)"	"unprognostic (3.94e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.08e-1)"	4.4	1.9	3.2	11.8	4.8	16.1	4.9	1.2	5.8	7.3	5.4	5.4	3.6	3.7	6.8	5.0	10.0	4.1	3.9	3.6	3.4	2.8	2.2	2.1	5.3	8.2	5.1	1.9	5.8	3.7	3.6	6.3	3.8	4.5	5.7	6.1	1.9	4.7	6.5	12.4	16.3	4.5	7.5	5.3	4.7	3.8	9.5	3.9	25.8	4.0	8.0	9.9	8.3	7.8	9.7	6.6	6.0	3.4	6.1	16.0	2.0	7.7	4.3	11.7	6.0	1.6	2.0	8.0	9.4	5.5	9.3	10.7	5.4	7.7	8.3	4.5	3.9	8.5	8.4	5.5	13.3	6.6	4.4	8.3	7.9	5.7	0.6	9.2	8.4	2.7	0.8	8.2	4.5	3.1	4.6	23.5	8.9	6.4	16.5	9.6	9.2	2.2	14.3	11.8	7.5	2.7	6.5	3.7	5.9	8.6	9.9	3.4	10.2	9.2	2.7	12.0	8.4	7.0	8.5	7.1	7.9	16.9	4.8	7.0	8.0	2.9	1.7	6.0	4.8	3.4	3.1	8.9	5.3	5.2	3.0	9.7	2.5	3.6	0.5	6.1	2.9	6.6	16.0	2.0	3.2	4.8	1.2	5.8	3.4	2.8	5.1	1.9	4.5	3.9
BCAS2	"DAM1, Snt309, SPF27"	ENSG00000116752	"BCAS2, pre-mRNA processing factor"	O75934	1	114567557-114581639	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 116.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067881	Supported		Supported	"Nuclear speckles,Centrosome"				"Nuclear speckles, Centrosome"		"HPA067881: "	"unprognostic (6.93e-2)"	"unprognostic (1.88e-2)"	"unprognostic (8.58e-3)"	"unprognostic (4.74e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.99e-3)"	"prognostic unfavourable (8.23e-7)"	"unprognostic (1.16e-1)"	"unprognostic (8.51e-3)"	"prognostic favourable (7.96e-4)"	"unprognostic (1.57e-2)"	"prognostic unfavourable (4.27e-4)"	"prognostic favourable (6.49e-4)"	"unprognostic (2.25e-3)"	"unprognostic (1.03e-1)"	"prognostic unfavourable (5.24e-4)"	"unprognostic (1.87e-1)"	23.2	28.0	36.7	17.6	34.1	43.0	25.0	30.4	40.6	21.3	19.7	16.5	17.3	16.7	22.9	33.2	26.0	16.6	20.7	24.5	31.6	41.8	28.7	32.9	17.5	22.4	37.0	28.8	26.8	18.2	22.9	32.5	17.4	39.0	24.1	21.0	13.9	19.5	26.7	38.4	19.0	19.0	20.1	26.9	20.8	18.3	21.2	24.6	20.0	27.8	24.5	22.1	31.1	19.5	30.4	24.8	30.9	22.6	35.4	40.1	32.9	18.9	6.9	14.4	13.6	7.7	9.0	21.6	14.3	11.0	19.0	19.6	9.7	7.8	16.9	19.8	9.2	9.3	16.7	14.1	26.5	15.2	15.0	8.8	13.8	14.0	13.9	22.2	9.6	8.1	15.5	19.6	24.3	12.4	16.9	12.7	15.6	116.3	19.8	16.6	24.9	15.8	14.2	25.4	11.8	13.3	16.6	18.8	12.5	17.8	13.8	21.9	12.2	17.6	10.8	11.6	15.5	23.3	26.8	13.8	14.2	27.3	22.7	18.6	43.9	21.6	18.5	30.9	29.3	21.9	40.1	30.4	36.7	35.7	19.4	26.7	38.2	37.2	17.6	35.4	22.6	24.8	35.8	32.9	36.7	34.1	30.4	40.6	31.6	41.8	37.0	28.8	39.0	24.6
BDNF		ENSG00000176697	"Brain derived neurotrophic factor"	P23560	11	27654893-27722058	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.5;smooth muscle: 10.5"	"Cell line enhanced"	"Detected in many"		"BJ: 22.4;BJ hTERT+ SV40 Large T+: 17.2;BJ hTERT+ SV40 Large T+ RasG12V: 13.1;HBF TERT88: 16.5;U-138 MG: 24.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009564, HPA031440, HPA056104"	Enhanced		Supported	"Nuclear speckles,Mitochondria"	"Secreted to blood"	19244000		"Nuclear speckles, Mitochondria"		"CAB009564: AB_2064213, HPA031440: , HPA056104: "	"unprognostic (1.25e-2)"	"unprognostic (2.84e-1)"	"unprognostic (4.35e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.01e-2)"	"unprognostic (6.82e-2)"	"unprognostic (2.39e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.20e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.22e-2)"	"unprognostic (3.88e-2)"	"unprognostic (5.88e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.84e-3)"	0.9	1.3	5.0	0.6	4.5	0.5	0.6	9.4	14.5	1.6	0.8	0.6	0.7	0.8	0.7	8.2	1.4	0.5	2.1	5.8	8.5	5.7	0.9	0.5	4.1	0.4	2.5	4.7	1.2	1.0	0.2	2.3	3.7	12.7	4.9	0.4	3.0	0.9	4.2	1.3	2.1	0.5	10.5	1.0	0.6	0.9	1.3	0.0	0.0	2.3	0.0	0.4	3.2	1.2	0.1	0.4	0.0	0.2	0.1	1.0	0.1	1.6	6.6	0.2	0.0	2.3	1.9	0.0	22.4	4.3	17.2	13.1	0.0	2.6	0.0	2.1	8.1	1.0	0.1	0.2	16.5	0.1	0.1	0.0	2.2	0.0	10.0	0.1	0.1	5.8	2.2	3.8	2.2	0.7	0.0	0.0	2.7	0.0	0.0	0.0	2.1	1.8	0.0	1.3	0.0	2.5	0.0	0.1	0.6	4.3	0.0	0.0	0.1	0.0	7.4	24.1	4.0	9.3	5.0	0.3	0.0	0.0	9.3	0.6	1.3	0.0	0.0	0.0	0.1	0.2	0.2	0.1	0.0	0.6	0.2	0.1	0.7	0.4	0.0	0.1	0.0	0.4	1.0	0.1	5.0	4.5	9.4	9.4	8.5	5.7	2.5	4.7	12.7	0.0
BMP2K	"BIKe, DKFZp434K0614"	ENSG00000138756	"BMP2 inducible kinase"	Q9NSY1	4	78776342-78916372	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 37.9;HMC-1: 41.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026436, HPA026451, HPA026501"	Approved		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA026436: AB_10600102, HPA026451: AB_10600228, HPA026501: AB_10601341"	"unprognostic (7.96e-2)"	"unprognostic (3.68e-1)"	"prognostic favourable (1.74e-4)"	"unprognostic (9.08e-2)"	"unprognostic (1.97e-1)"	"unprognostic (9.73e-3)"	"unprognostic (1.51e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.98e-1)"	"unprognostic (7.60e-2)"	"unprognostic (1.39e-1)"	"unprognostic (9.60e-2)"	"unprognostic (9.90e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.18e-2)"	11.4	11.1	15.6	18.6	15.0	15.3	12.0	8.2	12.7	11.1	13.9	20.3	2.1	8.0	11.3	9.6	15.7	10.0	12.3	17.0	18.0	9.5	8.3	10.2	14.1	22.9	20.9	12.0	6.5	6.4	7.7	7.8	14.4	14.5	8.4	18.9	11.4	10.2	6.0	7.5	14.5	15.9	10.4	28.3	19.2	7.4	19.6	16.5	19.9	12.5	5.9	24.4	9.7	12.8	2.7	1.7	3.8	2.6	0.4	0.4	0.5	5.4	2.0	3.0	3.9	5.9	5.6	2.3	5.2	8.1	5.9	7.7	3.7	2.9	6.6	2.7	25.2	1.3	3.5	4.2	10.8	1.8	1.2	37.9	2.4	1.7	6.5	7.9	41.1	8.2	5.5	9.2	8.5	7.9	10.2	19.0	6.9	1.1	4.7	3.3	1.4	1.3	6.8	5.4	1.6	7.2	2.9	4.7	2.5	7.6	3.9	4.6	1.4	4.1	7.7	5.8	2.3	9.6	5.6	3.5	1.4	2.5	5.1	9.9	4.0	0.4	2.2	1.2	0.1	0.9	0.1	2.7	0.1	0.0	1.7	2.7	0.4	0.2	3.8	0.4	2.6	1.3	0.0	0.5	15.6	15.0	8.2	12.7	18.0	9.5	20.9	12.0	14.5	16.5
BNIP3L	"BNIP3a, Nix"	ENSG00000104765	"BCL2 interacting protein 3 like"	O60238	8	26382898-26505636	"Cancer-related genes, Predicted membrane proteins, Transporters"	"Apoptosis, Host-virus interaction"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015652, CAB025371"	Enhanced		Supported	"Nuclear speckles,Mitochondria"				Mitochondria	"Nuclear speckles"	"CAB025371: , HPA015652: AB_1845406"	"unprognostic (1.02e-1)"	"unprognostic (2.90e-1)"	"unprognostic (2.00e-1)"	"unprognostic (8.36e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.64e-3)"	"unprognostic (1.46e-2)"	"unprognostic (5.04e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.06e-2)"	"unprognostic (2.97e-2)"	"prognostic unfavourable (5.92e-5)"	"unprognostic (8.72e-3)"	"unprognostic (5.16e-2)"	"prognostic unfavourable (3.95e-4)"	"unprognostic (7.59e-3)"	61.7	27.8	32.7	18.2	39.1	79.4	40.1	26.1	39.0	35.0	19.9	32.3	30.7	11.5	27.3	34.0	26.7	26.4	28.0	36.0	36.0	27.4	39.9	22.9	31.3	20.7	43.1	31.9	63.4	10.4	26.8	16.0	51.2	41.0	23.7	14.9	20.9	22.1	39.2	21.0	38.1	14.5	26.5	47.9	19.5	16.7	33.0	43.9	17.8	21.5	12.4	25.2	48.3	30.8	14.2	30.4	68.7	53.9	7.8	17.6	36.3	18.1	6.9	16.6	11.2	46.3	29.2	14.0	18.4	54.1	17.3	38.3	3.1	8.8	5.6	17.4	34.6	9.3	8.2	23.6	57.6	3.6	4.5	23.2	7.2	5.4	25.8	2.0	40.3	35.0	18.6	19.6	11.8	22.1	10.4	13.6	36.2	7.9	14.3	7.6	5.3	7.6	7.7	21.1	11.0	17.9	11.8	17.7	15.8	8.9	1.8	13.9	9.1	4.4	28.9	32.5	14.1	20.3	4.1	20.0	9.0	7.5	49.4	4.2	7.3	49.9	53.9	32.1	7.6	27.8	6.7	12.4	11.4	8.3	30.4	14.2	17.6	12.8	68.7	7.8	17.4	6.9	15.0	36.3	32.7	39.1	26.1	39.0	36.0	27.4	43.1	31.9	41.0	43.9
BRD1	"BRL, BRPF2"	ENSG00000100425	"Bromodomain containing 1"	O95696	22	49773283-49827512	"Predicted intracellular proteins"		"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000807, HPA001063"	Enhanced		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA000807: AB_1078298, HPA001063: AB_1078297"	"unprognostic (1.96e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.11e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.47e-2)"	"unprognostic (2.18e-2)"	"unprognostic (9.98e-2)"	"unprognostic (2.73e-2)"	"unprognostic (3.28e-2)"	"unprognostic (2.02e-3)"	"unprognostic (1.64e-3)"	"unprognostic (5.87e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.95e-3)"	12.1	9.3	11.3	11.5	12.8	17.0	17.3	32.4	13.0	15.8	14.5	10.8	11.8	15.3	18.9	9.3	14.6	15.5	14.6	8.9	8.6	7.5	7.4	8.0	11.3	11.2	9.6	11.1	19.3	20.3	10.8	13.5	14.8	11.3	11.9	8.2	13.9	14.0	11.7	16.8	23.7	14.7	14.3	7.6	14.8	14.9	38.9	11.7	23.8	13.4	12.1	16.0	15.3	14.2	2.2	2.3	1.7	6.3	1.9	2.9	1.1	8.4	8.6	15.9	8.9	6.6	5.9	13.5	9.4	6.5	9.9	7.8	13.0	5.7	9.0	5.6	7.7	12.2	10.1	6.7	4.3	8.9	18.4	8.9	13.1	7.9	12.8	20.2	12.7	8.7	10.5	5.8	7.4	7.2	10.1	9.9	5.0	13.9	15.1	10.6	10.9	7.0	22.5	13.9	9.2	3.9	12.4	10.2	18.1	12.0	15.8	12.3	7.3	16.8	8.8	9.2	10.0	6.9	8.5	11.8	2.8	12.8	6.5	7.2	8.1	0.8	1.6	1.7	1.5	0.7	2.9	1.2	2.4	2.7	1.1	2.2	2.4	2.7	1.7	1.9	6.3	2.3	0.8	1.1	11.3	12.8	32.4	13.0	8.6	7.5	9.6	11.1	11.3	11.7
CACTIN	"C19orf29, cactin, fSAPc, NY-REN-24"	ENSG00000105298	"Cactin, spliceosome C complex subunit"	Q8WUQ7	19	3610641-3626815	"Predicted intracellular proteins"	"Immunity, Innate immunity, mRNA processing, mRNA splicing"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042504, HPA042548"	Approved		Supported	"Nucleoplasm,Nuclear speckles,Cytosol"				"Nucleoplasm, Nuclear speckles"	Cytosol	"HPA042504: AB_10797501, HPA042548: AB_10794760"	"unprognostic (1.18e-1)"	"unprognostic (7.90e-3)"	"unprognostic (1.09e-1)"	"prognostic favourable (3.69e-5)"	"unprognostic (5.93e-2)"	"unprognostic (2.87e-3)"	"unprognostic (3.38e-2)"	"unprognostic (1.01e-2)"	"unprognostic (3.84e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.17e-2)"	"unprognostic (7.22e-3)"	"unprognostic (3.88e-2)"	"unprognostic (4.98e-3)"	"unprognostic (5.78e-2)"	"unprognostic (3.08e-2)"	"unprognostic (5.55e-3)"	16.1	14.4	18.3	19.4	17.8	19.8	16.2	19.2	19.9	11.8	12.4	13.1	12.3	14.5	14.2	9.6	11.9	13.0	13.0	10.3	14.2	10.9	11.9	14.8	11.7	16.5	14.3	9.9	21.4	14.9	8.9	11.1	11.3	13.4	13.4	8.5	10.3	15.5	12.8	28.6	22.0	16.2	12.2	9.8	23.0	15.7	14.4	15.0	13.9	12.6	11.9	12.7	11.3	18.5	2.1	4.3	0.8	2.9	0.9	3.7	1.3	14.4	8.4	7.1	12.1	5.2	5.1	10.8	10.4	4.2	6.3	7.0	8.3	6.5	12.2	8.9	6.5	13.5	7.4	8.7	3.8	12.2	9.7	7.5	11.4	9.9	7.2	10.2	11.0	5.0	8.5	5.8	4.0	9.0	16.7	13.6	3.3	8.7	18.2	8.9	15.1	9.8	19.3	9.2	11.4	5.8	7.4	9.8	13.7	11.7	8.3	8.4	6.6	11.8	11.6	8.4	10.7	18.4	18.1	20.9	13.9	13.4	10.4	16.4	11.3	0.0	1.2	0.0	3.7	2.9	1.3	2.0	1.8	1.7	1.0	2.1	2.0	2.5	0.8	0.9	0.4	4.3	1.4	1.3	18.3	17.8	19.2	19.1	14.2	10.9	14.3	9.9	13.4	15.0
CBLL1	"FLJ23109, HAKAI, RNF188"	ENSG00000105879	"Cbl proto-oncogene like 1"	Q75N03	7	107743697-107761667	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021773, HPA026699"	Enhanced		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA021773: AB_1846103, HPA026699: AB_1846104"	"unprognostic (1.90e-2)"	"unprognostic (2.25e-1)"	"unprognostic (8.57e-2)"	"unprognostic (3.79e-2)"	"unprognostic (8.16e-2)"	"unprognostic (7.20e-2)"	"unprognostic (1.37e-2)"	"unprognostic (3.96e-3)"	"unprognostic (4.28e-2)"	"unprognostic (2.16e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.12e-3)"	"unprognostic (9.12e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.71e-2)"	15.8	12.0	11.7	13.6	20.0	38.8	16.8	18.7	19.4	15.3	17.2	19.2	11.6	10.8	22.9	9.7	14.4	14.2	10.2	11.5	11.9	10.7	11.6	12.5	12.9	16.5	12.6	14.3	18.2	15.5	14.5	17.2	13.5	16.5	18.7	13.0	14.7	12.8	19.6	32.6	16.6	14.4	16.2	15.1	15.8	14.7	21.1	13.3	29.0	15.8	11.8	19.3	17.6	12.7	17.9	16.7	32.2	15.7	23.4	40.3	20.1	13.5	15.5	12.0	15.3	11.0	9.6	8.2	10.2	10.6	11.5	11.4	10.4	13.8	19.6	14.8	11.5	9.6	16.6	12.4	15.8	13.9	10.5	16.0	11.4	8.7	12.8	23.5	15.7	10.0	11.5	15.5	17.0	11.8	25.1	16.7	11.0	23.1	32.1	16.0	17.2	10.6	14.9	13.0	20.3	8.7	12.5	12.8	20.0	15.2	22.4	11.1	7.5	12.0	11.5	17.9	12.9	16.9	15.6	27.2	29.5	31.8	11.0	14.7	15.1	32.2	14.2	23.3	19.0	14.7	28.0	17.9	30.1	21.8	16.7	17.4	20.9	19.6	21.9	23.4	15.7	9.0	40.3	20.1	11.7	20.0	18.7	19.4	11.9	10.7	12.6	14.3	16.5	13.3
CCNB3		ENSG00000147082	"Cyclin B3"	Q8WWL7	X	50202713-50351910	"Predicted intracellular proteins"	"Cell cycle, Cell division, Meiosis"	Cyclin		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 6.1;epididymis: 11.6;pituitary gland: 3.7;testis: 14.8"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 4.8;Karpas-707: 3.9;U-2 OS: 3.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 2.2"	"Low lineage specificity"	"Detected in single"							"Low region specificity"	"Detected in all"			HPA000496			Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA000496: AB_1078605"	"unprognostic (1.57e-1)"	"unprognostic (1.99e-1)"	"unprognostic (7.19e-2)"	"unprognostic (1.06e-1)"	"unprognostic (9.96e-3)"	"unprognostic (8.11e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.48e-3)"	"unprognostic (6.93e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.67e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.87e-1)"	"unprognostic (4.51e-2)"	"unprognostic (2.63e-2)"	0.7	0.7	0.9	0.3	3.5	0.2	0.8	0.4	1.7	0.4	0.4	5.8	0.0	0.4	0.3	11.6	0.4	0.7	0.6	0.6	1.3	1.5	0.7	1.1	0.7	0.4	2.4	2.0	0.4	0.9	0.7	3.7	0.9	4.3	0.5	0.4	0.0	0.5	0.8	1.4	1.0	0.3	0.3	6.1	0.6	1.0	14.8	1.3	0.1	0.9	1.1	0.5	0.4	0.2	0.3	0.3	0.0	0.5	0.0	2.2	0.1	0.4	1.5	0.8	0.5	0.2	0.2	0.0	0.1	0.3	0.3	0.4	1.2	4.8	1.4	1.0	0.3	0.2	0.7	0.5	0.3	1.2	1.6	1.0	0.0	0.0	1.3	1.1	1.0	0.8	0.2	0.3	0.9	0.5	0.2	3.9	1.2	0.0	0.6	0.2	0.7	0.1	0.0	1.7	0.1	0.2	0.5	0.1	0.9	0.4	0.2	1.0	3.4	0.3	0.4	2.0	3.5	0.9	0.6	1.0	0.7	2.1	0.6	0.4	0.3	0.0	0.0	0.0	2.2	0.5	0.3	0.3	0.5	0.0	0.3	0.3	0.4	1.0	0.0	0.0	0.3	0.0	0.1	0.1	0.9	3.5	0.4	1.7	1.3	1.5	2.4	2.0	4.3	1.3
CDC25C	"CDC25, PPP1R60"	ENSG00000158402	"Cell division cycle 25C"	P30307	5	138285265-138338355	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Host-virus interaction, Mitosis"	"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"lymphoid tissue: 23.3;testis: 22.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.1;T-reg: 2.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"CAB003800, HPA066991"	Approved		Supported	"Nuclear speckles"				"Nuclear speckles"		"CAB003800: AB_562081, HPA066991: "	"unprognostic (2.45e-3)"	"unprognostic (5.89e-3)"	"prognostic favourable (2.49e-4)"	"unprognostic (9.72e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.53e-1)"	"prognostic unfavourable (3.03e-6)"	"prognostic unfavourable (4.38e-4)"	"unprognostic (5.56e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.70e-3)"	"unprognostic (1.00e-1)"	"unprognostic (0.00e+0)"	"unprognostic (5.04e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.59e-1)"	"unprognostic (3.06e-1)"	1.1	0.6	0.3	6.7	0.4	5.2	1.1	0.4	0.6	0.6	3.3	0.1	0.7	3.0	0.3	0.6	2.5	0.2	0.4	0.7	0.4	0.4	0.4	0.6	0.7	2.6	0.4	0.3	0.3	0.3	0.0	0.4	1.9	0.3	0.4	4.0	0.0	1.2	0.7	0.2	1.1	3.7	0.5	0.3	1.7	1.2	22.3	0.2	23.3	0.3	1.8	5.0	0.6	0.9	1.0	0.1	0.7	0.0	2.1	2.7	0.5	13.5	5.6	19.0	14.6	0.4	1.9	4.8	8.1	8.8	18.6	25.7	13.6	26.3	6.3	6.9	4.9	7.3	15.6	12.5	18.0	5.2	10.7	4.8	7.7	10.1	0.1	3.2	4.9	0.4	0.5	11.0	9.0	11.9	7.0	12.4	11.3	7.4	8.8	8.1	4.9	6.2	5.8	17.3	7.3	3.2	4.1	9.6	5.9	18.3	5.6	8.7	9.3	6.7	3.6	10.3	8.7	7.1	13.0	7.6	6.2	6.2	4.1	6.9	7.8	0.0	0.0	0.1	0.6	0.0	0.0	1.0	0.5	0.3	0.0	0.2	0.0	0.0	0.7	2.1	0.0	0.1	2.7	0.5	0.3	0.4	0.4	0.6	0.4	0.4	0.4	0.3	0.3	0.2
CDC34	"E2-CDC34, UBC3, UBE2R1"	ENSG00000099804	"Cell division cycle 34"	P49427	19	531712-542092	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Cell cycle, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA002382, CAB005109, CAB047311"	Approved		Supported	"Nuclear speckles,Cytosol"				"Nuclear speckles"	Cytosol	"CAB005109: AB_2276050, CAB047311: , HPA002382: AB_1846370"	"unprognostic (4.65e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.41e-1)"	"unprognostic (8.72e-2)"	"unprognostic (2.84e-1)"	"unprognostic (5.73e-2)"	"prognostic unfavourable (7.57e-4)"	"unprognostic (2.20e-1)"	"unprognostic (3.11e-1)"	"unprognostic (3.83e-2)"	"unprognostic (2.09e-2)"	"unprognostic (3.06e-2)"	"unprognostic (3.02e-2)"	"unprognostic (8.87e-3)"	"unprognostic (9.68e-2)"	"unprognostic (7.82e-3)"	"unprognostic (3.33e-2)"	16.5	15.9	21.3	11.3	19.1	24.7	20.4	25.7	30.9	16.0	20.5	19.5	10.5	15.4	13.3	13.4	15.6	14.5	13.6	35.6	21.1	18.2	12.1	36.0	13.0	9.9	18.5	19.8	17.0	37.4	11.3	17.0	24.9	16.2	17.2	10.6	15.3	26.4	18.5	63.9	19.0	13.2	18.6	14.3	12.7	15.7	43.6	15.0	12.2	13.1	17.0	8.7	19.2	16.4	2.9	2.8	11.5	4.5	1.5	4.1	1.3	18.4	18.4	23.7	19.5	10.8	10.3	23.7	16.6	12.7	17.9	18.7	28.6	11.3	10.2	17.4	11.8	12.8	18.6	14.0	9.2	16.6	50.0	9.4	12.2	30.9	26.9	13.2	11.4	13.3	21.0	15.1	15.8	21.3	40.2	20.4	11.8	26.4	18.0	17.6	29.9	17.9	16.7	12.2	17.1	13.5	11.0	30.9	22.9	14.4	15.0	27.6	12.0	19.4	17.4	13.1	15.6	30.4	22.1	20.4	15.6	13.6	17.9	18.7	13.5	4.5	3.5	6.2	2.3	3.4	1.7	2.9	3.2	4.1	2.8	1.7	2.5	2.4	11.5	1.5	4.5	2.3	3.1	1.3	21.3	19.1	25.7	30.9	21.1	18.2	18.5	19.8	16.2	15.0
CDK11A	"CDC2L2, CDC2L3, CDK11-p110, CDK11-p46, CDK11-p58, p58GTA, PITSLRE"	ENSG00000008128	"Cyclin dependent kinase 11A"	Q9UQ88	1	1702730-1724324	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 33.5"	"Low lineage specificity"	"Detected in all"											"CAB010467, HPA025061, HPA073626"	Supported		Supported	"Nuclear speckles,Cytosol"				"Nuclear speckles"	Cytosol	"CAB010467: AB_631212, HPA025061: AB_1846407, HPA073626: "	"unprognostic (6.25e-2)"	"unprognostic (8.32e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.74e-1)"	"unprognostic (9.32e-3)"	"unprognostic (3.54e-2)"	"unprognostic (2.25e-3)"	"unprognostic (7.97e-2)"	"prognostic unfavourable (5.06e-4)"	"unprognostic (1.28e-1)"	"unprognostic (5.58e-3)"	"unprognostic (3.07e-2)"	"prognostic unfavourable (1.15e-6)"	"unprognostic (1.97e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.70e-2)"	14.3	14.9	17.2	23.7	26.9	39.7	13.0	35.2	32.7	12.5	16.4	14.3	6.1	29.2	16.5	8.5	12.1	12.6	10.2	10.2	19.4	8.4	11.7	12.5	19.0	20.3	22.6	9.0	16.2	12.9	12.2	27.5	12.9	17.1	14.4	14.6	11.6	12.7	10.3	21.5	15.1	34.9	13.1	26.0	24.2	15.7	16.4	25.1	14.9	14.6	7.6	22.4	13.5	15.2	7.4	11.8	33.5	6.3	4.4	5.5	1.4	16.1	9.7	7.0	6.4	9.2	7.4	6.9	15.9	7.1	7.9	9.2	12.2	14.8	17.2	9.7	4.6	12.0	6.5	8.2	6.3	13.1	10.4	15.3	18.3	10.9	6.1	17.1	22.1	8.5	5.6	6.9	4.5	13.6	17.9	14.4	6.6	9.1	7.9	13.4	9.7	8.3	14.5	10.7	8.3	6.4	7.3	7.8	11.3	13.9	16.4	19.1	11.0	7.1	13.8	12.5	12.1	5.6	8.8	20.1	14.6	21.6	4.2	13.9	3.9	16.7	6.3	7.7	5.5	3.4	4.2	6.2	4.7	4.2	2.0	7.4	4.7	4.0	33.5	4.4	3.7	11.8	4.5	1.4	17.2	26.9	35.2	32.7	19.4	8.4	22.6	9.0	17.1	25.1
CDK13	"CDC2L, CDC2L5, CHED, KIAA1791"	ENSG00000065883	"Cyclin dependent kinase 13"	Q14004	7	39949646-40099580	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059241	Uncertain		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA059241: "	"unprognostic (1.99e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.18e-3)"	"unprognostic (3.42e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.13e-2)"	"unprognostic (3.77e-2)"	"unprognostic (8.13e-2)"	"unprognostic (8.20e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.33e-2)"	"unprognostic (3.53e-1)"	"unprognostic (3.53e-2)"	16.9	15.3	16.0	29.0	14.5	26.7	20.4	23.3	18.2	16.6	18.3	16.4	14.2	11.3	20.3	17.7	20.9	18.1	20.2	13.6	14.3	11.3	14.7	17.5	19.6	21.9	16.5	15.1	24.2	15.3	26.3	15.3	14.8	12.0	15.5	15.5	14.9	17.6	14.5	19.4	16.7	16.3	16.4	11.5	17.4	14.5	20.2	15.7	31.2	23.1	14.6	21.5	18.5	23.6	14.0	3.9	7.9	3.4	5.0	5.0	1.4	15.6	9.3	16.3	15.5	14.7	14.4	11.2	12.5	13.6	11.5	14.4	9.7	10.8	28.4	7.3	13.1	19.1	13.3	11.0	17.0	13.9	9.8	12.6	11.4	8.8	14.1	19.2	13.8	8.5	14.8	13.1	17.6	13.5	21.3	19.7	11.9	8.0	15.2	13.6	23.5	10.9	16.9	10.8	11.4	10.8	15.8	11.6	16.8	15.9	34.4	11.3	14.1	23.9	16.0	15.9	15.2	10.2	17.0	16.2	13.7	23.4	11.6	17.4	20.2	7.9	2.7	4.4	5.0	2.2	3.4	7.6	4.8	3.7	1.5	14.0	4.9	4.9	7.6	5.0	3.4	3.9	4.3	1.4	16.0	14.5	23.3	18.2	14.3	11.3	16.5	15.1	12.0	15.7
CDYL	"CDYL1, DKFZP586C1622"	ENSG00000153046	"Chromodomain Y like"	Q9Y232	6	4706159-4955551	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Lyase, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 11.2"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035578	Enhanced		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA035578: "	"unprognostic (1.25e-1)"	"unprognostic (8.99e-2)"	"unprognostic (6.03e-2)"	"unprognostic (2.38e-3)"	"prognostic favourable (1.53e-4)"	"unprognostic (1.92e-1)"	"prognostic unfavourable (2.20e-4)"	"unprognostic (2.62e-2)"	"prognostic unfavourable (7.52e-4)"	"unprognostic (2.06e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.09e-1)"	"unprognostic (5.21e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.60e-2)"	"unprognostic (3.94e-1)"	18.4	9.2	13.3	14.2	14.4	19.3	16.5	8.1	15.8	19.8	16.2	13.3	20.6	8.2	22.2	15.5	19.6	14.7	11.7	14.5	11.0	8.6	9.9	6.9	11.8	12.7	12.5	10.7	13.3	8.5	12.7	8.3	35.4	12.8	12.5	15.8	11.0	12.8	15.3	24.7	23.2	12.2	17.7	8.5	12.6	13.3	10.1	12.9	11.3	11.7	12.5	15.2	17.7	24.8	1.8	11.2	5.1	2.1	2.3	2.4	1.9	13.6	12.0	17.2	14.5	13.6	9.3	20.0	13.1	10.6	12.5	13.1	9.6	9.5	2.9	13.7	10.1	12.1	14.0	15.9	15.1	9.5	12.6	11.6	11.7	8.7	17.3	15.1	13.4	7.4	28.5	14.2	21.8	12.1	21.1	8.8	6.2	12.2	8.6	14.1	17.9	13.2	10.8	15.4	23.7	8.3	11.2	14.9	9.0	16.0	13.9	20.7	8.4	14.9	16.1	14.8	13.0	10.7	15.2	20.3	32.6	10.7	5.0	9.9	16.0	5.1	2.1	0.8	2.4	1.1	1.7	1.4	1.7	1.8	2.5	1.8	1.0	1.7	0.6	2.3	1.2	11.2	0.2	1.9	13.3	14.4	8.1	15.8	11.0	8.6	12.5	10.7	12.8	12.9
CHD5		ENSG00000116254	"Chromodomain helicase DNA binding protein 5"	Q8TDI0	1	6101793-6180123	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Differentiation, Neurogenesis, Spermatogenesis, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 41.4;pituitary gland: 22.3;testis: 16.4"	"Group enriched"	"Detected in some"	4	"SCLC-21H: 16.6;U-2 OS: 7.4"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA015809			Supported	"Nucleoplasm,Nuclear speckles,Cytosol"				"Nucleoplasm, Nuclear speckles"	Cytosol	"HPA015809: "	"unprognostic (5.03e-4)"	"unprognostic (1.89e-1)"	"unprognostic (2.47e-3)"	"unprognostic (9.40e-6)"	"unprognostic (1.91e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.95e-2)"	"unprognostic (6.64e-4)"	"unprognostic (1.34e-1)"	"unprognostic (1.34e-4)"	"unprognostic (1.16e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.98e-1)"	1.1	7.9	19.8	1.3	17.1	1.0	1.0	12.1	41.4	1.2	1.4	0.7	0.0	1.3	1.2	1.2	1.5	1.2	1.2	1.6	15.3	10.1	1.3	1.0	1.2	1.0	4.3	19.1	1.1	1.4	1.3	22.3	1.0	8.0	1.9	1.3	2.3	1.2	4.8	1.2	1.0	1.4	1.2	1.6	1.1	1.2	16.4	0.8	0.0	1.0	0.0	1.0	1.1	0.4	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.7	0.0	0.1	0.1	0.0	0.0	0.1	0.2	2.5	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.3	1.5	0.0	0.3	1.3	0.0	0.0	0.0	0.0	16.6	0.2	0.1	0.0	0.0	2.8	0.1	0.0	0.1	7.4	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	19.8	17.1	12.1	34.2	15.3	10.1	4.3	19.1	8.0	0.8
CIR1	CIR	ENSG00000138433	"Corepressor interacting with RBPJ, 1"	Q86X95	2	174348022-174395715	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 56.9"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 56.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015784, HPA061442"	Approved		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA015784: AB_1846782, HPA061442: "	"unprognostic (3.17e-3)"	"unprognostic (4.07e-2)"	"unprognostic (1.65e-1)"	"prognostic unfavourable (9.56e-4)"	"unprognostic (2.40e-1)"	"unprognostic (1.56e-1)"	"prognostic unfavourable (2.52e-4)"	"unprognostic (1.00e-2)"	"unprognostic (4.39e-2)"	"prognostic favourable (9.80e-4)"	"unprognostic (1.27e-1)"	"unprognostic (3.66e-2)"	"prognostic unfavourable (1.04e-7)"	"unprognostic (2.23e-1)"	"unprognostic (1.48e-1)"	"unprognostic (8.10e-3)"	"prognostic favourable (2.04e-5)"	24.1	20.8	27.0	21.9	38.1	48.4	31.0	41.0	34.8	33.6	22.8	19.8	27.2	21.4	23.9	38.6	23.8	24.7	19.8	23.1	25.1	24.7	28.4	22.3	22.2	23.4	26.2	28.3	30.0	24.4	22.5	54.0	36.9	32.3	31.6	22.8	14.0	21.2	23.5	30.8	27.5	34.3	20.3	27.6	32.4	21.0	26.9	30.7	35.8	35.8	21.4	23.7	37.8	22.2	12.0	11.9	56.9	10.1	13.3	10.9	7.6	10.3	5.9	14.1	11.2	19.7	27.7	20.9	17.2	24.4	17.2	21.3	11.0	16.1	7.2	16.2	16.8	12.6	11.6	12.2	20.8	13.3	15.3	15.0	9.4	17.8	19.2	17.8	13.9	22.7	22.3	18.9	14.2	17.0	15.4	16.2	16.3	9.9	22.1	28.2	12.9	16.7	12.6	20.3	21.3	20.3	16.6	16.4	19.3	11.8	15.2	26.0	11.4	26.5	17.4	14.1	10.2	13.2	8.8	18.5	15.7	2.7	20.1	9.3	12.2	17.8	10.1	15.8	9.1	9.2	9.0	12.0	10.3	9.6	6.4	11.8	10.9	10.0	56.9	13.3	9.4	11.9	10.5	7.6	27.0	38.1	41.0	34.8	25.1	24.7	26.2	28.3	32.3	30.7
COPS4	CSN4	ENSG00000138663	"COP9 signalosome subunit 4"	Q9BT78	4	83034447-83075818	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA036894, HPA042828"	Uncertain		Supported	"Nuclear speckles"			84000	"Nuclear speckles"		"HPA036894: AB_10670929, HPA042828: "	"unprognostic (1.82e-3)"	"unprognostic (1.01e-2)"	"prognostic favourable (4.14e-4)"	"unprognostic (7.97e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.57e-1)"	"unprognostic (8.96e-2)"	"unprognostic (3.26e-1)"	"unprognostic (3.10e-2)"	"unprognostic (9.21e-2)"	"prognostic favourable (5.21e-6)"	"unprognostic (5.84e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.80e-1)"	16.3	24.1	22.5	12.5	35.8	21.1	19.4	20.8	33.0	20.5	15.6	13.4	11.5	13.8	19.2	18.0	20.6	16.1	13.5	34.9	22.0	28.9	23.3	18.3	13.1	16.0	24.2	25.4	20.2	14.5	22.3	32.0	21.7	35.7	18.8	15.4	11.6	14.1	19.4	55.1	16.3	12.9	20.1	15.6	17.0	14.3	27.6	14.6	24.8	23.2	23.9	18.6	20.8	14.9	20.3	22.4	34.2	27.7	25.4	28.5	24.1	16.9	10.1	22.1	20.1	19.8	25.5	12.0	22.5	29.3	25.8	23.0	14.5	17.7	29.0	19.9	47.4	12.9	27.3	23.2	35.0	18.2	19.3	16.8	16.6	13.9	16.4	28.3	47.8	19.2	16.2	19.3	16.5	34.2	21.0	16.4	31.2	14.1	33.7	20.9	12.1	13.8	24.2	16.7	15.9	20.7	15.7	23.3	13.6	15.0	23.8	14.3	17.9	15.6	22.3	18.1	19.3	13.6	16.0	17.2	10.4	31.9	17.4	18.4	17.8	34.2	18.4	26.0	22.9	24.9	28.5	20.3	25.4	26.2	22.4	18.6	24.3	26.0	4.2	25.4	27.7	14.6	23.1	24.1	22.5	35.8	20.8	33.0	22.0	28.9	24.2	25.4	35.7	14.6
CRY2		ENSG00000121671	"Cryptochrome circadian regulator 2"	Q49AN0	11	45847118-45883248	"Predicted intracellular proteins"	"Biological rhythms, Sensory transduction, Transcription, Transcription regulation"	"Photoreceptor protein, Receptor, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037577	Supported		Supported	"Nuclear speckles,Cytosol"	"Intracellular and membrane"			"Nuclear speckles"	Cytosol	"HPA037577: AB_10672497"	"unprognostic (1.67e-1)"	"unprognostic (9.35e-2)"	"prognostic unfavourable (1.67e-4)"	"unprognostic (1.31e-2)"	"unprognostic (9.16e-2)"	"unprognostic (3.09e-2)"	"prognostic favourable (6.82e-5)"	"unprognostic (1.48e-3)"	"unprognostic (1.67e-1)"	"unprognostic (5.07e-2)"	"prognostic favourable (4.39e-4)"	"unprognostic (1.01e-1)"	"prognostic favourable (6.44e-15)"	"unprognostic (8.13e-3)"	"unprognostic (1.89e-1)"	"unprognostic (4.24e-2)"	"unprognostic (2.24e-1)"	17.4	13.3	18.2	8.8	27.4	17.2	16.7	29.8	36.5	17.7	12.1	15.4	10.5	7.6	16.2	12.4	11.2	20.8	18.7	39.5	15.6	13.1	15.7	27.8	15.7	6.7	12.7	15.0	26.3	23.4	20.6	16.4	9.3	11.5	15.0	7.3	35.5	14.4	17.1	58.2	24.3	8.5	18.7	10.4	9.2	12.2	17.4	9.6	5.9	23.6	22.4	10.3	17.4	10.6	7.8	5.2	7.6	10.6	10.4	10.4	7.1	1.2	3.6	5.6	6.6	15.3	7.7	12.3	4.3	7.8	5.5	4.1	5.9	2.9	8.4	3.4	9.1	7.4	5.3	4.5	3.8	8.9	4.8	5.5	6.3	8.0	5.8	6.7	7.6	9.0	6.7	4.3	6.8	3.8	10.7	14.4	5.0	4.5	5.7	8.0	15.2	4.4	9.8	8.1	3.9	4.0	6.8	9.0	3.4	7.3	6.6	3.7	8.8	4.8	4.8	7.9	4.8	12.0	3.0	13.4	9.2	6.9	4.8	3.0	4.7	5.7	5.0	7.6	8.7	7.1	7.2	7.8	8.4	9.3	5.2	7.7	10.3	10.4	2.6	10.4	10.6	3.8	6.9	7.1	18.2	27.4	29.8	36.5	15.6	13.1	12.7	15.0	11.5	9.6
CWC22	"EIF4GL, fSAPb, KIAA1604, NCM"	ENSG00000163510	"CWC22 spliceosome associated protein homolog"	Q9HCG8	2	179944876-180007113	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA036748	Approved		Supported	"Nuclear speckles,Cytosol"				"Nuclear speckles"	Cytosol	"HPA036748: AB_10669913"	"unprognostic (1.90e-1)"	"unprognostic (7.10e-2)"	"unprognostic (7.30e-2)"	"unprognostic (6.14e-2)"	"unprognostic (4.96e-2)"	"unprognostic (4.33e-2)"	"prognostic unfavourable (7.42e-4)"	"unprognostic (3.15e-1)"	"unprognostic (1.31e-2)"	"unprognostic (3.30e-2)"	"unprognostic (3.84e-2)"	"unprognostic (4.80e-2)"	"prognostic unfavourable (7.76e-5)"	"unprognostic (1.74e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.44e-3)"	20.4	14.2	15.8	17.3	16.8	18.1	19.2	33.5	24.6	21.1	17.0	10.5	13.5	12.4	21.5	14.3	18.4	17.6	15.5	14.8	17.5	11.9	17.2	20.7	14.7	21.3	14.4	19.6	25.4	14.7	21.8	25.0	17.8	17.0	20.4	15.2	9.1	15.4	14.7	20.2	15.9	17.4	23.6	19.0	20.5	15.4	10.9	16.3	26.5	20.7	17.6	21.7	21.8	23.8	12.4	9.9	26.4	11.9	10.9	16.4	8.2	9.4	5.9	16.5	11.0	11.9	14.3	12.6	12.6	14.8	15.5	15.1	13.3	12.0	18.7	11.3	9.1	10.4	15.6	11.7	23.5	16.4	13.8	25.0	7.7	18.0	11.8	34.7	13.9	9.3	14.2	19.5	26.4	11.5	27.1	11.5	10.1	9.5	18.1	18.1	25.3	9.5	16.7	20.4	14.0	10.7	12.0	11.3	15.3	10.3	8.3	14.3	6.2	22.0	9.8	13.2	11.3	8.7	13.0	10.1	10.6	22.8	11.9	14.1	13.3	26.4	9.5	21.5	12.3	11.9	12.4	12.4	13.3	14.5	9.9	11.3	16.4	12.8	15.9	10.9	8.9	6.3	11.3	8.2	15.8	16.8	33.5	24.6	17.5	11.9	14.4	19.6	17.0	16.3
CYGB	"HGB, STAP"	ENSG00000161544	Cytoglobin	Q8WWM9	17	76527356-76551175	"Predicted intracellular proteins, Transporters"	"Oxygen transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"ASC diff: 24.4;Hep G2: 18.6;HHSteC: 37.2;HSkMC: 30.3;SH-SY5Y: 40.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 4.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017757, HPA061642"	Approved	Approved	Supported	"Nuclear speckles,Cytosol"				"Nuclear speckles"	Cytosol	"HPA017757: AB_1847410, HPA061642: "	"unprognostic (6.96e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.97e-2)"	"prognostic favourable (2.55e-5)"	"prognostic unfavourable (1.85e-4)"	"unprognostic (3.36e-2)"	"unprognostic (3.31e-3)"	"unprognostic (2.01e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.08e-2)"	"unprognostic (4.14e-2)"	"prognostic unfavourable (2.13e-4)"	"unprognostic (3.34e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.49e-2)"	"unprognostic (7.76e-2)"	48.1	16.1	6.2	9.5	8.3	1.1	34.4	10.9	11.6	13.3	19.0	1.5	8.4	15.2	8.8	8.4	12.5	8.8	24.1	43.4	4.2	11.2	6.9	13.6	17.8	9.5	6.3	5.5	11.2	7.6	8.5	5.0	10.0	17.7	22.8	7.0	23.7	10.4	9.4	17.1	8.2	17.8	17.6	3.5	8.0	13.1	9.3	2.2	1.1	22.0	11.4	3.4	35.1	41.5	4.4	0.4	2.4	0.3	2.5	1.3	0.5	0.0	0.3	0.6	0.1	24.4	7.2	8.2	0.2	0.6	0.1	0.2	0.0	0.1	0.0	7.9	0.7	0.2	0.0	10.5	0.0	0.0	0.0	0.1	0.1	18.6	37.2	0.0	0.0	30.3	2.3	0.8	0.8	0.1	0.0	0.0	0.3	0.2	0.0	0.1	0.1	0.4	0.1	0.1	0.0	0.1	0.0	0.2	40.6	0.0	0.0	0.8	0.0	0.2	0.0	1.0	0.5	0.1	0.0	0.4	0.0	0.1	0.0	0.1	3.1	0.0	0.3	0.4	0.5	0.2	0.3	3.4	0.4	0.2	0.4	4.4	0.7	1.3	2.4	2.5	0.2	0.0	0.5	0.5	6.2	8.3	10.9	11.6	4.2	11.2	6.3	5.5	17.7	2.2
DAZAP2	KIAA0058	ENSG00000183283	"DAZ associated protein 2"	Q15038	12	51238292-51271362	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045940			Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA045940: "	"unprognostic (1.00e-2)"	"unprognostic (3.13e-2)"	"unprognostic (7.35e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.00e-1)"	"unprognostic (5.47e-2)"	"unprognostic (4.75e-3)"	"unprognostic (8.43e-2)"	"unprognostic (4.75e-2)"	"unprognostic (3.30e-1)"	"unprognostic (5.80e-2)"	"unprognostic (1.42e-1)"	"prognostic favourable (3.94e-9)"	"unprognostic (1.79e-1)"	"unprognostic (2.40e-1)"	"unprognostic (3.04e-1)"	"unprognostic (5.84e-3)"	53.5	54.3	45.1	46.0	52.2	152.2	47.8	35.9	67.9	43.5	53.9	88.3	30.4	52.3	56.8	37.5	48.6	59.8	51.1	57.2	43.5	39.2	72.8	64.1	53.3	63.6	68.6	46.0	40.5	38.5	46.0	20.5	30.3	57.0	38.7	60.2	51.3	50.8	53.3	50.7	42.6	63.7	48.0	72.0	63.8	47.7	23.8	57.8	63.6	62.4	30.2	64.1	63.4	37.1	55.4	71.7	186.5	108.9	50.4	70.2	204.7	29.5	43.0	17.7	16.4	38.8	33.7	9.7	19.7	43.9	40.1	32.2	28.3	41.7	25.9	55.2	44.0	25.7	28.6	37.1	34.4	35.2	35.2	44.5	25.5	13.3	45.1	43.7	61.3	46.9	43.4	39.4	31.9	50.9	24.5	59.1	27.4	45.7	44.5	18.3	3.1	13.3	23.4	25.7	28.4	37.0	41.1	20.2	18.4	33.1	22.5	20.9	33.6	58.2	37.9	19.4	19.5	24.1	25.5	45.1	47.7	32.4	31.0	29.3	13.1	84.8	108.9	170.2	60.0	88.0	54.2	55.4	53.3	56.3	71.7	51.9	60.8	51.1	186.5	50.4	80.9	46.6	70.2	204.7	45.1	52.2	35.9	67.9	43.5	39.2	68.6	46.0	57.0	57.8
DDX17	P72	ENSG00000100201	"DEAD-box helicase 17"	Q92841	22	38483440-38507660	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Immunity, mRNA processing, mRNA splicing, RNA-mediated gene silencing, rRNA processing, Transcription, Transcription regulation"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB024908, HPA063142"	Supported		Supported	"Nuclear speckles"	"Intracellular and membrane"		90000	"Nuclear speckles"		"CAB024908: , HPA063142: "	"unprognostic (1.46e-2)"	"unprognostic (5.99e-3)"	"unprognostic (4.24e-3)"	"unprognostic (6.67e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.36e-2)"	"prognostic favourable (6.06e-4)"	"unprognostic (1.17e-1)"	"unprognostic (5.51e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.76e-1)"	"unprognostic (4.31e-2)"	"unprognostic (3.19e-3)"	49.7	43.1	46.3	49.2	54.5	19.8	50.8	69.7	52.0	47.7	53.3	56.5	54.4	33.1	58.5	82.9	37.5	52.2	46.1	39.9	47.0	31.2	34.3	41.9	41.5	52.6	64.0	37.7	67.8	41.5	68.5	83.7	49.4	46.0	46.2	36.8	51.4	43.9	51.8	89.2	60.3	38.7	52.7	47.1	54.1	39.7	24.6	63.1	69.3	59.8	29.2	47.7	54.5	52.9	10.3	12.4	23.7	9.5	4.0	9.9	6.1	29.6	28.8	58.8	35.3	39.0	44.9	30.7	25.3	25.3	37.0	36.0	27.5	24.8	57.6	17.5	33.1	32.8	64.3	35.9	41.4	56.7	36.7	35.8	48.2	32.9	41.8	45.7	42.6	31.3	47.1	24.1	41.7	42.2	36.9	65.2	29.3	19.3	32.1	38.9	37.8	14.0	58.3	32.8	35.3	35.1	39.7	34.0	20.0	39.7	31.4	41.9	27.1	35.3	34.2	31.6	19.7	20.1	19.0	50.4	34.8	49.6	40.8	29.6	38.8	8.5	9.5	11.0	9.9	7.3	9.4	9.0	8.0	7.1	6.8	10.3	5.8	7.5	23.7	4.0	6.8	12.4	7.9	6.1	46.3	54.5	69.7	52.0	47.0	31.2	64.0	37.7	46.0	63.1
DGKZ	"DAGK5, DAGK6, DGK-ZETA, hDGKzeta"	ENSG00000149091	"Diacylglycerol kinase zeta"	Q13574	11	46332905-46380554	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 50.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051336	Enhanced		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA051336: "	"unprognostic (2.85e-2)"	"unprognostic (3.90e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.12e-2)"	"unprognostic (3.08e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.49e-2)"	"unprognostic (3.66e-3)"	"unprognostic (8.18e-2)"	"prognostic unfavourable (4.74e-5)"	"unprognostic (1.48e-3)"	"unprognostic (7.75e-2)"	"unprognostic (3.61e-2)"	"unprognostic (7.84e-3)"	8.6	6.7	34.5	11.8	27.4	28.0	6.8	22.6	50.7	7.5	7.4	8.5	2.5	21.0	6.1	4.3	7.1	6.3	6.7	16.0	48.0	9.2	5.3	3.3	8.3	20.7	9.4	26.7	5.0	17.3	7.0	18.6	8.4	7.5	5.9	4.2	4.8	24.1	7.0	42.8	8.3	23.2	5.6	7.2	15.6	9.9	5.0	7.5	14.2	4.1	9.1	9.9	7.6	5.0	0.9	12.3	11.2	11.8	7.7	7.5	8.1	11.7	10.5	7.1	10.7	3.8	4.2	33.2	9.2	6.9	9.8	8.6	12.5	5.5	15.1	6.7	9.5	13.7	8.6	13.3	3.5	15.1	20.0	9.9	7.7	9.1	6.8	18.6	19.9	5.7	6.3	5.3	7.3	10.7	13.8	9.4	6.9	31.0	17.9	29.2	20.8	16.2	21.4	12.4	6.4	3.0	11.6	49.0	8.3	10.5	35.3	7.2	25.4	23.5	12.0	12.9	14.0	20.3	16.5	6.2	7.0	12.4	17.6	16.9	11.9	11.2	11.8	5.8	7.5	6.1	4.5	0.4	4.7	6.3	12.3	0.9	4.9	5.0	9.8	7.7	5.9	5.9	4.5	8.1	34.5	27.4	22.6	50.7	48.0	9.2	9.4	26.7	7.5	7.5
E2F3		ENSG00000112242	"E2F transcription factor 3"	O00716	6	20401906-20493715	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029779, HPA065012"			Supported	"Nucleoplasm,Nuclear speckles,Cytosol"				"Nucleoplasm, Nuclear speckles"	Cytosol	"HPA029779: , HPA065012: "	"unprognostic (4.10e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.80e-3)"	"unprognostic (2.96e-1)"	"unprognostic (9.14e-2)"	"unprognostic (8.99e-3)"	"unprognostic (9.13e-2)"	"unprognostic (1.10e-1)"	"prognostic favourable (1.69e-4)"	"unprognostic (1.14e-2)"	"unprognostic (5.64e-2)"	"prognostic unfavourable (1.63e-8)"	"unprognostic (1.23e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.50e-1)"	"unprognostic (5.99e-3)"	9.5	8.4	7.6	12.2	13.4	22.1	10.8	1.7	10.1	4.8	7.1	2.9	3.2	6.8	6.3	6.9	8.0	4.9	9.9	11.1	8.3	6.8	14.6	6.1	7.8	19.7	5.8	7.3	4.0	3.6	2.9	3.2	7.4	7.9	5.0	8.6	5.1	4.7	4.5	15.1	4.3	8.0	7.9	5.0	16.9	5.0	8.9	3.1	17.7	11.4	10.2	12.0	9.2	4.8	0.7	3.7	10.3	3.1	4.8	3.6	1.5	6.7	5.5	15.9	17.0	5.3	5.9	11.0	9.1	7.9	8.8	9.7	6.8	4.2	15.1	17.7	8.5	7.1	18.1	8.2	14.8	5.9	12.8	27.5	9.1	7.5	5.7	18.0	16.5	4.7	6.1	8.6	10.5	6.0	30.4	9.4	9.9	6.9	20.4	20.1	11.9	5.7	22.2	14.0	17.4	10.5	11.8	11.5	21.0	8.5	11.7	12.0	6.0	10.9	8.0	14.2	8.9	7.0	14.5	5.9	18.7	19.0	3.5	11.2	20.1	6.9	3.1	1.4	2.3	2.3	3.1	0.7	1.5	3.6	3.7	0.7	1.3	2.8	10.3	4.8	1.5	1.6	2.2	1.5	7.6	13.4	1.7	10.1	8.3	6.8	5.8	7.3	7.9	3.1
E2F7		ENSG00000165891	"E2F transcription factor 7"	Q96AV8	12	77021247-77065580	"Predicted intracellular proteins, Transcription factors"	"Cell cycle, DNA damage, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 42.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	4	"plasmacytoid DC: 5.0"	"Lineage enriched"	"Detected in many"	4	"dendritic cells: 5.0"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"midbrain: 7.6;pons and medulla: 7.4;thalamus: 12.1"	HPA064866			Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA064866: "	"unprognostic (1.21e-1)"	"unprognostic (8.92e-2)"	"unprognostic (7.39e-2)"	"unprognostic (7.27e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.80e-2)"	"unprognostic (6.14e-5)"	"unprognostic (1.05e-3)"	"unprognostic (1.72e-1)"	"unprognostic (3.57e-2)"	"unprognostic (5.67e-5)"	"unprognostic (1.42e-1)"	"unprognostic (0.00e+0)"	"unprognostic (3.05e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.51e-1)"	1.3	0.4	0.6	4.7	0.7	8.4	0.4	0.5	0.8	1.1	1.7	1.2	0.5	1.3	1.2	1.4	5.0	1.2	1.3	0.8	0.7	0.6	0.5	0.5	1.4	2.7	0.5	0.0	0.7	0.7	0.5	1.8	2.1	0.6	0.7	3.0	0.4	0.9	1.0	0.3	2.1	2.3	0.9	0.6	2.4	1.2	6.1	0.2	42.0	0.4	2.3	6.3	1.4	1.7	0.6	5.0	1.2	0.0	0.2	1.0	0.0	9.5	4.5	12.8	5.0	0.4	1.3	15.5	13.4	14.6	7.1	8.6	6.2	3.2	5.3	2.7	2.6	7.4	7.6	14.5	13.7	2.1	5.1	4.7	13.2	3.5	3.0	4.0	4.4	0.4	3.8	18.6	11.5	6.9	4.8	4.4	14.5	4.8	15.0	0.0	9.0	10.8	10.9	11.1	3.0	1.7	8.1	8.1	5.3	11.1	3.9	3.2	6.2	4.2	19.1	26.9	13.6	11.4	17.6	4.7	2.6	3.4	9.7	1.8	16.7	0.0	0.0	1.2	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.6	0.0	0.0	0.2	0.2	0.0	5.0	1.0	0.0	0.6	0.7	0.5	0.8	0.7	0.6	0.5	0.0	0.6	0.2
EHMT2	"BAT8, C6orf30, Em:AF134726.3, G9A, KMT1C, NG36/G9a"	ENSG00000204371	"Euchromatic histone lysine methyltransferase 2"	Q96KQ7	6	31879759-31897687	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Chromatin regulator, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HL-60: 10.2;NTERA-2: 15.5;U-266/84: 12.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050550, HPA060259"	Supported		Supported	"Nucleoplasm,Nuclear speckles"	"Intracellular and membrane"			"Nuclear speckles"	Nucleoplasm	"HPA050550: , HPA060259: "	"unprognostic (3.11e-2)"	"unprognostic (2.72e-1)"	"unprognostic (4.39e-2)"	"unprognostic (1.92e-2)"	"unprognostic (5.44e-2)"	"unprognostic (3.51e-2)"	"prognostic unfavourable (1.79e-4)"	"unprognostic (3.55e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.89e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.78e-3)"	"unprognostic (8.72e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.25e-1)"	"unprognostic (9.03e-2)"	9.4	12.2	13.1	9.6	21.4	7.6	6.3	17.1	17.5	8.0	7.7	12.3	8.4	14.6	15.0	11.7	18.0	7.6	8.1	7.6	12.3	12.4	5.3	4.4	8.5	6.9	12.6	10.6	10.6	13.2	2.2	8.1	6.0	10.3	10.4	4.3	7.2	5.6	9.6	5.2	5.5	10.1	9.6	8.4	9.1	9.8	7.6	14.9	14.6	9.5	4.8	7.2	8.7	7.6	0.3	0.6	0.0	0.7	0.1	1.1	1.3	0.0	3.5	6.3	0.0	2.8	1.5	4.0	2.7	2.2	3.1	2.6	0.0	0.0	0.0	6.2	4.5	0.0	0.0	6.8	1.5	4.1	9.4	0.0	0.0	0.0	0.0	10.2	0.0	3.8	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	15.5	0.0	6.8	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.8	5.2	0.0	0.0	3.0	3.3	2.6	5.6	0.0	9.0	12.2	2.9	3.8	0.0	0.0	0.0	0.3	0.0	0.4	0.1	0.2	0.1	0.8	0.6	0.3	0.3	1.1	1.1	0.0	0.1	0.7	0.6	0.2	1.3	13.1	21.4	17.1	16.5	12.3	12.4	12.6	10.6	10.3	14.9
ELOA	"SIII, TCEB3, TCEB3A"	ENSG00000011007	"Elongin A"	Q14241	1	23743155-23762059	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005910	Approved		Approved	"Nuclear speckles,Cytosol"				"Nuclear speckles"	Cytosol	"HPA005910: AB_1080227"	"unprognostic (6.90e-2)"	"unprognostic (5.99e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.93e-2)"	"prognostic unfavourable (1.44e-5)"	"unprognostic (1.72e-1)"	"unprognostic (8.84e-3)"	"unprognostic (6.00e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.14e-2)"	"unprognostic (2.95e-3)"	"unprognostic (2.90e-1)"	"unprognostic (4.27e-2)"	"unprognostic (4.80e-2)"	"unprognostic (4.14e-2)"	25.6	13.7	10.0	14.2	16.1	22.9	16.3	16.0	17.2	13.7	12.2	15.2	15.1	9.8	15.0	9.0	23.6	13.3	15.7	12.9	9.9	9.8	18.1	41.7	20.3	24.1	10.3	12.5	16.0	41.5	19.1	17.1	19.6	12.7	13.6	13.5	13.0	18.6	13.4	26.0	18.3	14.1	14.0	10.9	20.5	24.6	14.4	10.0	19.3	18.4	22.4	21.8	15.6	14.5	20.7	18.8	18.3	20.9	11.0	14.8	13.2	20.0	11.2	16.2	13.9	19.2	12.0	10.3	20.8	18.8	31.0	27.1	13.7	17.6	10.5	25.6	21.0	19.3	33.2	21.9	34.7	30.1	16.4	23.7	17.6	15.9	17.0	24.8	14.4	12.7	17.7	33.8	25.9	18.5	35.1	18.3	24.7	15.2	12.8	10.1	18.8	17.0	19.3	20.6	20.0	14.6	13.7	31.0	17.5	18.9	19.1	23.1	13.8	9.2	19.6	24.4	21.6	43.2	24.4	19.0	21.2	23.2	21.4	24.8	24.3	18.3	19.8	15.4	14.8	20.9	14.6	20.7	12.4	13.3	18.8	16.6	10.2	13.4	5.5	11.0	18.4	15.5	14.0	13.2	10.0	16.1	16.0	17.2	9.9	9.8	10.3	12.5	12.7	10.0
ERBIN	"ERBB2IP, LAP2"	ENSG00000112851	"Erbb2 interacting protein"	Q96RT1	5	65926475-66082549	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048606, HPA059863"	Approved		Supported	"Nuclear speckles,Plasma membrane"			250000	"Nuclear speckles, Plasma membrane"		"HPA048606: , HPA059863: "	"unprognostic (4.34e-1)"	"unprognostic (5.56e-2)"	"unprognostic (9.88e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.04e-1)"	"unprognostic (4.23e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.46e-2)"	"unprognostic (6.52e-2)"	"unprognostic (5.45e-3)"	"unprognostic (7.98e-2)"	"unprognostic (5.62e-3)"	"unprognostic (7.21e-3)"	"unprognostic (3.08e-1)"	"unprognostic (6.86e-2)"	"unprognostic (7.81e-2)"	20.1	8.7	33.2	28.5	32.7	13.3	13.0	5.4	15.9	16.1	21.1	10.6	16.3	12.1	14.5	22.1	17.2	10.5	17.2	12.6	29.5	22.5	15.8	24.1	20.1	21.1	32.5	7.4	11.1	13.7	15.4	6.9	10.4	16.0	18.2	13.8	11.1	17.3	26.0	16.4	16.9	37.4	15.3	31.0	27.6	20.3	13.3	17.6	40.2	19.6	16.3	19.6	20.7	14.9	6.2	4.5	13.5	7.6	5.0	7.1	3.6	30.2	10.2	13.3	15.9	10.0	12.1	10.1	19.5	20.0	27.8	31.1	9.6	36.2	25.5	19.0	30.1	10.1	8.5	14.2	49.3	11.2	3.8	8.8	12.9	7.6	13.2	6.8	8.6	13.1	9.5	15.2	22.3	10.3	8.9	17.6	18.7	10.3	17.9	7.8	3.3	2.9	16.5	10.7	14.1	16.3	20.7	6.5	6.0	20.7	7.0	14.7	12.1	16.7	9.4	15.8	28.1	9.5	25.0	15.2	9.4	21.9	10.4	11.3	9.0	13.5	5.2	6.7	7.1	7.6	6.5	6.2	5.5	6.3	4.5	4.9	6.5	6.7	11.9	5.0	6.0	2.9	4.8	3.6	33.2	32.7	5.4	15.3	29.5	22.5	32.5	7.4	16.0	17.6
ESX1	"ESX1L, ESXR1"	ENSG00000123576	"ESX homeobox 1"	Q8N693	X	104250038-104254933	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	99	"testis: 25.4"	"Cell line enriched"	"Detected in some"	11	"TIME: 23.2"	"Cancer enriched"	"Detected in single"	5	"testis cancer: 0.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA051992	Enhanced		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA051992: "															"unprognostic (1.87e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	23.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
EXOSC7	"EAP1, hRrp42p, KIAA0116, p8, RRP42, Rrp42p"	ENSG00000075914	"Exosome component 7"	Q15024	3	44975241-45036066	"Predicted intracellular proteins"	"rRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036182, HPA057980"	Approved		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA036182: AB_10673346, HPA057980: "	"unprognostic (1.69e-2)"	"unprognostic (3.92e-3)"	"unprognostic (1.84e-3)"	"unprognostic (4.97e-2)"	"unprognostic (3.00e-3)"	"unprognostic (2.16e-1)"	"unprognostic (2.34e-3)"	"unprognostic (2.21e-2)"	"unprognostic (2.96e-1)"	"unprognostic (7.85e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.67e-3)"	"prognostic favourable (2.69e-4)"	"unprognostic (4.33e-1)"	"unprognostic (7.30e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.20e-1)"	13.2	37.1	11.2	14.2	18.8	13.0	17.2	16.5	17.6	17.7	11.9	15.8	14.2	10.5	17.7	17.8	21.1	14.8	12.5	23.4	17.4	12.9	17.0	18.8	12.1	15.6	13.3	15.5	16.1	18.6	11.3	17.6	13.9	15.8	14.7	10.0	16.2	14.4	17.8	30.3	33.2	10.8	15.7	9.3	12.9	15.6	26.0	11.9	14.8	18.2	19.6	18.3	16.5	17.1	27.4	27.6	3.0	17.7	22.7	23.6	17.8	18.5	17.3	14.1	11.4	14.8	16.4	12.8	8.0	13.1	17.8	18.5	28.7	14.9	23.6	12.8	14.0	10.5	17.4	22.4	14.5	15.8	15.4	20.4	19.7	27.7	29.0	28.5	8.4	14.3	14.3	19.4	39.7	17.1	31.9	11.7	12.5	19.2	20.3	50.9	16.9	24.6	10.3	13.1	35.7	15.9	26.4	6.5	9.9	11.5	9.9	11.9	14.6	23.7	12.1	9.1	13.7	15.0	21.9	14.9	13.8	28.0	13.5	40.2	8.0	2.0	17.7	3.0	17.2	17.1	19.1	27.4	20.0	17.8	27.6	20.9	23.6	18.9	0.9	22.7	12.0	16.7	18.9	17.8	11.2	18.8	16.5	17.6	17.4	12.9	13.3	15.5	15.8	11.9
FAM107A	"DRR1, TU3A"	ENSG00000168309	"Family with sequence similarity 107 member A"	O95990	3	58564117-58627610	"Predicted intracellular proteins"	"Cell cycle, Growth regulation, Stress response"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 149.7"	"Group enriched"	"Detected in some"	7	"ASC diff: 11.4;HUVEC TERT2: 34.8"	"Cancer enriched"	"Detected in many"	6	"glioma: 110.0"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055888	Enhanced		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA055888: "	"unprognostic (1.20e-2)"	"unprognostic (1.19e-3)"	"unprognostic (1.47e-2)"	"prognostic unfavourable (3.56e-4)"	"unprognostic (3.11e-1)"	"unprognostic (7.80e-3)"	"prognostic favourable (3.38e-4)"	"unprognostic (1.92e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.73e-2)"	"unprognostic (7.82e-3)"	"unprognostic (2.22e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.92e-1)"	"unprognostic (7.95e-3)"	22.4	4.6	119.4	4.7	86.5	1.3	8.4	32.4	149.7	17.0	7.6	68.6	1.7	3.6	9.4	25.1	13.9	39.6	8.4	15.8	91.5	52.0	12.4	3.5	18.1	2.4	66.6	44.3	4.3	11.1	4.1	12.0	13.8	33.5	16.3	8.4	10.7	17.5	19.4	7.5	3.5	5.8	19.8	77.5	12.0	5.8	2.5	87.2	1.2	9.9	1.4	4.8	6.5	10.2	0.3	0.3	1.3	0.9	0.7	0.6	0.1	0.0	0.0	0.5	0.0	11.4	0.7	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.2	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	34.8	0.0	0.4	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	1.9	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.2	1.3	0.4	0.5	0.3	0.4	0.6	0.2	0.3	0.2	0.2	0.3	0.2	0.3	0.6	0.7	0.9	0.3	0.3	0.1	119.4	86.5	32.4	80.7	91.5	52.0	66.6	44.3	33.5	87.2
FBXL4	"FBL4, FBL5"	ENSG00000112234	"F-box and leucine rich repeat protein 4"	Q9UKA2	6	98868538-98948006	"Disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029140, CAB033362"	Approved		Supported	"Nuclear speckles"				"Nuclear speckles"		"CAB033362: AB_2103974, HPA029140: AB_10611967"	"unprognostic (1.24e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.03e-1)"	"unprognostic (3.10e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.68e-1)"	"unprognostic (4.53e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.62e-1)"	13.7	18.9	9.2	11.2	13.1	7.9	18.4	10.7	14.2	12.7	10.9	14.2	14.4	9.9	12.9	19.2	11.9	13.2	11.6	13.5	10.1	11.1	22.3	24.9	13.2	16.4	15.2	8.4	14.4	21.7	26.8	17.4	11.3	13.8	13.9	11.8	11.5	14.9	14.8	21.2	11.9	12.2	15.2	20.1	10.5	12.5	6.9	13.2	19.9	20.3	7.5	12.2	12.6	12.6	6.8	3.9	16.5	5.7	4.1	6.7	3.9	4.6	7.4	6.4	8.6	10.8	19.9	6.9	10.5	8.9	6.2	8.8	3.4	8.8	10.6	9.8	8.7	6.7	7.3	7.6	9.4	17.3	6.0	7.5	5.3	7.5	8.4	9.1	7.6	11.3	13.9	5.6	15.7	7.9	10.0	8.4	11.1	4.5	3.4	4.5	3.3	4.6	11.8	4.4	8.5	11.8	6.7	8.1	6.5	5.5	7.5	9.8	5.5	6.7	10.9	7.2	3.2	10.0	7.5	2.9	2.6	4.5	8.9	8.5	8.5	16.5	4.8	12.6	5.1	4.5	6.7	6.8	5.1	5.0	3.9	6.7	6.6	6.0	6.1	4.1	5.7	2.5	6.1	3.9	9.2	13.1	10.7	14.2	10.1	11.1	15.2	8.4	13.8	13.2
FEV	Pet-1	ENSG00000163497	"FEV, ETS transcription factor"	Q99581	2	218981087-218985657	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 6.9;intestine: 7.0;pituitary gland: 5.4;stomach 1: 6.1"	"Group enriched"	"Detected in some"	6	"HMC-1: 18.7;SH-SY5Y: 23.9"	"Group enriched"	"Detected in some"	10	"pancreatic cancer: 3.0;prostate cancer: 9.9;stomach cancer: 2.4"	"Region enhanced"	"Detected in many"		"pons and medulla: 6.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"midbrain: 2.3;pons and medulla: 0.9"	"Group enriched"	"Detected in some"	34	"midbrain: 7.3;pons and medulla: 3.9"	HPA067679		Supported	Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA067679: "			"unprognostic (4.58e-1)"		"unprognostic (1.60e-1)"					"unprognostic (7.21e-2)"	"prognostic favourable (4.85e-4)"	"unprognostic (2.87e-1)"	"unprognostic (3.96e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.15e-1)"			0.1	4.1	0.0	1.2	3.5	0.0	0.0	0.0	2.6	0.0	2.0	0.7	0.0	7.0	0.1	0.0	0.0	0.1	0.0	0.0	1.1	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	4.2	0.0	5.4	0.0	6.9	4.0	3.2	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.1	0.0	6.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	18.7	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	23.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	2.6	1.1	0.2	0.2	0.0	6.9	1.0
FIBP	FGFIBP	ENSG00000172500	"FGF1 intracellular binding protein"	O43427	11	65883741-65888539	"Disease related genes, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011729	Approved		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA011729: AB_1848579"	"unprognostic (1.70e-1)"	"unprognostic (6.06e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.49e-2)"	"prognostic unfavourable (1.74e-4)"	"unprognostic (2.23e-1)"	"unprognostic (2.95e-1)"	"unprognostic (3.10e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.83e-2)"	"unprognostic (4.89e-2)"	17.9	27.8	33.8	20.0	33.4	21.4	18.8	27.2	53.7	21.6	20.6	22.4	16.4	23.2	21.1	23.7	19.9	29.5	17.9	34.5	31.5	31.3	26.1	29.7	17.7	29.8	29.9	27.8	19.7	23.9	28.4	18.4	22.7	36.8	17.2	21.6	20.0	15.7	20.5	30.8	24.2	27.1	23.9	22.2	25.2	20.0	40.7	17.4	35.2	25.0	28.5	31.3	21.0	15.3	33.3	56.7	34.7	46.0	31.6	32.4	33.9	18.1	25.7	14.9	35.9	22.7	28.6	11.2	16.8	33.9	22.6	19.1	10.7	24.9	23.6	30.0	36.7	19.8	14.5	36.1	15.0	27.4	19.5	23.5	26.7	15.6	31.3	29.9	20.6	23.2	20.9	16.4	35.8	28.3	7.9	42.6	29.6	56.0	24.7	25.6	14.6	40.7	30.8	14.4	57.3	26.8	23.4	26.9	24.8	18.3	34.0	33.0	34.5	17.1	25.1	24.8	21.2	40.0	11.8	23.6	25.6	14.3	31.7	21.9	9.2	34.7	41.8	32.1	26.3	44.7	26.4	33.3	24.7	23.7	56.7	28.4	19.8	21.2	7.3	31.6	46.0	29.1	32.4	33.9	33.8	33.4	27.2	53.7	31.5	31.3	29.9	27.8	36.8	17.4
FOXO4	"AFX1, MLLT7"	ENSG00000184481	"Forkhead box O4"	P98177	X	71096197-71103535	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, RAS pathway related proteins, Transcription factors"	"Cell cycle, Differentiation, Myogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 98.6"	"Cell line enriched"	"Detected in many"	5	"BEWO: 60.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039560, HPA040232"	Enhanced		Supported	"Nuclear speckles,Cytosol"				"Nuclear speckles"	Cytosol	"HPA039560: , HPA040232: "	"unprognostic (4.64e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.49e-1)"	"unprognostic (4.79e-2)"	"prognostic favourable (4.61e-4)"	"unprognostic (1.09e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.58e-1)"	"unprognostic (7.18e-2)"	"unprognostic (2.13e-2)"	"unprognostic (8.16e-2)"	"prognostic favourable (3.46e-4)"	"unprognostic (2.45e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.75e-3)"	8.5	13.2	21.7	3.8	21.5	9.9	5.1	9.1	15.6	4.8	8.4	9.1	11.9	6.3	6.8	10.2	7.3	7.7	5.8	9.7	21.4	14.5	5.2	3.6	5.5	3.6	22.8	8.4	13.4	6.8	8.7	3.0	98.6	9.2	7.0	4.7	4.9	8.5	11.3	33.8	5.5	6.6	9.4	17.3	6.0	5.2	13.9	13.1	4.4	5.9	7.5	4.2	7.5	11.0	0.9	0.2	3.4	0.6	1.0	1.8	0.9	1.7	0.5	1.4	1.8	3.3	2.3	60.0	1.4	1.6	0.7	1.7	1.2	2.4	2.3	1.8	1.8	0.8	3.6	1.6	0.8	2.3	5.5	3.4	11.2	1.9	1.9	1.9	2.7	1.9	3.8	0.6	0.4	1.8	6.9	4.6	0.3	0.3	3.0	3.1	6.5	2.1	2.1	3.5	3.6	1.2	1.0	1.0	2.9	2.9	0.4	3.1	0.7	1.2	1.7	0.4	0.9	3.1	0.3	3.0	1.6	0.4	1.6	5.2	0.5	0.2	0.6	3.2	0.9	0.6	0.3	0.8	0.5	0.9	0.2	0.9	0.4	1.8	3.4	1.0	0.3	0.0	1.3	0.9	21.7	21.5	9.1	15.6	21.4	14.5	22.8	8.4	9.2	13.1
FYTTD1	"DKFZp761B1514, UIF"	ENSG00000122068	"Forty-two-three domain containing 1"	Q96QD9	3	197737179-197787596	"Predicted intracellular proteins"	"mRNA transport, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 82.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054474			Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA054474: "	"unprognostic (3.61e-2)"	"unprognostic (6.01e-2)"	"unprognostic (4.88e-2)"	"prognostic unfavourable (3.08e-4)"	"unprognostic (2.33e-2)"	"unprognostic (3.80e-1)"	"unprognostic (3.69e-2)"	"unprognostic (9.57e-3)"	"unprognostic (4.44e-2)"	"unprognostic (1.66e-1)"	"unprognostic (5.04e-3)"	"unprognostic (8.74e-2)"	"unprognostic (8.49e-3)"	"unprognostic (3.40e-2)"	"unprognostic (3.36e-1)"	"unprognostic (3.29e-1)"	"unprognostic (3.15e-1)"	12.0	10.2	12.8	13.6	13.1	14.5	24.5	20.5	13.9	11.3	11.9	6.9	13.3	6.6	13.2	10.2	19.0	13.2	10.3	19.4	11.0	12.5	11.1	12.0	11.8	13.5	11.1	10.9	13.3	17.0	13.8	13.2	13.9	13.4	11.0	9.2	6.0	10.0	13.9	82.6	11.6	10.1	21.8	17.1	11.4	10.3	16.7	10.7	10.5	12.6	15.8	15.3	15.7	21.8	11.2	15.9	23.7	16.6	32.5	22.7	21.5	29.6	6.6	13.0	12.3	15.3	17.0	4.0	14.5	14.9	22.6	18.5	10.2	10.2	19.1	53.5	17.2	10.7	16.4	14.9	24.1	4.2	7.4	28.5	10.0	4.6	15.0	21.2	13.9	12.2	19.3	12.2	17.6	17.7	12.8	41.1	19.9	24.9	23.0	5.1	2.8	12.1	21.4	15.9	13.4	16.4	19.5	24.7	10.7	22.4	17.8	16.5	41.7	11.3	15.6	11.6	11.6	14.6	15.3	25.0	37.9	22.9	12.3	30.7	11.9	23.7	14.2	13.6	18.3	16.6	22.7	11.2	17.6	20.1	15.9	9.9	19.4	18.7	4.6	32.5	15.2	8.9	15.5	21.5	12.8	13.1	20.5	13.9	11.0	12.5	11.1	10.9	13.4	10.7
GADD45A	"DDIT1, GADD45"	ENSG00000116717	"Growth arrest and DNA damage inducible alpha"	P24522	1	67685061-67688338	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, DNA damage, Growth arrest"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 86.7;skeletal muscle: 102.1"	"Cell line enhanced"	"Detected in many"		"HHSteC: 59.4;hTERT-HME1: 91.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 24.9"	"Group enriched"	"Detected in all"	5	"granulocytes: 24.9;T-cells: 9.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			HPA053420			Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA053420: "	"unprognostic (1.36e-2)"	"unprognostic (3.29e-2)"	"unprognostic (9.58e-2)"	"unprognostic (3.76e-3)"	"unprognostic (5.81e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.57e-3)"	"unprognostic (2.80e-3)"	"unprognostic (1.42e-1)"	"unprognostic (6.26e-2)"	"unprognostic (3.43e-2)"	"unprognostic (5.21e-2)"	"prognostic favourable (8.06e-6)"	"unprognostic (6.11e-2)"	"unprognostic (2.89e-1)"	"unprognostic (3.43e-3)"	"unprognostic (1.93e-1)"	29.6	6.8	10.7	8.2	20.9	46.2	20.9	1.7	15.8	11.7	10.8	5.8	18.8	10.1	23.3	13.8	12.2	8.8	16.7	12.9	18.1	9.8	86.7	66.9	17.1	4.9	11.4	4.1	13.8	8.3	4.1	5.1	10.8	21.2	16.5	9.0	9.4	9.5	15.6	102.1	14.8	20.4	16.1	15.5	7.4	14.1	9.2	7.5	9.2	26.2	10.1	10.9	23.9	11.1	1.1	2.2	24.9	3.2	3.1	9.3	4.8	21.9	1.4	3.7	1.1	6.7	7.0	35.4	39.1	18.2	13.0	14.2	7.7	3.7	9.5	12.0	6.3	13.2	0.4	33.4	24.6	6.9	3.8	11.8	3.5	7.7	59.4	3.4	1.1	11.8	16.9	16.5	91.6	9.3	25.3	16.9	15.3	0.7	1.0	4.2	4.8	15.5	2.5	29.1	9.7	6.7	16.6	16.2	2.8	8.2	2.3	23.4	0.4	3.7	9.6	13.6	18.3	14.4	27.3	43.3	8.4	17.2	6.0	1.6	13.3	7.2	3.2	24.9	3.7	1.5	3.0	1.1	2.5	3.0	1.4	0.7	0.7	1.2	4.1	3.1	1.0	2.2	9.3	4.8	10.7	20.9	1.7	15.8	18.1	9.8	11.4	4.1	21.2	7.5
GCAT	KBL	ENSG00000100116	"Glycine C-acetyltransferase"	O75600	22	37807905-37817176	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 81.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA020460	Uncertain		Supported	"Nucleoplasm,Nuclear speckles,Mitochondria"				Nucleoplasm	"Nuclear speckles, Mitochondria"	"HPA020460: AB_1849548"	"unprognostic (1.61e-1)"	"unprognostic (1.80e-2)"	"unprognostic (8.38e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.10e-2)"	"unprognostic (4.17e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.37e-2)"	"unprognostic (3.56e-2)"	"unprognostic (2.76e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.36e-3)"	"unprognostic (8.00e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.73e-3)"	"unprognostic (3.99e-1)"	2.9	6.0	8.9	2.4	8.8	8.1	4.2	8.3	12.3	4.5	4.7	5.2	8.0	3.5	3.0	4.0	6.3	3.9	6.0	21.5	8.6	8.4	8.1	19.1	2.3	2.1	10.1	7.4	4.0	81.6	3.5	3.7	2.2	7.4	12.2	3.5	4.3	12.0	5.0	10.3	3.2	3.2	3.1	6.3	1.1	4.4	5.9	4.3	2.8	10.7	9.3	4.3	3.3	2.2	0.3	2.5	0.8	1.3	2.3	7.1	2.8	8.7	2.3	5.9	33.6	12.2	9.9	4.1	12.6	13.3	9.6	8.2	5.1	1.0	2.7	5.9	5.6	5.1	5.9	8.9	2.2	1.2	10.7	6.1	7.3	20.1	19.9	10.8	8.0	11.6	5.4	6.3	14.0	7.8	15.6	3.2	4.5	7.7	11.3	20.0	2.5	9.4	11.9	1.2	16.1	12.1	6.9	12.2	8.3	9.8	15.9	6.7	12.8	5.3	5.9	9.7	5.3	6.4	4.3	10.7	5.2	5.7	6.7	10.1	10.1	0.2	1.3	0.8	1.5	1.2	0.6	0.3	3.4	1.0	2.4	0.1	7.1	2.9	0.6	2.3	0.8	2.5	3.3	2.8	8.9	8.8	8.3	12.3	8.6	8.4	10.1	7.4	7.4	4.3
GCNT1	"C2GNT, NACGT2, NAGCT2"	ENSG00000187210	"Glucosaminyl (N-acetyl) transferase 1, core 2"	Q02742	9	76419850-76507416	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 32.0;parathyroid gland: 57.8"	"Cell line enhanced"	"Detected in many"		"HHSteC: 25.8;HSkMC: 21.9;U-2197: 18.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 16.8"	"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"cerebellum: 8.2;olfactory region: 30.1"	"Low region specificity"	"Detected in all"			"HPA003522, HPA003523, HPA031151"	Uncertain		Supported	"Nuclear speckles"			72000	"Nuclear speckles"		"HPA003522: , HPA003523: , HPA031151: AB_10602904"	"unprognostic (3.14e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.19e-1)"	"prognostic favourable (8.44e-4)"	"unprognostic (5.53e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.65e-2)"	"unprognostic (3.37e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.06e-1)"	"unprognostic (3.02e-3)"	"unprognostic (4.21e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.80e-1)"	"prognostic unfavourable (4.96e-4)"	5.6	1.1	1.6	7.9	3.9	2.2	8.2	10.9	2.7	5.3	24.5	0.7	3.0	23.2	5.2	1.2	2.1	1.8	4.1	3.1	2.1	1.4	1.4	1.0	4.5	9.2	1.6	2.1	0.9	2.0	57.8	1.9	3.9	1.0	4.9	4.6	0.5	9.1	1.8	0.8	1.5	32.0	2.5	1.2	7.6	18.6	1.4	0.6	2.8	16.9	1.2	6.4	2.4	3.3	9.4	4.7	16.8	6.4	4.7	1.9	1.6	2.4	0.2	0.1	0.0	3.1	14.9	3.6	10.0	4.5	8.1	5.8	2.5	0.6	1.7	1.0	7.4	2.1	5.0	4.1	9.1	1.2	0.8	4.2	0.2	0.4	25.8	3.1	1.4	21.9	1.1	7.9	8.5	7.4	0.0	1.7	8.1	3.7	1.6	5.0	4.7	0.6	2.8	5.0	0.8	9.5	4.4	1.0	0.0	1.2	1.3	0.0	0.0	2.1	3.0	5.1	3.3	18.3	4.4	2.6	0.4	0.0	10.3	5.3	1.2	4.3	2.7	16.8	1.3	6.4	0.4	1.3	1.5	1.3	4.7	9.4	0.2	1.0	0.9	4.7	5.7	2.3	1.9	1.6	1.6	3.9	10.9	2.7	2.1	1.4	1.6	2.1	1.0	0.6
GPATCH2	"CT110, FLJ10252, GPATC2, Pfa1, PPP1R30"	ENSG00000092978	"G-patch domain containing 2"	Q9NW75	1	217426992-217631082	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027181, HPA027322"	Uncertain		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA027181: AB_10602601, HPA027322: AB_1848645"	"unprognostic (3.27e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.27e-2)"	"unprognostic (5.13e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.28e-1)"	"unprognostic (6.24e-3)"	"unprognostic (2.46e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.03e-1)"	"prognostic unfavourable (9.99e-6)"	"unprognostic (3.52e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.53e-2)"	"unprognostic (5.41e-2)"	11.0	10.4	14.6	13.7	19.0	6.7	17.1	12.2	19.9	15.1	12.4	10.6	19.4	11.4	15.9	19.2	13.4	12.2	14.8	11.6	12.9	13.7	12.7	11.4	10.4	11.0	11.0	13.4	13.6	12.5	18.2	27.7	14.6	12.8	17.0	11.2	8.5	12.2	19.5	13.0	12.0	13.8	12.3	11.5	11.7	11.2	16.6	12.2	20.6	16.5	11.7	12.7	12.2	13.3	5.2	9.0	6.6	6.0	4.8	6.0	2.7	6.9	7.9	8.6	6.7	7.6	7.7	7.1	6.5	8.0	9.1	8.6	6.9	9.1	7.4	6.7	5.6	8.2	9.6	7.7	10.7	5.5	5.5	4.9	6.5	4.4	9.4	7.4	5.8	6.8	11.3	10.6	17.5	6.2	11.9	0.1	6.6	6.5	9.9	5.3	15.5	8.7	4.9	19.6	8.9	6.4	15.1	10.1	14.4	11.6	10.7	8.5	10.0	7.3	6.4	8.6	6.0	12.0	6.0	7.8	5.5	7.1	6.5	4.9	6.1	6.6	6.0	1.9	5.1	3.4	3.5	4.6	6.0	3.5	6.1	5.2	5.3	4.8	0.9	4.8	4.9	9.0	5.1	2.7	14.6	19.0	12.2	19.9	12.9	13.7	11.0	13.4	12.8	12.2
GRK5	GPRK5	ENSG00000198873	"G protein-coupled receptor kinase 5"	P34947	10	119207589-119459742	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 36.5;HUVEC TERT2: 28.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025579, HPA046838"	Approved		Supported	"Nuclear membrane,Nuclear speckles,Plasma membrane"				"Nuclear membrane, Nuclear speckles"	"Plasma membrane"	"CAB025579: , HPA046838: "	"unprognostic (1.09e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.02e-2)"	"unprognostic (6.56e-2)"	"unprognostic (3.74e-2)"	"unprognostic (4.62e-2)"	"unprognostic (3.69e-1)"	"unprognostic (4.11e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.70e-1)"	"unprognostic (2.32e-1)"	"prognostic unfavourable (2.38e-7)"	"unprognostic (1.10e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.90e-2)"	15.9	8.3	3.4	16.8	7.8	2.7	10.2	6.5	5.0	12.5	18.8	3.9	4.5	12.4	13.4	12.2	8.1	7.7	19.5	45.4	4.2	4.2	4.3	5.7	27.6	8.8	3.7	2.5	16.5	3.5	26.2	6.3	24.0	4.5	7.5	6.4	5.6	5.0	6.7	12.8	4.7	10.4	10.8	4.8	17.0	13.9	3.5	4.7	9.8	8.9	10.7	8.6	9.5	13.6	9.3	2.2	6.5	3.7	0.2	11.3	4.2	4.0	2.3	6.0	6.1	13.8	13.3	1.8	7.8	36.5	4.9	2.7	1.9	5.9	4.3	1.8	12.2	1.0	2.6	8.6	3.2	17.1	2.1	0.7	5.0	7.7	9.5	0.2	2.2	1.8	1.3	9.8	1.4	28.8	0.4	4.2	1.7	0.6	4.0	3.9	0.9	6.0	1.4	0.8	1.0	0.8	1.6	2.0	5.5	2.7	1.2	7.5	0.1	1.0	8.7	2.6	1.9	15.8	3.0	0.9	4.6	2.6	5.5	4.8	2.5	0.9	3.7	6.5	5.3	3.2	0.4	9.3	7.7	3.8	2.2	9.1	11.3	5.0	5.0	0.2	0.9	0.0	9.2	4.2	3.4	7.8	6.5	5.0	4.2	4.2	3.7	2.5	4.5	4.7
GTF2H2	"BTF2, BTF2P44, p44, T-BTF2P44, TFIIH"	ENSG00000145736	"General transcription factor IIH subunit 2"	Q13888	5	71032670-71067689	"Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 15.1"	"Low cancer specificity"	"Detected in single"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA047001			Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA047001: "	"unprognostic (7.40e-3)"	"unprognostic (4.71e-1)"	"unprognostic (6.31e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.29e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.22e-3)"	"unprognostic (3.74e-1)"	"unprognostic (3.06e-1)"	"unprognostic (3.67e-2)"	"unprognostic (3.93e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.87e-3)"	"unprognostic (1.62e-1)"	3.9	3.0	1.5	1.3	1.6	1.4	2.0	1.3	2.2	5.0	3.1			0.1	3.3	3.0	3.7	2.8	1.5	1.8	1.4	1.8	4.4	2.8	2.1	6.4	1.4		4.0	4.2	2.1	1.6	0.9		3.1	1.3		2.2	0.7	3.2	2.2	2.2	7.4	1.4	3.6	2.2	3.9			4.6		0.1	2.4	2.0	2.9	1.8	6.2	1.8	1.2	2.1	0.6	3.4	0.0	3.3	0.0	8.0	9.5	10.5	0.4	0.1	0.2	0.5	8.5	0.3	13.1	6.3	7.0	2.3	0.4	0.1	0.2	10.4	10.2	7.9	0.2	0.7	9.0	0.5	0.0	0.0	1.9	0.3	0.0	0.0	0.2	2.4	0.0	4.9	5.0	4.3	0.2	0.1	4.6	2.3	8.5	15.1	0.0	0.3	3.4	8.1	1.0	8.6	5.8	5.7	3.3	3.9	1.0	0.6	6.5	0.2	0.5	3.8	0.3	0.8	7.7	1.1	1.8	0.7	1.9	1.0	0.7	1.5	2.0	1.9	0.9	2.9	2.1	1.7	6.2	1.2	1.1	1.8	0.3	0.6										
GTF2H4	"P52, TFB2, TFIIH"	ENSG00000213780	"General transcription factor IIH subunit 4"	Q92759	6	30908184-30914106	"Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074336			Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA074336: "	"unprognostic (7.05e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.07e-1)"	"unprognostic (4.79e-4)"	"unprognostic (7.42e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.54e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.36e-2)"	"unprognostic (5.66e-4)"	"unprognostic (7.74e-3)"	"prognostic unfavourable (4.08e-4)"	"unprognostic (1.22e-1)"	"unprognostic (9.53e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.07e-2)"	11.2	13.8	13.4	16.1	13.3	10.5	17.8	27.3	17.7	12.2	9.8	9.7	9.1	7.1	12.4	12.8	13.0	11.8	11.2	8.4	12.6	8.4	13.3	18.6	10.2	11.6	10.3	14.8	14.6	9.9	8.5	12.9	9.8	11.2	9.6	10.0	7.5	13.4	16.8	10.9	12.1	12.9	10.4	13.4	11.3	10.7	9.9	12.4	13.1	12.7	8.9	9.5	9.5	10.4	2.3	3.4	5.5	2.2	1.3	3.0	1.7	7.4	3.7	6.4	7.2	5.7	4.0	6.1	2.0	1.8	4.1	3.4	5.9	3.8	6.9	3.3	5.5	6.1	7.8	9.9	2.7	6.3	6.3	5.5	5.0	3.8	3.5	0.0	5.3	5.2	6.9	5.7	0.0	3.7	14.7	2.8	4.4	6.9	5.7	8.2	5.1	1.5	9.8	4.8	3.6	10.4	3.3	2.7	1.8	3.7	2.8	2.6	7.4	3.9	3.1	5.6	6.9	4.9	9.5	4.4	6.2	7.6	2.8	8.8	3.4	5.5	2.2	1.4	2.1	1.7	1.7	2.3	2.1	2.1	3.4	2.2	2.5	3.0	0.0	1.3	1.3	2.8	2.5	1.7	13.4	13.3	27.3	17.7	12.6	8.4	10.3	14.8	11.2	12.4
H2AFX	H2AX	ENSG00000188486	"H2A histone family member X"	P16104	11	119093854-119095467	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA recombination, DNA repair, Host-virus interaction, Meiosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"lymphoid tissue: 135.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB012264, HPA041189, HPA051647"	Supported		Supported	"Nucleoplasm,Nuclear speckles"				Nucleoplasm	"Nuclear speckles"	"CAB012264: AB_297215, HPA041189: , HPA051647: "	"unprognostic (1.44e-1)"	"unprognostic (1.96e-1)"	"unprognostic (6.46e-2)"	"unprognostic (6.41e-2)"	"unprognostic (3.07e-1)"	"unprognostic (3.25e-1)"	"prognostic unfavourable (1.51e-4)"	"unprognostic (2.32e-3)"	"unprognostic (1.93e-1)"	"unprognostic (3.07e-3)"	"unprognostic (6.78e-2)"	"unprognostic (9.31e-2)"	"prognostic unfavourable (5.47e-9)"	"unprognostic (1.21e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.99e-2)"	5.9	10.1	10.7	17.9	9.4	24.0	4.2	9.4	13.9	5.0	12.0	15.2	2.5	15.4	5.7	2.8	9.8	5.5	4.0	4.7	10.6	10.1	6.4	5.0	7.1	17.0	13.3	5.3	8.0	9.2	3.8	8.1	12.8	9.3	6.4	5.4	6.3	5.8	6.3	7.2	10.8	13.7	4.2	13.6	11.1	12.6	28.3	9.5	135.1	5.9	11.3	23.2	4.8	6.6	2.0	3.4	7.4	2.4	3.8	3.4	1.8	26.1	15.8	25.0	14.9	2.3	1.7	26.4	29.8	9.1	16.8	14.8	25.0	11.3	18.0	18.0	6.8	27.2	11.8	8.5	4.5	26.5	33.1	36.4	4.3	25.7	2.4	17.9	22.7	1.4	1.8	7.1	4.4	8.4	29.4	29.6	8.0	66.7	40.9	53.6	18.2	33.5	40.0	29.5	8.4	7.6	11.4	26.7	31.7	23.6	13.8	4.1	20.6	13.6	10.3	16.3	43.1	13.2	22.1	8.1	7.9	18.2	3.7	29.2	31.8	7.0	2.4	7.4	3.4	1.1	1.8	2.0	3.4	3.4	3.4	1.8	2.3	2.0	1.2	3.8	1.5	1.5	2.8	1.8	10.7	9.4	9.4	13.9	10.6	10.1	13.3	5.3	9.3	9.5
HDAC4	"BDMR, HA6116, HD4, HDAC-4, HDAC-A, HDACA, KIAA0288"	ENSG00000068024	"Histone deacetylase 4"	P56524	2	239048168-239401654	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase, Repressor"	"Autism spectrum disorder, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 54.6"	"Cell line enhanced"	"Detected in many"		"MOLT-4: 31.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"basophil: 10.5;classical monocyte: 7.4;neutrophil: 28.3"	"Group enriched"	"Detected in many"	8	"granulocytes: 28.3;monocytes: 7.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004431, HPA048723"	Approved		Supported	"Nucleoplasm,Nuclear speckles,Cytosol"				"Nuclear speckles"	"Nucleoplasm, Cytosol"	"CAB004431: AB_627706, HPA048723: "	"unprognostic (1.54e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.18e-3)"	"unprognostic (2.43e-2)"	"unprognostic (2.39e-3)"	"unprognostic (3.06e-4)"	"unprognostic (1.00e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavourable (6.33e-4)"	"prognostic favourable (1.13e-4)"	"unprognostic (1.40e-1)"	"unprognostic (4.82e-3)"	"unprognostic (2.40e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.32e-2)"	"unprognostic (6.04e-2)"	7.9	6.8	6.1	6.8	5.2	17.1	4.6	6.4	12.3	11.3	21.4	4.6	4.3	2.5	10.2	6.4	8.8	9.0	24.6	5.2	5.0	6.0	3.2	3.1	4.2	4.3	6.1	5.4	8.5	5.8	4.9	8.3	2.5	5.2	7.5	4.8	8.3	3.7	7.3	54.6	6.9	6.5	15.8	4.2	5.4	7.0	8.1	4.3	6.5	4.8	13.2	5.6	10.2	4.6	0.5	1.7	28.3	7.4	2.1	1.2	0.4	4.3	4.3	5.5	6.6	3.1	5.3	6.5	4.5	3.1	3.6	3.4	2.0	7.8	2.0	1.8	3.9	4.3	3.8	1.8	1.8	12.0	2.0	3.2	5.3	6.3	4.2	4.9	2.9	3.6	4.6	6.6	5.3	3.8	4.5	4.6	1.7	5.3	31.6	6.7	4.3	2.2	8.2	10.4	3.2	4.1	5.5	4.4	7.8	6.3	2.8	11.1	1.5	13.4	6.1	4.2	0.3	7.2	6.1	3.3	3.1	3.9	6.1	6.8	8.3	10.5	7.4	1.1	0.9	2.4	1.1	0.5	0.9	0.8	0.8	0.5	0.5	1.0	28.3	2.1	1.0	1.7	1.2	0.4	6.1	5.2	6.4	7.5	5.0	6.0	6.1	5.4	5.2	4.3
HDAC5	"FLJ90614, KIAA0600, NY-CO-9"	ENSG00000108840	"Histone deacetylase 5"	Q9UQL6	17	44076746-44123702	"Cancer-related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase, Repressor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019400, HPA030991"	Approved		Supported	"Nuclear speckles,Golgi apparatus,Cytosol"				"Nuclear speckles"	"Golgi apparatus, Cytosol"	"CAB019400: AB_2116626, HPA030991: AB_10795286"	"unprognostic (1.30e-2)"	"prognostic favourable (6.14e-4)"	"unprognostic (6.65e-2)"	"unprognostic (8.06e-2)"	"unprognostic (3.49e-1)"	"unprognostic (3.52e-2)"	"prognostic unfavourable (3.12e-5)"	"unprognostic (8.80e-3)"	"unprognostic (3.80e-2)"	"unprognostic (2.37e-2)"	"unprognostic (4.91e-3)"	"unprognostic (4.30e-1)"	"prognostic favourable (3.30e-5)"	"unprognostic (1.51e-2)"	"unprognostic (3.11e-1)"	"unprognostic (6.00e-2)"	"unprognostic (1.76e-2)"	15.6	17.6	24.9	7.9	15.8	13.2	18.1	35.9	25.8	16.5	8.8	19.6	9.5	8.4	15.0	11.9	20.1	16.9	11.3	24.4	22.1	24.2	8.6	6.3	13.6	8.8	24.7	22.1	24.5	16.1	28.2	17.5	23.0	19.3	13.6	5.5	11.7	14.2	11.9	42.6	34.0	9.7	12.4	20.5	13.8	9.3	10.3	18.1	7.6	15.0	9.8	8.2	14.9	20.4	7.6	9.4	17.9	13.6	3.5	4.9	5.0	3.5	2.3	6.4	1.5	12.4	9.7	23.1	9.6	24.0	4.8	7.9	5.1	3.8	5.6	3.9	22.8	2.9	7.5	4.1	2.0	8.7	12.2	10.9	7.7	11.7	5.3	3.5	15.4	13.7	7.1	5.5	6.9	3.9	8.1	11.4	27.8	2.7	5.8	10.7	7.0	5.5	22.5	17.9	14.4	0.5	1.6	16.7	8.8	2.8	11.8	13.0	16.8	20.7	2.1	12.1	7.8	2.8	4.8	18.8	15.7	6.7	7.0	4.4	5.7	7.1	7.3	7.7	4.9	11.6	3.5	6.6	3.9	4.9	9.4	7.6	4.1	3.5	17.9	3.5	13.6	8.3	3.5	5.0	24.9	15.8	35.9	25.8	22.1	24.2	24.7	22.1	19.3	18.1
HEXIM2	FLJ32384	ENSG00000168517	"Hexamethylene bisacetamide inducible 2"	Q96MH2	17	45160700-45170040	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 36.4"	"Cell line enhanced"	"Detected in all"		"Hep G2: 30.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023323, HPA028455"	Enhanced		Supported	"Nucleoplasm,Nuclear speckles"				"Nucleoplasm, Nuclear speckles"		"HPA023323: AB_1850651, HPA028455: AB_10602603"	"unprognostic (9.03e-3)"	"unprognostic (2.18e-2)"	"unprognostic (4.01e-2)"	"prognostic favourable (2.53e-4)"	"unprognostic (2.36e-1)"	"unprognostic (6.35e-3)"	"unprognostic (9.70e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.03e-1)"	"prognostic favourable (9.85e-4)"	"unprognostic (2.34e-3)"	"unprognostic (1.93e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.32e-3)"	"unprognostic (6.98e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.90e-2)"	4.0	7.7	8.3	4.2	8.0	3.6	3.4	9.0	11.8	4.3	4.8	5.0	6.5	8.8	4.3	5.6	4.2	5.1	7.9	6.3	6.7	6.2	9.3	9.6	4.1	5.6	7.8	6.7	5.7	9.3	7.5	6.1	3.0	6.6	5.1	2.5	6.9	9.9	5.5	36.4	5.6	6.4	4.3	5.4	5.2	6.9	27.7	6.4	6.4	9.1	6.6	3.0	4.7	4.7	9.7	13.2	10.0	12.2	7.3	8.6	13.3	4.9	17.9	4.0	8.8	4.4	7.3	7.6	2.8	3.4	4.5	5.0	6.7	13.3	3.1	14.5	1.9	8.2	3.9	3.4	1.4	7.1	6.2	2.3	16.7	30.4	3.2	2.0	5.1	6.3	3.2	3.9	1.4	2.2	2.5	7.7	2.0	8.6	3.1	4.2	4.3	7.9	4.2	6.0	9.3	5.7	4.9	4.8	4.1	2.5	5.0	11.5	13.3	3.4	2.1	8.2	4.4	5.4	6.5	12.0	12.6	2.9	6.4	3.6	6.1	8.4	12.2	10.0	5.4	9.7	8.6	9.7	3.8	6.1	10.3	6.5	3.0	5.3	8.3	7.3	3.0	13.2	4.6	13.3	8.3	8.0	9.0	11.8	6.7	6.2	7.8	6.7	6.6	6.4
HIST1H1E	"H1.4, H1e, H1F4, H1s-4"	ENSG00000168298	"Histone cluster 1 H1 family member e"	P10412	6	26156354-26157107	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"		DNA-binding	"Cancer-related genes, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"blood: 56.4;bone marrow: 102.3;lymphoid tissue: 123.9"	"Cell line enhanced"	"Detected in many"		"RPMI-8226: 9.7;U-266/70: 11.8;U-266/84: 13.2;U-87 MG: 12.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB011506, HPA055907"	Supported		Supported	"Nuclear speckles"				"Nuclear speckles"		"CAB011506: AB_470256, HPA055907: "	"unprognostic (6.96e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.86e-1)"	"unprognostic (9.62e-2)"	"unprognostic (1.04e-2)"	"unprognostic (5.78e-3)"	"unprognostic (2.31e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.37e-1)"	"unprognostic (7.72e-13)"	"unprognostic (4.54e-3)"	"unprognostic (3.46e-2)"	"unprognostic (1.30e-3)"	"unprognostic (2.18e-2)"	6.7	3.6	3.1	14.3	3.5	102.3	10.3	8.1	9.0	10.7	7.7	4.7	4.2	4.1	6.8	7.5	13.7	4.0	11.3	7.4	4.0	3.5	6.6	6.7	13.1	18.4	3.4	2.4	19.3	17.1	3.7	9.0	7.3	3.5	10.2	4.4	9.8	10.0	4.0	4.1	14.4	9.0	7.4	6.8	14.6	5.3	5.9	0.7	123.9	4.6	10.0	18.4	14.3	10.7	39.6	14.6	56.4	12.9	19.2	24.4	9.4	2.4	0.3	0.4	5.2	0.1	0.0	6.3	0.0	0.4	1.1	0.8	0.1	1.5	1.2	0.7	0.1	1.1	0.3	0.7	0.5	1.7	1.5	0.8	0.5	0.4	0.1	0.7	1.0	0.1	0.3	0.3	0.5	0.5	3.9	6.7	0.1	0.5	7.7	7.1	1.8	0.8	3.6	1.2	9.7	0.3	0.0	3.8	0.9	3.1	0.8	1.1	1.0	2.5	0.4	2.4	3.6	1.4	2.4	11.8	13.2	5.3	12.1	2.1	1.1	56.4	12.7	30.0	21.1	12.9	24.4	21.4	16.7	19.2	14.3	39.6	12.7	11.6	18.6	19.2	10.9	14.6	16.4	9.4	3.1	3.5	8.1	9.0	4.0	3.5	3.4	2.4	3.5	0.7
HOXA6	"HOX1, HOX1B"	ENSG00000106006	"Homeobox A6"	P31267	7	27145396-27150603	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"fallopian tube: 10.4"	"Group enriched"	"Detected in some"	9	"AN3-CA: 28.6;HEK 293: 39.0"	"Low cancer specificity"	"Detected in many"							"Group enriched"	"Detected in some"	8	"basophil: 5.9;NK-cell: 2.0"	"Group enriched"	"Detected in many"	8	"granulocytes: 5.9;NK-cells: 2.0"	"Region enriched"	"Detected in single"	34	"pons and medulla: 3.5"					"HPA004203, HPA077900"	Approved		Supported	"Nucleoplasm,Nuclear speckles"				Nucleoplasm	"Nuclear speckles"	"HPA004203: AB_1079079, HPA077900: "	"unprognostic (1.70e-1)"	"unprognostic (6.76e-3)"	"unprognostic (2.70e-2)"	"prognostic unfavourable (1.40e-4)"	"unprognostic (1.06e-1)"	"unprognostic (6.06e-2)"		"unprognostic (9.73e-2)"	"unprognostic (6.32e-2)"	"unprognostic (2.94e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.17e-1)"	"prognostic favourable (2.03e-4)"	"unprognostic (1.45e-1)"	"unprognostic (2.81e-2)"		"unprognostic (3.93e-1)"	3.2	2.9	0.0	1.2	0.0	0.0	2.3	0.0	0.0	1.6	5.4			0.0	6.7	4.6	0.1	10.4	0.0	0.0	0.0	0.0	5.9	0.0	2.3	0.8	0.0		0.0	0.0	0.5	0.0	0.0		2.5	1.5		0.0	2.2	1.0	3.2	4.2	1.4	1.0	0.0	1.2	0.0			0.0		0.0	4.3	1.3	0.1	0.5	5.9	0.1	2.0	0.2	0.0	0.5	0.9	0.0	28.6	0.0	0.0	0.1	0.2	0.3	0.2	0.3	0.6	3.3	0.6	1.0	0.2	1.3	0.7	0.0	0.0	0.8	39.0	0.4	0.5	0.3	0.0	0.6	1.0	2.3	0.0	0.0	0.3	1.3	0.2	0.0	0.3	0.3	0.0	0.1	0.0	1.0	3.7	0.0	0.0	2.8	1.8	3.0	0.0	1.3	0.1	0.6	0.3	0.3	0.0	0.0	0.4	1.5	1.0	0.0	0.0	0.6	0.0	2.8	2.8	5.9	0.0	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	2.0	0.0	0.5	0.2	0.0										
HP1BP3	HP1-BP74	ENSG00000127483	"Heterochromatin protein 1 binding protein 3"	Q5SSJ5	1	20742661-20787323	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028215, HPA054295"	Supported		Supported	"Nuclear speckles"			50000	"Nuclear speckles"		"HPA028215: AB_10601021, HPA054295: "	"unprognostic (3.90e-3)"	"unprognostic (6.83e-2)"	"unprognostic (7.69e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.25e-3)"	"prognostic unfavourable (2.76e-4)"	"unprognostic (1.97e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.94e-2)"	"unprognostic (9.50e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.65e-1)"	"unprognostic (6.30e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.43e-2)"	40.1	41.4	52.6	41.2	59.0	62.2	39.0	53.3	60.0	52.8	46.8	45.8	41.2	34.1	65.7	32.2	46.9	38.6	36.9	35.9	49.1	33.7	42.4	31.7	39.7	41.4	47.6	41.2	70.8	36.5	54.6	46.7	55.1	46.7	41.6	44.2	32.5	39.5	44.5	48.7	41.7	43.9	49.7	50.1	41.9	39.6	27.9	58.6	58.1	52.7	30.9	42.9	48.0	62.9	21.9	18.9	60.5	17.0	18.3	27.3	14.0	43.4	23.1	58.4	35.1	35.0	42.3	35.0	49.2	41.3	36.3	38.4	20.8	50.5	45.1	25.0	39.3	37.3	30.4	28.8	47.1	64.9	28.0	63.3	45.1	18.6	23.0	43.6	40.8	31.8	21.4	35.4	48.4	36.5	35.1	55.6	41.3	13.8	67.0	20.1	15.4	28.2	53.1	56.6	46.9	25.9	14.1	39.3	40.5	60.7	25.2	39.9	25.9	30.8	42.3	39.7	36.7	40.0	29.9	31.8	38.3	50.7	34.0	47.3	44.8	25.5	17.0	60.5	19.4	13.9	20.0	21.9	20.9	20.7	15.5	19.0	27.3	18.6	21.8	18.3	15.8	18.9	21.3	14.0	52.6	59.0	53.3	60.0	49.1	33.7	47.6	41.2	46.7	58.6
HSF4	CTM	ENSG00000102878	"Heat shock transcription factor 4"	Q9ULV5	16	67164681-67169945	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Stress response, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cataract, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"T-47d: 11.6;U-266/70: 21.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA048584			Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA048584: "	"unprognostic (1.90e-1)"	"unprognostic (3.05e-2)"	"prognostic unfavourable (8.24e-5)"	"unprognostic (9.20e-3)"	"unprognostic (2.61e-1)"	"unprognostic (1.43e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.06e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.85e-2)"	"unprognostic (4.26e-3)"	"prognostic unfavourable (2.19e-6)"	"unprognostic (1.20e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.48e-2)"	"unprognostic (8.74e-3)"	6.9	16.8	11.8	2.5	14.7	2.6	5.5	16.4	20.2	7.1	4.6	2.6	16.0	6.4	6.5	13.7	7.5	7.9	5.3	8.7	11.6	5.5	6.4	8.3	6.0	2.6	19.3	16.9	7.1	17.4	10.2	12.3	5.0	11.5	12.2	3.4	19.1	16.4	4.3	36.8	13.2	6.3	26.8	11.7	3.4	16.1	3.4	15.1	0.3	7.4	10.6	1.9	10.9	8.4	0.0	0.5	0.0	0.9	0.0	0.4	0.2	1.4	0.9	0.0	1.1	0.5	2.8	5.1	0.6	0.5	0.2	0.0	2.1	2.6	0.0	2.3	1.0	5.0	0.4	0.6	0.2	1.6	2.0	0.8	1.9	3.0	2.1	0.3	3.6	1.5	4.3	0.3	2.3	0.8	1.4	4.8	2.0	1.3	0.6	1.3	0.1	1.8	2.4	1.8	5.9	3.8	2.2	2.8	5.9	4.1	2.7	6.2	11.6	4.0	1.2	1.5	1.7	5.6	1.6	21.2	3.0	1.3	3.1	1.5	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.2	11.8	14.7	16.4	20.2	11.6	5.5	19.3	16.9	11.5	15.1
HSPB3	HSPL27	ENSG00000169271	"Heat shock protein family B (small) member 3"	Q12988	5	54455601-54456384	"Disease related genes, Predicted intracellular proteins"	"Stress response"		"Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 106.0;skeletal muscle: 46.1;tongue: 22.3"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 37.1;fHDF/TERT166: 16.6;HSkMC: 7.3;LHCN-M2: 5.4"	"Cancer enriched"	"Detected in many"	6	"head and neck cancer: 7.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA062124			Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA062124: "		"unprognostic (1.44e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.78e-3)"	"unprognostic (3.06e-1)"	"unprognostic (2.25e-3)"		"unprognostic (1.13e-1)"	"unprognostic (4.41e-3)"	"unprognostic (6.42e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.70e-2)"		"unprognostic (2.73e-1)"	"unprognostic (2.82e-2)"		"unprognostic (7.15e-2)"	0.7	0.1	1.1	0.1	1.0	0.0	0.5	0.0	2.7	0.2	1.0	0.0	0.1	0.1	1.8	4.3	3.7	0.7	0.1	106.0	0.5	0.4	0.0	0.0	0.5	0.0	0.1	1.1	0.3	0.0	0.0	0.9	0.0	0.2	2.0	0.5	0.1	2.1	0.2	46.1	0.5	0.2	2.4	0.0	0.2	0.2	0.3	0.0	0.0	0.1	22.3	0.9	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	37.1	0.0	0.0	0.1	0.0	0.0	0.1	16.6	2.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	7.3	2.2	0.0	0.0	0.0	0.1	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.1	1.0	0.0	2.7	0.5	0.4	0.1	1.1	0.2	0.0
IL15	"IL-15, MGC9721"	ENSG00000164136	"Interleukin 15"	P40933	4	141636599-141733987	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins"		Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 15.5;Karpas-707: 15.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"CAB004457, HPA037738"	Approved		Supported	"Nucleoplasm,Nuclear speckles"	"Secreted to blood"	20753		"Nucleoplasm, Nuclear speckles"		"CAB004457: AB_2124575, HPA037738: "	"unprognostic (1.10e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.04e-2)"	"unprognostic (8.57e-2)"	"unprognostic (8.77e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.48e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.74e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.03e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.54e-1)"	7.7	3.7	1.1	21.3	1.5	2.9	9.2	1.8	2.2	6.0	8.8	0.8	2.2	6.3	11.3	7.4	5.6	4.6	9.9	9.3	1.1	1.5	6.9	3.7	14.4	18.8	2.3	1.6	3.2	3.1	0.5	4.5	9.9	2.1	7.7	5.7	5.9	6.9	3.6	9.1	3.2	14.2	7.1	2.6	17.0	5.3	2.6	2.0	9.8	18.1	5.9	11.0	9.8	16.9	3.7	4.6	8.1	14.0	2.6	4.5	4.4	2.4	5.2	0.2	0.5	0.8	4.7	1.3	5.6	5.3	5.8	4.7	2.8	6.8	2.3	7.3	4.8	3.6	0.1	3.0	3.2	15.5	1.4	0.4	13.7	0.4	3.9	1.6	1.1	1.7	1.2	3.8	0.4	3.7	3.8	15.2	3.7	0.8	3.4	0.3	2.6	1.6	0.9	13.4	0.3	7.6	0.6	0.5	1.3	2.4	3.7	2.7	0.9	0.2	5.5	5.9	3.8	1.7	3.4	10.7	1.3	0.7	6.3	0.6	2.1	8.1	14.0	0.8	2.5	12.4	4.5	3.7	2.9	2.2	4.6	3.4	1.2	1.3	1.0	2.6	12.5	0.1	1.5	4.4	1.1	1.5	1.8	2.2	1.1	1.5	2.3	1.6	2.1	2.0
ITPKC	"IP3-3KC, IP3KC"	ENSG00000086544	"Inositol-trisphosphate 3-kinase C"	Q96DU7	19	40717103-40740860	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Calmodulin-binding, Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 24.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050760, HPA053003"	Approved		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA050760: , HPA053003: "	"unprognostic (4.27e-2)"	"unprognostic (3.73e-2)"	"unprognostic (8.31e-2)"	"unprognostic (9.12e-3)"	"unprognostic (1.10e-2)"	"unprognostic (9.81e-2)"	"unprognostic (6.06e-2)"	"prognostic unfavourable (4.91e-4)"	"unprognostic (1.48e-1)"	"unprognostic (1.54e-3)"	"unprognostic (1.84e-3)"	"unprognostic (2.63e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.86e-2)"	"unprognostic (3.45e-2)"	"unprognostic (3.32e-1)"	26.0	8.2	6.6	9.8	10.9	2.4	13.4	4.4	7.7	14.2	9.3	3.7	7.6	8.5	8.8	5.2	46.8	11.0	17.1	10.8	13.2	3.7	7.3	7.7	18.4	6.9	4.4	2.7	6.8	16.4	6.4	9.9	10.8	23.8	12.1	5.2	6.0	15.4	8.4	8.1	21.6	9.8	11.9	17.8	6.5	11.4	3.8	5.2	3.2	7.8	31.4	28.0	10.6	17.1	3.3	2.3	3.9	3.2	0.9	3.5	1.7	6.5	6.2	3.8	6.0	17.5	15.2	6.2	3.9	8.3	4.1	3.6	8.9	6.8	1.8	4.5	5.0	6.9	3.8	16.9	1.7	3.4	3.9	1.4	2.2	6.2	17.3	1.5	1.9	21.1	24.7	3.8	14.2	9.9	5.3	3.2	3.9	8.0	2.2	2.3	1.9	2.8	2.4	1.9	2.5	6.3	11.1	2.7	3.4	3.9	16.1	3.6	7.4	3.9	6.3	2.6	3.9	1.7	2.6	1.8	0.4	1.9	4.1	1.5	2.8	3.9	3.2	1.7	3.5	1.6	1.4	1.4	2.7	1.9	1.5	3.3	1.9	2.2	1.6	0.9	2.2	2.3	2.6	1.7	6.6	10.9	4.4	7.7	13.2	3.7	4.4	2.7	23.8	5.2
KAZN	"FLJ43806, KAZRIN, KIAA1026"	ENSG00000189337	"Kazrin, periplakin interacting protein"	Q674X7	1	13892792-15118043	"Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 64.9"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 39.7;SK-BR-3: 21.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	21	"neutrophil: 6.9"	"Lineage enriched"	"Detected in single"	21	"granulocytes: 6.9"									"HPA032095, HPA032096"	Approved		Supported	"Nucleoplasm,Nuclear speckles,Cytosol"				Nucleoplasm	"Nuclear speckles, Cytosol"	"HPA032095: , HPA032096: AB_10670826"	"unprognostic (2.81e-1)"	"unprognostic (5.82e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.42e-3)"	"unprognostic (5.34e-2)"	"unprognostic (2.15e-3)"	"unprognostic (6.57e-3)"	"unprognostic (7.88e-3)"	"unprognostic (3.21e-1)"	"unprognostic (4.96e-3)"	"unprognostic (1.10e-1)"	"unprognostic (5.55e-2)"	"prognostic favourable (1.20e-6)"	"unprognostic (3.61e-2)"	"unprognostic (7.93e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.06e-2)"	8.0	11.0	13.4	3.0	17.4	1.2	7.6	41.1	21.9	8.0	3.8	27.5	5.7	4.6	3.1	11.1	18.8	11.0	7.0	4.1	12.4	12.4	13.2	5.2	8.5	1.5	25.1	12.1	10.4	8.0	22.9	2.7	11.0	15.0	4.1	4.0	10.5	16.8	7.2	1.7	14.2	4.9	3.7	25.0	64.9	4.9	4.1	18.9	0.0	6.6	7.0	6.3	7.9	9.4	0.3	0.0	6.9	0.0	0.0	0.0	0.0	7.8	1.4	8.6	39.7	3.8	3.9	2.9	3.8	3.2	7.1	5.1	1.8	4.2	0.0	9.9	8.1	2.8	1.9	6.2	3.5	0.2	3.9	4.5	4.7	11.8	2.8	0.0	2.3	5.5	8.3	1.6	1.1	0.0	1.8	9.2	5.6	5.7	0.0	0.4	2.4	1.2	2.7	0.2	4.8	11.9	2.4	4.6	3.3	0.6	21.6	14.8	1.2	3.0	0.0	5.8	5.5	9.2	4.5	1.5	1.3	0.0	5.4	7.9	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	13.4	17.4	41.1	21.4	12.4	12.4	25.1	12.1	15.0	18.9
KIF22	"Kid, KNSL4, OBP-1, OBP-2"	ENSG00000079616	"Kinesin family member 22"	Q14807	16	29790719-29805385	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		"DNA-binding, Motor protein"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 78.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA041076, HPA048213"	Approved		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA041076: AB_10794540, HPA048213: "	"unprognostic (3.71e-2)"	"prognostic favourable (3.87e-8)"	"unprognostic (1.86e-1)"	"unprognostic (2.21e-3)"	"unprognostic (1.25e-1)"	"unprognostic (6.06e-3)"	"unprognostic (5.06e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.70e-1)"	"unprognostic (4.73e-2)"	"unprognostic (7.84e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.21e-2)"	"unprognostic (3.67e-2)"	"unprognostic (2.62e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.67e-1)"	5.6	4.3	8.5	21.7	11.2	38.9	7.0	6.4	10.9	5.1	12.5	8.8	3.0	8.4	5.1	10.1	13.6	6.5	6.0	5.6	6.2	5.9	7.2	4.5	5.8	16.1	6.3	6.2	5.8	3.9	18.6	5.7	22.1	5.8	13.2	10.7	8.9	6.3	9.6	4.0	16.7	9.6	4.1	5.8	11.6	5.9	17.9	5.9	78.2	16.8	13.1	19.0	6.5	7.6	13.6	6.6	19.7	9.1	13.3	25.0	17.1	21.5	23.1	30.5	22.0	2.1	3.1	26.8	16.3	13.1	31.4	29.4	22.2	25.8	31.4	15.3	8.4	22.5	29.8	16.8	14.7	20.5	23.9	17.4	25.1	28.1	0.7	18.9	19.3	1.7	4.5	17.4	13.1	16.9	25.4	26.3	16.4	43.8	41.3	47.6	25.7	14.3	57.8	27.1	30.0	11.3	10.1	25.5	16.5	11.9	23.8	8.3	21.4	25.7	7.4	16.4	17.3	14.5	17.6	24.6	24.3	33.9	10.7	31.3	20.9	19.7	6.4	17.0	23.6	9.1	17.6	13.6	23.7	25.0	6.6	11.3	19.5	18.5	2.8	13.3	7.7	4.2	24.0	17.1	8.5	11.2	6.4	10.9	6.2	5.9	6.3	6.2	5.8	5.9
LHPP	HDHD2B	ENSG00000107902	"Phospholysine phosphohistidine inorganic pyrophosphate phosphatase"	Q9H008	10	124461834-124617888	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 106.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009163, HPA009269"	Enhanced		Supported	"Nuclear speckles,Cytosol"			880000	"Nuclear speckles, Cytosol"		"HPA009163: AB_1079250, HPA009269: AB_1079249"	"unprognostic (3.46e-2)"	"unprognostic (1.23e-2)"	"unprognostic (4.78e-2)"	"unprognostic (3.89e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.96e-1)"	"unprognostic (5.77e-3)"	"unprognostic (2.02e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.93e-1)"	"unprognostic (6.42e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.79e-3)"	"unprognostic (2.52e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.64e-1)"	9.6	14.2	37.3	6.0	34.0	6.9	7.9	11.9	34.2	12.3	13.6	29.7	8.2	17.9	7.5	11.0	12.7	8.1	8.3	9.8	43.0	31.5	18.6	33.8	6.6	8.2	62.7	19.3	5.5	12.2	6.6	5.6	7.2	20.5	6.9	6.7	6.7	13.3	10.6	6.5	8.9	15.7	8.1	106.0	8.2	12.4	14.2	19.5	7.1	20.5	3.6	11.2	8.7	5.7	24.7	20.0	13.3	16.1	3.9	17.2	12.9	14.7	7.3	3.0	7.5	11.6	9.5	7.9	5.4	11.1	3.4	6.3	1.3	13.7	14.6	12.6	8.1	16.0	0.9	2.8	3.6	3.2	10.5	10.6	2.3	6.7	11.8	2.1	17.3	7.0	12.5	3.4	8.2	5.4	5.2	5.8	4.2	14.6	7.0	6.8	5.3	4.1	7.5	3.3	18.6	7.4	1.9	1.6	9.0	3.8	13.9	4.9	10.5	0.3	2.5	5.3	7.9	4.4	1.4	4.9	1.5	4.7	4.9	4.1	1.2	4.6	16.1	13.3	9.5	13.5	12.4	23.7	11.1	10.1	20.0	24.7	13.7	9.6	2.7	3.9	14.9	7.5	17.2	12.9	37.3	34.0	11.9	25.0	43.0	31.5	62.7	19.3	20.5	19.5
LIMK1	LIMK	ENSG00000106683	"LIM domain kinase 1"	P53667	7	74082933-74122525	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 45.2"	"Cell line enhanced"	"Detected in all"		"U-87 MG: 51.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028064, HPA028516"	Approved		Supported	"Nuclear speckles,Cytosol"				"Nuclear speckles, Cytosol"		"HPA028064: AB_10600111, HPA028516: AB_10601751"	"unprognostic (1.45e-2)"	"unprognostic (2.75e-1)"	"prognostic unfavourable (4.95e-5)"	"unprognostic (2.77e-2)"	"unprognostic (1.40e-3)"	"unprognostic (3.35e-2)"	"prognostic unfavourable (7.79e-6)"	"unprognostic (1.90e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.32e-2)"	"unprognostic (3.16e-2)"	"prognostic unfavourable (6.63e-8)"	"unprognostic (4.14e-2)"	"unprognostic (7.00e-2)"	"unprognostic (3.84e-2)"	"unprognostic (5.79e-2)"	8.8	8.6	31.6	18.2	18.6	6.3	7.4	14.3	44.1	11.5	6.6	7.1	6.6	6.9	7.3	5.3	6.4	6.0	10.8	6.3	26.8	32.9	5.2	2.6	12.5	22.0	33.4	22.2	12.1	8.1	4.0	7.2	8.0	45.2	6.1	4.7	4.8	18.1	9.6	10.9	6.8	7.2	7.6	10.8	18.4	7.8	10.4	6.5	4.3	7.5	3.7	18.1	14.1	7.2	4.6	8.6	3.8	7.7	6.9	2.4	3.1	17.2	13.5	10.3	17.1	13.6	18.5	7.5	10.7	10.3	8.7	9.7	7.8	17.0	10.7	4.8	13.1	10.4	3.8	6.6	3.3	18.5	6.7	7.9	4.6	8.9	15.6	6.0	29.0	18.2	5.9	7.0	3.7	12.9	5.3	3.4	10.8	15.1	5.1	10.8	19.5	8.4	7.5	16.0	6.7	9.6	3.7	4.1	9.4	6.9	16.5	8.6	5.2	5.4	15.3	13.9	12.9	35.7	17.1	3.9	4.3	19.5	51.4	4.4	9.4	0.1	6.5	3.8	2.4	7.7	1.8	4.6	0.6	1.5	8.6	2.4	0.2	0.7	0.7	6.9	4.7	0.8	0.4	3.1	31.6	18.6	14.3	44.1	26.8	32.9	33.4	22.2	45.2	6.5
LPXN	LDPL	ENSG00000110031	Leupaxin	O60711	11	58526871-58578220	"Predicted intracellular proteins"	"Cell adhesion, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 42.0;lymphoid tissue: 75.1"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 39.3;HMC-1: 65.8;Karpas-707: 56.4;U-2197: 39.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043741, CAB046478, HPA061441"	Enhanced		Supported	"Nuclear speckles,Focal adhesion sites,Cytosol"				"Focal adhesion sites"	"Nuclear speckles, Cytosol"	"CAB046478: AB_10603113, HPA043741: AB_2678647, HPA061441: AB_2684518"	"unprognostic (1.61e-3)"	"unprognostic (6.91e-2)"	"unprognostic (6.54e-2)"	"prognostic favourable (8.81e-4)"	"unprognostic (5.16e-2)"	"unprognostic (2.07e-3)"	"unprognostic (2.16e-2)"	"unprognostic (8.87e-3)"	"unprognostic (5.18e-2)"	"unprognostic (3.96e-2)"	"unprognostic (2.39e-2)"	"unprognostic (3.05e-1)"	"unprognostic (3.60e-3)"	"unprognostic (1.91e-1)"	"unprognostic (5.25e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.41e-3)"	16.3	5.6	5.1	34.2	4.7	4.2	5.1	3.5	4.9	4.4	6.7	9.0	4.1	5.1	6.5	5.9	3.8	4.7	7.2	3.9	5.2	5.1	6.3	7.1	19.7	37.2	6.3	2.5	6.6	5.6	3.9	4.8	2.6	5.0	5.7	9.6	6.2	7.6	5.1	2.1	3.7	16.0	4.7	11.4	32.2	5.7	5.9	4.9	75.1	6.8	4.4	52.9	11.2	3.9	19.9	36.5	3.8	19.1	20.1	42.0	20.9	0.3	0.4	0.4	0.7	1.5	1.9	0.2	9.8	39.3	2.4	4.4	0.0	1.0	28.7	0.4	11.9	0.3	0.3	26.7	10.3	12.4	0.1	1.3	0.2	0.1	2.6	7.7	65.8	1.4	0.6	33.9	4.4	15.8	0.3	56.4	19.9	0.2	27.1	9.7	0.3	8.9	0.4	0.5	24.7	1.6	13.7	0.2	0.3	0.4	0.6	3.9	0.5	2.2	15.4	6.2	1.8	39.6	8.8	3.6	3.5	28.2	14.3	7.0	14.0	1.7	19.1	3.1	28.2	11.0	42.0	19.9	29.0	32.4	36.5	11.5	22.6	26.8	3.8	20.1	5.6	33.1	38.7	20.9	5.1	4.7	3.5	4.9	5.2	5.1	6.3	2.5	5.0	4.9
MAML3	"CAGH3, GDN, KIAA1816, MAM2, TNRC3"	ENSG00000196782	"Mastermind like transcriptional coactivator 3"	Q96JK9	4	139716753-140154184	"Predicted intracellular proteins"	"Notch signaling pathway, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 11.2;SCLC-21H: 11.9;SH-SY5Y: 18.1;WM-115: 15.1"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 29.1"	"Cell type enhanced"	"Detected in many"		"basophil: 11.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"							HPA037717	Approved		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA037717: AB_10794323"	"unprognostic (1.83e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.17e-1)"	"unprognostic (7.83e-3)"	"unprognostic (4.73e-2)"	"unprognostic (2.63e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.89e-1)"	"unprognostic (5.52e-3)"	"unprognostic (1.73e-1)"	"prognostic favourable (7.60e-5)"	"unprognostic (3.38e-1)"	"unprognostic (1.20e-1)"	"unprognostic (7.22e-2)"	"unprognostic (2.88e-1)"	5.9	5.5	6.0	10.3	4.2	3.9	6.4	29.1	4.1	10.0	6.3	5.4	8.3	6.8	19.4	11.5	10.5	8.4	11.2	3.7	3.2	3.6	4.2	4.8	6.8	6.0	4.9	2.8	13.3	11.3	7.4	16.7	7.2	5.8	8.4	5.7	5.5	15.3	16.2	2.5	12.9	6.2	9.2	7.8	4.9	6.0	6.5	5.1	13.5	6.2	5.9	6.8	8.9	8.9	0.6	1.8	11.0	1.9	3.9	0.6	1.3	0.3	6.0	4.1	2.0	1.6	3.4	3.7	0.7	3.3	0.3	0.2	2.3	1.7	1.3	0.3	0.6	0.1	1.6	1.4	0.2	0.0	0.9	4.2	1.3	0.2	0.3	2.0	6.6	3.3	1.1	0.1	0.7	11.2	1.1	0.0	0.2	0.6	0.4	0.9	1.0	2.6	2.5	0.4	2.6	1.8	8.3	11.9	18.1	0.0	3.2	4.1	1.7	0.6	9.6	0.5	1.1	0.0	1.3	2.2	2.5	0.0	0.6	6.7	15.1	11.0	1.9	3.5	0.0	1.3	0.2	0.0	0.0	0.0	1.8	0.6	0.6	0.5	4.5	3.9	1.2	1.5	0.0	1.3	6.0	4.2	29.1	4.1	3.2	3.6	4.9	2.8	5.8	5.1
MAPK14	"CSBP1, CSBP2, CSPB1, Mxi2, p38, PRKM14, PRKM15"	ENSG00000112062	"Mitogen-activated protein kinase 14"	Q16539	6	36027677-36111236	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Apoptosis, Stress response, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 32.1;neutrophil: 12.3"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 32.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010285, CAB040578, HPA051825"	Approved		Supported	"Nuclear speckles,Cytosol"			7100000	"Nuclear speckles"	Cytosol	"CAB010285: AB_632140, CAB040578: , HPA051825: "	"unprognostic (6.76e-3)"	"unprognostic (6.28e-2)"	"unprognostic (6.30e-3)"	"unprognostic (3.30e-3)"	"unprognostic (6.98e-2)"	"unprognostic (4.04e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.20e-3)"	"unprognostic (8.39e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.47e-2)"	"unprognostic (3.66e-3)"	"unprognostic (6.66e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.58e-1)"	21.5	20.6	11.7	18.4	15.5	49.9	20.7	26.5	18.1	22.0	20.5	12.5	11.9	16.9	38.8	12.1	24.0	18.9	16.0	16.4	9.3	9.5	16.0	29.8	21.5	29.0	12.0	11.3	17.7	18.5	15.0	27.2	27.3	10.2	23.4	18.3	17.0	16.7	16.5	21.2	25.6	22.5	26.0	10.6	35.5	18.2	11.1	10.3	34.1	20.9	17.6	20.8	25.0	30.0	2.3	4.0	32.1	4.9	3.0	2.8	2.1	18.3	10.1	10.9	17.5	24.8	24.8	24.0	19.2	25.0	22.8	23.8	24.7	9.5	14.9	19.1	21.1	13.2	18.0	16.6	23.9	16.8	14.3	34.4	14.4	20.6	13.7	21.6	20.8	17.4	16.2	16.4	16.3	25.8	19.0	18.7	15.5	8.7	22.2	26.0	6.7	10.1	26.4	17.7	13.8	16.1	25.3	8.2	7.0	17.3	13.0	20.1	15.3	40.4	18.1	20.5	11.9	12.9	17.6	9.2	21.0	14.9	9.3	42.8	16.8	32.1	4.9	3.0	2.4	3.5	2.8	1.5	2.2	2.6	4.0	2.3	2.5	2.4	12.3	3.0	4.7	1.9	2.6	2.1	11.7	15.5	26.5	18.1	9.3	9.5	12.0	11.3	10.2	10.3
MBD4	MED1	ENSG00000129071	"Methyl-CpG binding domain 4, DNA glycosylase"	O95243	3	129430944-129440179	"Cancer-related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Hydrolase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002031	Supported		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA002031: AB_1079319"	"unprognostic (2.70e-2)"	"unprognostic (3.48e-3)"	"unprognostic (1.18e-2)"	"unprognostic (6.37e-2)"	"unprognostic (4.31e-2)"	"unprognostic (7.11e-2)"	"unprognostic (4.70e-2)"	"unprognostic (3.25e-2)"	"unprognostic (2.02e-2)"	"unprognostic (5.73e-2)"	"prognostic unfavourable (2.18e-4)"	"prognostic unfavourable (4.75e-4)"	"prognostic unfavourable (2.73e-6)"	"unprognostic (9.27e-2)"	"unprognostic (1.59e-2)"	"unprognostic (8.58e-2)"	"unprognostic (3.35e-2)"	18.1	14.5	14.9	41.9	19.0	26.2	22.8	22.1	16.3	24.0	17.2	14.2	11.2	16.0	16.6	17.8	14.1	15.3	17.4	22.0	15.3	12.8	24.1	30.1	19.0	41.6	17.6	13.7	26.5	18.9	14.8	23.8	17.4	13.6	14.7	16.2	8.4	16.2	16.2	18.2	16.0	21.9	14.7	15.9	34.2	18.7	11.3	15.4	30.4	16.0	14.7	47.8	18.3	18.0	40.3	8.7	19.6	9.5	9.3	15.1	8.7	19.3	11.8	14.3	16.0	16.5	14.8	16.6	16.8	16.0	16.1	19.3	14.4	13.1	27.4	13.7	10.4	17.6	10.9	10.4	19.7	15.4	7.2	16.4	13.5	10.3	26.4	29.8	21.8	17.6	14.9	13.7	12.2	15.2	18.2	20.7	11.9	18.0	17.2	21.0	12.6	10.1	16.2	8.5	18.8	17.9	9.7	16.1	9.0	21.2	11.1	17.6	14.1	26.5	10.0	15.4	11.8	16.4	11.1	14.1	8.5	48.0	13.1	17.0	12.6	19.6	8.7	11.6	11.5	7.8	8.7	40.3	12.3	11.3	7.3	36.0	15.1	12.6	15.4	9.3	9.5	8.7	10.5	8.7	14.9	19.0	22.1	16.3	15.3	12.8	17.6	13.7	13.6	15.4
MECOM	"EVI1, KMT8E, MDS1, MDS1-EVI1, PRDM3"	ENSG00000085276	"MDS1 and EVI1 complex locus"	Q03112	3	169083499-169663618	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Methyltransferase, Transferase"	"Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 21.5;RPTEC TERT1: 27.6;RT4: 43.5;TIME: 20.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"NK-cell: 1.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA046537	Supported		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA046537: "	"unprognostic (4.09e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.24e-3)"	"unprognostic (7.29e-2)"	"unprognostic (2.87e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.83e-2)"	"unprognostic (4.77e-3)"	"unprognostic (1.53e-2)"	"unprognostic (3.27e-3)"	"prognostic unfavourable (2.59e-4)"	"unprognostic (1.87e-1)"	"unprognostic (2.60e-3)"	"unprognostic (6.54e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.81e-2)"	"unprognostic (3.37e-3)"	25.9	0.7	3.3	5.7	5.6	0.3	9.1	3.4	5.3	13.5	13.9	1.6	22.1	11.2	15.4	5.7	10.4	14.3	8.1	8.2	3.3	2.9	32.2	2.6	30.0	1.5	4.6	1.4	6.2	27.8	1.1	5.3	10.0	4.7	9.3	17.5	4.2	5.9	25.3	16.0	2.3	5.9	5.6	5.8	6.4	39.4	2.7	3.5	0.2	4.7	3.3	3.5	18.1	18.5	0.3	0.0	0.6	1.5	1.8	1.0	0.0	9.6	0.1	0.2	0.0	1.3	1.0	0.1	1.3	1.5	0.5	0.8	3.8	9.9	0.0	15.2	0.2	5.1	4.0	5.9	1.1	0.5	6.3	6.1	1.6	0.1	0.1	0.0	1.9	2.1	0.8	0.3	4.5	21.5	4.6	0.7	3.8	1.0	0.0	0.0	0.2	2.5	3.6	4.9	0.2	27.6	43.5	0.3	1.1	0.4	2.5	0.1	2.9	0.0	20.4	3.8	2.5	1.0	6.4	0.5	0.1	0.3	1.9	0.0	0.5	0.3	0.0	0.6	0.4	0.2	1.0	0.1	0.1	0.0	0.0	0.3	0.2	0.0	0.3	1.8	1.5	0.0	0.1	0.0	3.3	5.6	3.4	5.3	3.3	2.9	4.6	1.4	4.7	3.5
MKL2	"FLJ31823, MRTF-B"	ENSG00000186260	"MKL1/myocardin like 2"	Q9ULH7	16	14071321-14266773	"Disease related genes, Predicted intracellular proteins"	"Differentiation, Myogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011286	Enhanced		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA011286: AB_1853973"	"unprognostic (2.00e-1)"	"unprognostic (5.28e-1)"	"unprognostic (1.30e-2)"	"unprognostic (3.62e-1)"	"unprognostic (7.16e-2)"	"unprognostic (7.14e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.19e-1)"	"unprognostic (2.32e-1)"	"prognostic favourable (6.20e-4)"	"unprognostic (5.22e-2)"	"unprognostic (3.55e-1)"	"unprognostic (2.47e-2)"	"unprognostic (5.96e-2)"	25.2	9.8	32.5	7.7	44.9	5.5	22.0	7.4	47.8	19.0	9.1	5.1	9.2	8.9	18.1	8.8	13.7	13.5	12.4	13.2	18.3	9.0	8.2	8.0	16.2	7.0	7.7	26.8	8.2	10.9	28.2	16.4	19.6	8.5	15.2	10.5	8.3	15.0	15.4	11.1	15.9	9.6	14.7	9.9	4.7	10.3	15.4	12.1	2.6	16.3	6.8	7.4	14.0	15.1	7.1	3.7	0.9	1.5	2.3	5.0	1.2	12.8	13.3	14.1	10.1	4.5	8.6	6.4	3.7	10.3	5.7	8.6	5.9	12.6	7.1	9.6	6.2	10.6	9.7	10.8	10.5	16.8	5.3	4.8	10.6	9.8	6.4	3.2	4.2	7.0	11.5	9.8	6.6	11.0	5.8	8.7	4.4	11.0	9.6	2.4	4.5	3.9	15.3	10.5	6.5	5.7	13.3	4.9	8.5	17.9	7.7	3.7	13.7	2.6	7.5	11.9	11.6	3.4	4.8	5.9	6.2	6.7	12.8	5.4	8.9	0.4	1.0	0.3	2.7	1.4	3.6	7.1	4.0	2.0	1.5	3.9	5.0	3.0	0.9	2.3	1.5	3.7	1.8	1.2	32.5	44.9	7.4	47.8	18.3	9.0	7.7	26.8	8.5	12.1
MORF4L1	"Eaf3, HsT17725, MEAF3, MORFRG15, MRG15"	ENSG00000185787	"Mortality factor 4 like 1"	Q9UBU8	15	78810487-78898133	"Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Growth regulation, Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042360, HPA062010"	Approved		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA042360: AB_10794275, HPA062010: "	"unprognostic (5.36e-2)"	"unprognostic (4.30e-1)"	"unprognostic (3.68e-1)"	"unprognostic (9.69e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.83e-3)"	"unprognostic (3.61e-3)"	"unprognostic (8.61e-3)"	"unprognostic (3.15e-1)"	"unprognostic (3.58e-2)"	"unprognostic (6.96e-2)"	"unprognostic (3.69e-1)"	"unprognostic (5.77e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.12e-1)"	"unprognostic (3.92e-2)"	"unprognostic (2.60e-3)"	49.3	57.8	59.9	40.8	60.9	66.9	44.2	76.6	70.6	55.5	50.1	32.5	37.5	29.8	58.8	41.7	45.3	48.1	46.5	85.0	54.8	75.3	60.9	46.0	43.3	40.5	71.1	52.6	68.2	32.2	44.5	60.1	60.1	60.1	45.7	41.8	41.5	41.6	54.6	89.5	28.2	46.2	63.6	58.8	37.2	40.3	215.8	40.7	23.0	65.0	38.3	48.0	57.0	92.6	45.9	61.3	51.6	53.8	37.5	72.5	73.3	46.6	63.5	115.6	48.0	83.4	86.8	61.3	85.4	83.5	76.0	73.8	57.1	71.0	56.8	70.4	85.5	58.9	140.5	57.3	72.2	57.3	56.3	63.1	68.3	52.8	85.8	52.3	57.8	60.4	65.3	43.4	61.3	91.4	65.7	53.7	88.2	43.5	49.9	38.8	125.8	28.0	56.0	90.4	55.4	62.4	64.0	60.1	62.6	76.0	49.1	107.3	59.1	70.0	70.7	92.0	65.4	48.7	71.5	35.0	95.8	64.1	56.7	84.2	67.0	25.9	53.8	51.6	36.2	50.6	43.2	45.9	52.4	40.8	61.3	43.6	72.5	52.0	43.2	37.5	39.8	58.7	56.1	73.3	59.9	60.9	76.6	70.6	54.8	75.3	71.1	52.6	60.1	40.7
MSX2	"CRS2, FPP, HOX8, MSH, PFM, PFM1"	ENSG00000120149	"Msh homeobox 2"	P35548	5	174724533-174730893	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Osteogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Craniosynostosis, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 44.7;urinary bladder: 18.2"	"Cell line enriched"	"Detected in some"	6	"BEWO: 83.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	7	"cerebellum: 6.9"	"Low region specificity"	"Detected in single"			HPA005652	Uncertain		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA005652: AB_1079418"	"unprognostic (1.29e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.84e-1)"	"prognostic favourable (8.43e-5)"	"unprognostic (2.50e-2)"	"unprognostic (1.22e-2)"	"unprognostic (3.13e-1)"	"prognostic unfavourable (6.93e-4)"	"unprognostic (2.08e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.51e-2)"	"unprognostic (7.26e-2)"	"unprognostic (1.36e-4)"	"unprognostic (7.64e-3)"	"unprognostic (5.06e-2)"	"unprognostic (2.12e-6)"	"unprognostic (1.43e-2)"	2.0	0.4	0.3	0.4	0.5	0.0	7.6	6.3	1.6	2.6	0.9	2.0	0.0	0.3	6.2	0.2	0.9	1.1	1.5	1.7	2.5	0.5	0.3	0.1	0.9	0.1	1.5	1.2	0.4	0.6	9.4	0.5	44.7	7.2	6.3	0.1	6.6	0.9	0.8	2.1	6.4	0.9	10.4	6.6	1.1	2.6	5.2	1.3	0.0	0.8	0.2	0.3	18.2	2.4	0.0	0.0	0.0	0.0	0.2	0.5	0.1	0.1	1.0	0.2	0.8	0.0	0.0	83.8	0.5	0.9	0.2	0.0	14.2	5.8	0.0	2.2	0.0	1.5	4.5	1.6	0.0	0.0	2.7	0.0	0.3	0.0	0.6	0.0	0.7	0.9	1.1	0.8	0.9	0.0	0.0	0.0	1.2	6.9	0.0	0.1	0.6	2.2	0.0	2.2	0.0	1.0	8.9	0.0	0.6	0.0	11.0	0.7	6.6	0.0	0.0	0.2	1.4	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.1	0.0	0.0	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.1	0.3	0.5	6.3	1.6	2.5	0.5	1.5	1.2	7.2	1.3
NCAPG2	"CAP-G2, FLJ20311, hCAP-G2, LUZP5, MTB"	ENSG00000146918	"Non-SMC condensin II complex subunit G2"	Q86XI2	7	158631311-158704829	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA condensation, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 39.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026631, HPA049637"	Approved		Supported	"Nucleoplasm,Nuclear speckles"				Nucleoplasm	"Nuclear speckles"	"HPA026631: AB_1845983, HPA049637: "	"unprognostic (2.73e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.81e-2)"	"prognostic unfavourable (7.94e-4)"	"unprognostic (1.66e-1)"	"prognostic favourable (1.91e-4)"	"prognostic unfavourable (3.00e-5)"	"unprognostic (5.33e-3)"	"prognostic unfavourable (3.21e-4)"	"unprognostic (7.79e-2)"	"prognostic unfavourable (8.50e-4)"	"unprognostic (5.19e-2)"	"prognostic unfavourable (4.06e-5)"	"unprognostic (2.58e-3)"	"unprognostic (1.28e-1)"	"unprognostic (8.21e-2)"	"unprognostic (7.37e-2)"	5.9	4.0	4.4	8.6	4.2	20.1	5.4	9.0	5.1	4.4	6.6	5.8	3.5	4.2	5.1	5.1	9.9	3.7	3.1	4.0	4.3	3.5	3.3	3.9	4.4	11.4	6.2	4.2	4.4	4.4	6.0	5.8	6.9	4.9	4.5	7.7	3.9	5.3	4.2	4.5	6.5	5.5	4.6	6.2	6.1	5.3	14.6	5.1	39.1	3.6	7.6	13.0	4.8	5.5	1.8	2.8	6.9	5.4	6.1	9.3	2.5	29.7	15.8	19.3	12.4	2.9	4.7	7.7	21.8	14.1	27.0	30.3	14.0	15.6	18.4	13.6	8.9	15.3	16.0	10.0	36.1	19.6	11.9	16.6	19.7	11.0	1.3	20.5	18.8	2.0	1.1	22.0	6.3	15.0	20.3	27.7	24.8	31.6	34.0	13.9	19.0	12.8	20.0	20.3	17.5	6.7	13.4	21.1	16.3	26.9	10.5	5.9	9.5	13.4	7.8	18.5	14.1	49.9	34.9	18.3	13.5	22.4	19.6	26.2	35.1	6.9	1.0	1.2	6.5	1.4	9.3	1.8	6.6	4.5	2.8	1.2	2.2	2.4	0.6	6.1	5.4	1.4	8.3	2.5	4.4	4.2	9.0	5.1	4.3	3.5	6.2	4.2	4.9	5.1
NFATC4	NFAT3	ENSG00000100968	"Nuclear factor of activated T cells 4"	Q14934	14	24365673-24379604	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 19.7;BJ hTERT+: 25.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"HPA031641, CAB032859, HPA076526"	Uncertain		Supported	"Nuclear speckles,Cytosol"				"Nuclear speckles, Cytosol"		"CAB032859: AB_1128521, HPA031641: AB_10600826, HPA076526: "	"unprognostic (3.51e-1)"	"unprognostic (5.61e-2)"	"prognostic unfavourable (5.84e-4)"	"unprognostic (8.08e-2)"	"unprognostic (1.67e-1)"	"unprognostic (6.57e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.39e-1)"	"unprognostic (9.11e-2)"	"prognostic unfavourable (1.81e-6)"	"unprognostic (1.47e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.35e-1)"	"unprognostic (4.19e-2)"	9.0	11.3	4.3	5.5	6.7	0.4	10.9	4.2	5.1	28.2	14.0	3.3	8.9	3.4	19.0	11.4	9.1	13.8	21.6	7.8	4.9	1.3	6.4	0.9	5.6	3.3	8.0	4.1	33.1	2.7	8.4	8.6	14.0	6.3	14.8	3.9	9.3	4.0	13.5	4.6	6.9	5.9	20.9	2.8	4.2	7.7	9.6	3.1	1.5	11.0	5.9	5.8	22.3	14.7	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	0.0	13.4	19.7	0.0	8.8	25.4	12.0	10.5	0.0	7.4	7.4	0.2	12.6	0.0	3.6	0.1	7.3	0.0	0.3	5.7	9.2	0.0	6.5	0.0	0.0	14.2	0.1	7.2	0.0	9.3	1.8	0.0	2.3	0.4	0.0	0.8	1.1	0.0	0.5	0.8	1.0	0.0	0.1	1.5	6.3	0.0	1.7	2.9	5.3	2.3	5.3	11.2	2.3	10.5	0.0	5.4	0.7	5.2	2.3	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	4.3	6.7	4.2	5.1	4.9	1.3	8.0	4.1	6.3	3.1
NFKBIZ	"FLJ34463, INAP, MAIL"	ENSG00000144802	"NFKB inhibitor zeta"	Q9BYH8	3	101827991-101861022	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 116.9"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 31.3;RPTEC TERT1: 31.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 20.0"	"Group enriched"	"Detected in many"	4	"granulocytes: 15.8;monocytes: 20.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA010547, HPA075363"	Enhanced		Supported	"Nuclear speckles,Cytoplasmic bodies"				"Nuclear speckles"	"Cytoplasmic bodies"	"HPA010547: AB_1854442, HPA075363: "	"unprognostic (2.20e-2)"	"unprognostic (1.11e-2)"	"unprognostic (6.76e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.62e-1)"	"unprognostic (9.22e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.40e-1)"	"unprognostic (8.82e-2)"	"prognostic unfavourable (4.30e-8)"	"unprognostic (2.69e-1)"	"unprognostic (8.90e-2)"	"unprognostic (3.30e-1)"	"unprognostic (8.52e-3)"	26.4	4.4	2.2	35.5	3.4	116.9	46.9	2.4	2.0	17.4	23.7	3.6	5.5	16.8	21.3	13.0	22.1	39.5	31.5	17.3	2.8	1.9	13.8	26.8	29.6	21.3	4.4	0.3	18.2	15.7	2.4	7.2	18.8	5.0	16.3	10.4	10.9	37.4	8.1	9.8	21.0	18.5	17.9	5.2	21.5	16.8	7.1	3.3	3.3	26.5	30.8	23.8	18.7	20.0	3.2	3.8	15.8	20.0	0.5	4.1	1.1	2.7	2.2	1.5	1.9	4.4	7.6	2.4	11.3	31.3	5.0	4.8	2.6	3.4	5.2	14.5	3.0	8.9	1.1	4.9	13.1	15.2	1.0	4.9	3.9	1.4	6.8	0.3	0.3	5.2	7.7	13.4	6.2	3.7	0.8	10.8	7.1	3.5	0.1	2.9	2.6	6.7	0.6	6.9	0.7	31.4	18.3	0.7	0.9	1.9	2.3	12.2	2.7	2.1	4.6	8.1	8.2	3.0	3.6	9.1	3.1	3.6	14.8	1.0	1.1	4.9	3.6	1.0	1.0	8.3	1.1	1.9	1.4	1.0	2.4	3.2	4.1	2.7	15.8	0.5	20.0	3.8	0.7	1.1	2.2	3.4	2.4	2.0	2.8	1.9	4.4	0.3	5.0	3.3
NONO	"NMT55, NRB54, P54, P54NRB, PPP1R114"	ENSG00000147140	"Non-POU domain containing octamer binding"	Q15233	X	71283192-71301168	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, DNA damage, DNA recombination, DNA repair, Immunity, Innate immunity, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor, RNA-binding"	"Cancer-related genes, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022069, HPA054094, HPA054559"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli fibrillar center,Nuclear speckles"			150000	Nucleoplasm	"Nucleoli fibrillar center, Nuclear speckles"	"CAB022069: , HPA054094: AB_2682376, HPA054559: AB_2682522"	"unprognostic (2.39e-3)"	"unprognostic (2.22e-2)"	"unprognostic (2.64e-1)"	"prognostic unfavourable (9.29e-4)"	"unprognostic (8.87e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.02e-3)"	"unprognostic (9.34e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.12e-1)"	"unprognostic (2.07e-1)"	"unprognostic (7.29e-3)"	"unprognostic (6.79e-2)"	"unprognostic (5.73e-3)"	"unprognostic (2.76e-2)"	"unprognostic (3.04e-2)"	37.2	55.9	30.2	37.7	30.8	51.2	37.2	54.8	38.6	45.4	33.4	36.0	38.4	29.9	52.4	40.5	41.0	40.5	37.2	30.5	27.5	29.0	40.1	43.3	37.3	45.7	28.8	31.7	69.2	61.0	39.4	48.2	42.4	27.5	40.8	37.5	42.5	39.8	41.4	37.2	38.4	35.2	40.5	38.3	45.9	40.3	34.4	29.0	98.4	51.0	39.1	57.4	43.6	36.8	44.1	47.3	35.3	51.8	45.4	51.8	58.9	58.5	64.8	89.7	49.2	36.6	37.8	49.1	48.0	44.7	65.0	57.4	51.4	43.5	66.6	53.5	44.2	43.8	133.8	41.7	71.6	50.7	89.4	54.6	68.0	51.1	31.0	76.6	48.0	40.0	29.8	65.7	44.1	53.3	69.6	69.9	59.9	52.0	99.0	69.8	111.6	52.6	89.1	94.0	57.1	49.8	51.8	62.3	77.3	62.2	40.6	55.1	38.2	49.6	48.9	42.1	63.2	58.8	55.5	40.3	76.3	75.8	31.4	89.1	60.1	35.3	44.8	34.9	45.8	47.6	51.8	43.7	46.6	44.9	47.3	44.1	50.8	50.2	20.8	45.4	51.8	41.2	50.1	58.9	30.2	30.8	54.8	38.6	27.5	29.0	28.8	31.7	27.5	29.0
NR4A2	"HZF-3, NOT, NURR1, RNR1, TINUR"	ENSG00000153234	"Nuclear receptor subfamily 4 group A member 2"	P43354	2	156324432-156342348	"Cancer-related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"seminal vesicle: 102.1"	"Cell line enhanced"	"Detected in many"		"HeLa: 14.2;HMC-1: 10.5;U-266/70: 14.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 10.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA000543, CAB010481"	Uncertain		Supported	"Nuclear speckles"				"Nuclear speckles"		"CAB010481: AB_2298676, HPA000543: AB_1854631"	"unprognostic (4.26e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.42e-2)"	"unprognostic (4.10e-2)"	"unprognostic (3.04e-2)"	"unprognostic (5.26e-2)"	"unprognostic (2.30e-1)"	"unprognostic (6.14e-2)"	"unprognostic (8.63e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.89e-1)"	"unprognostic (2.39e-2)"	"unprognostic (3.58e-2)"	"unprognostic (3.43e-1)"	"unprognostic (9.29e-3)"	"unprognostic (1.11e-1)"	15.0	58.5	3.1	10.2	5.7	49.1	7.5	15.2	14.4	9.1	4.2	7.3	11.0	1.4	6.4	7.5	5.7	13.6	21.3	15.8	5.2	2.6	5.9	7.6	12.5	2.8	4.8	4.2	60.0	4.2	8.7	23.7	2.3	5.1	11.7	8.5	5.3	18.0	102.1	6.1	5.3	6.0	8.4	5.9	2.1	8.3	3.8	3.7	2.1	6.8	8.0	5.3	17.8	7.5	0.7	2.8	10.1	2.3	0.0	1.6	0.6	0.8	1.2	0.5	1.7	3.1	0.6	0.8	1.0	5.2	0.4	1.3	0.0	3.6	0.0	1.2	0.4	1.5	2.5	0.7	0.4	1.2	1.3	0.9	14.2	0.0	0.6	0.8	10.5	0.6	1.1	0.4	0.4	0.3	1.4	1.0	1.0	1.7	0.0	0.8	2.2	0.9	0.2	0.7	3.0	0.6	0.8	2.6	0.1	2.5	3.9	6.9	0.2	0.9	0.7	2.8	0.8	0.7	0.4	14.2	1.5	0.0	5.2	0.9	6.6	3.0	2.3	3.4	1.6	0.5	0.9	0.7	0.5	0.8	2.8	0.5	0.9	0.4	10.1	0.0	0.9	0.0	0.5	0.6	3.1	5.7	15.2	14.4	5.2	2.6	4.8	4.2	5.1	3.7
NSL1	"C1orf48, DC8, DKFZP566O1646, MIS14"	ENSG00000117697	"NSL1, MIS12 kinetochore complex component"	Q96IY1	1	212726153-212791782	"Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA045761, HPA053721"	Enhanced		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA045761: , HPA053721: "	"unprognostic (1.47e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.08e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.58e-2)"	"unprognostic (1.78e-2)"	"unprognostic (8.22e-3)"	"unprognostic (3.55e-1)"	"unprognostic (4.78e-2)"	"unprognostic (6.09e-3)"	"unprognostic (3.44e-3)"	"unprognostic (1.58e-1)"	"unprognostic (3.10e-3)"	"unprognostic (2.59e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.67e-1)"	"unprognostic (6.66e-2)"	15.1	14.6	23.1	16.5	26.3	16.1	19.7	22.9	20.6	14.5	12.9	27.2	9.9	15.4	14.9	12.3	14.2	13.8	13.2	21.5	23.9	21.5	17.4	20.6	12.5	22.0	25.6	15.0	17.1	10.9	12.0	19.2	17.2	20.7	13.9	11.8	12.8	12.4	11.3	19.4	8.3	17.1	13.3	36.0	18.9	11.5	12.4	25.0	24.4	14.9	8.8	16.2	16.3	11.4	33.1	32.4	35.3	35.6	24.4	29.9	31.2	14.7	17.5	18.8	17.2	9.6	9.3	23.4	12.5	10.0	16.8	14.9	14.8	16.6	21.7	11.6	7.8	11.2	17.7	13.1	14.6	39.6	13.4	14.3	14.7	23.5	9.2	23.6	14.0	8.8	7.7	16.8	9.2	12.7	31.5	18.8	12.7	8.9	30.3	11.9	33.7	13.1	26.4	27.7	24.4	16.4	7.6	16.2	22.9	18.0	8.8	21.2	25.4	17.5	12.7	16.0	13.6	14.4	20.5	10.5	28.1	27.7	13.9	16.6	19.5	12.7	29.1	35.3	22.7	35.6	26.6	33.1	24.6	24.3	32.4	26.9	29.9	26.6	29.4	24.4	35.1	31.4	28.5	31.2	23.1	26.3	22.9	18.9	23.9	21.5	25.6	15.0	20.7	25.0
OIP5	"CT86, hMIS18beta, MIS18B"	ENSG00000104147	"Opa interacting protein 5"	O43482	15	41309268-41332621	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 16.7;testis: 41.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA052271, HPA059602"	Enhanced		Supported	"Nuclear speckles,Vesicles"				"Nuclear speckles, Vesicles"		"HPA052271: , HPA059602: "	"unprognostic (5.17e-2)"	"unprognostic (7.26e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.59e-2)"	"unprognostic (6.94e-2)"	"unprognostic (6.58e-2)"	"prognostic unfavourable (1.79e-4)"	"prognostic unfavourable (2.26e-4)"	"unprognostic (2.71e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavourable (9.34e-5)"	"unprognostic (5.51e-2)"	"unprognostic (0.00e+0)"	"unprognostic (3.84e-2)"	"unprognostic (2.02e-1)"	"unprognostic (5.75e-2)"	"unprognostic (2.86e-2)"	1.3	2.1	0.5	3.8	0.8	7.5	0.7	1.5	1.1	1.1	3.4	0.7	2.3	3.0	0.6	0.6	4.6	0.6	1.3	1.9	0.9	0.4	1.1	1.1	1.0	4.3	0.6	0.4	1.2	0.6	0.0	0.3	1.6	0.5	0.5	3.1	0.2	1.2	1.3	8.3	2.5	3.1	0.6	0.8	2.7	1.4	41.7	0.7	16.7	0.5	6.3	4.0	0.7	1.5	2.5	7.7	1.1	1.3	1.9	5.9	1.7	13.3	7.1	14.0	10.2	0.7	0.9	13.4	8.2	3.8	9.9	10.7	12.6	6.6	7.9	7.2	3.0	20.8	14.2	6.3	7.8	17.1	16.4	16.8	20.7	13.1	0.1	18.3	9.5	0.3	1.3	5.6	5.9	8.4	23.0	15.4	6.6	6.4	10.7	13.7	12.7	15.5	13.3	11.7	12.0	4.4	6.1	22.3	7.4	13.6	13.9	3.8	13.8	10.5	4.1	10.2	15.8	10.1	14.6	7.3	32.2	28.2	2.9	22.4	14.6	0.0	0.8	1.1	0.6	1.3	1.5	2.1	1.8	1.6	1.4	2.5	2.6	1.7	0.0	1.9	0.8	7.7	5.9	1.7	0.5	0.8	1.5	1.1	0.9	0.4	0.6	0.4	0.5	0.7
PARN	DAN	ENSG00000140694	"Poly(A)-specific ribonuclease"	O95453	16	14435701-14632728	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Nonsense-mediated mRNA decay"	"Exonuclease, Hydrolase, Nuclease, RNA-binding"	"Disease mutation, Dyskeratosis congenita"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006314, CAB011673, HPA012010"	Supported		Supported	"Nuclear speckles"				"Nuclear speckles"		"CAB011673: AB_778216, HPA006314: AB_1079567, HPA012010: AB_1854976"	"unprognostic (2.54e-1)"	"unprognostic (3.43e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.28e-1)"	"prognostic unfavourable (4.64e-4)"	"unprognostic (2.99e-3)"	"unprognostic (5.07e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.16e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.25e-2)"	"unprognostic (2.46e-1)"	"unprognostic (3.10e-3)"	"unprognostic (1.09e-2)"	19.4	25.9	14.9	23.5	19.1	12.5	19.8	16.8	23.5	21.3	21.0	22.7	23.3	14.4	24.6	29.0	19.0	19.4	22.5	18.4	15.4	19.0	17.9	18.9	26.7	31.6	22.2	17.9	21.8	22.7	37.4	26.0	21.9	21.0	21.4	21.8	21.0	18.9	31.0	19.2	21.0	18.8	28.7	18.3	20.1	19.6	25.4	19.6	29.4	27.8	14.0	26.8	25.6	19.3	16.1	15.6	13.3	14.8	15.0	17.8	11.0	11.8	13.9	7.3	9.2	12.2	14.0	8.5	10.0	14.1	12.5	12.0	7.7	11.0	21.0	25.5	11.5	12.8	16.8	11.3	17.4	17.8	9.9	14.4	9.6	17.1	12.8	17.1	14.4	12.7	14.2	11.2	16.1	8.4	12.3	11.9	12.2	14.6	17.2	11.1	9.9	8.3	22.8	16.5	21.2	8.5	8.2	9.2	6.6	20.5	11.1	13.8	11.8	9.9	7.7	12.2	6.4	6.6	10.2	12.1	12.9	25.7	13.4	12.6	13.4	11.9	11.1	13.3	13.5	14.8	13.9	16.1	13.1	15.5	15.6	13.9	17.8	17.8	7.2	15.0	14.3	10.8	14.7	11.0	14.9	19.1	16.8	23.5	15.4	19.0	22.2	17.9	21.0	19.6
PLAG1	ZNF912	ENSG00000181690	"PLAG1 zinc finger"	Q6DJT9	8	56160904-56211324	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 13.0;ASC TERT1: 17.2;HSkMC: 12.2;hTERT-HME1: 12.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA072290			Supported	"Nucleoplasm,Nuclear speckles,Centrosome,Cytosol"				"Nucleoplasm, Nuclear speckles"	"Centrosome, Cytosol"	"HPA072290: "	"unprognostic (1.89e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.63e-4)"	"unprognostic (6.81e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.63e-3)"	"unprognostic (8.56e-2)"	"unprognostic (1.18e-1)"	"unprognostic (7.99e-2)"	"unprognostic (3.42e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.32e-3)"	"unprognostic (2.83e-2)"	"unprognostic (3.94e-1)"	"unprognostic (1.21e-2)"	"unprognostic (6.14e-2)"	1.9	3.6	2.4	3.5	2.9	2.1	2.5	11.0	2.7	7.6	3.8	4.1	9.0	3.4	3.4	9.8	2.0	7.5	2.1	6.8	1.9	1.8	3.7	1.2	4.6	6.7	4.8	2.1	11.6	2.2	2.1	17.8	8.0	4.6	5.1	1.6	7.9	7.5	9.2	1.4	3.4	5.5	2.5	6.3	6.2	3.0	5.2	4.5	11.7	3.5	1.5	5.2	4.8	7.0	3.5	0.2	1.1	0.5	0.7	4.6	1.0	1.5	0.0	9.5	0.1	13.0	17.2	3.0	4.2	5.5	2.0	0.9	0.6	4.9	0.2	4.1	2.3	0.3	2.6	5.6	2.0	0.1	5.8	6.0	0.5	1.4	2.7	1.9	1.8	12.2	3.1	1.1	12.6	3.7	2.5	0.1	4.2	0.0	0.5	3.6	2.7	1.4	4.7	0.7	3.7	2.6	0.5	0.1	0.0	0.1	0.0	0.3	0.1	1.8	5.6	2.9	3.8	4.7	1.0	1.5	1.1	2.2	3.3	0.7	0.8	1.1	0.1	1.1	0.3	0.1	0.2	3.5	1.0	0.6	0.1	2.0	4.6	4.3	1.0	0.7	0.5	0.2	0.2	1.0	2.4	2.9	11.0	2.7	1.9	1.8	4.8	2.1	4.6	4.5
PNISR	"bA98I9.2, C6orf111, DKFZp564B0769, FLJ14752, SFRS18, SRrp130"	ENSG00000132424	"PNN interacting serine and arginine rich protein"	Q8TF01	6	99398051-99425331	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038796, HPA075076"	Approved		Supported	"Nuclear speckles,Plasma membrane,Cytosol"				"Nuclear speckles"	"Plasma membrane, Cytosol"	"HPA038796: AB_10672652, HPA075076: "	"unprognostic (2.95e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.11e-1)"	"unprognostic (9.72e-3)"	"unprognostic (1.68e-2)"	"unprognostic (8.55e-3)"	"unprognostic (4.41e-2)"	"unprognostic (1.58e-3)"	"unprognostic (5.82e-2)"	"unprognostic (4.32e-3)"	"prognostic favourable (5.27e-4)"	"unprognostic (1.47e-2)"	"prognostic unfavourable (1.41e-4)"	"unprognostic (3.43e-2)"	"unprognostic (2.59e-1)"	"unprognostic (8.89e-2)"	"prognostic favourable (1.09e-4)"	24.7	28.5	48.9	28.3	49.8	53.7	29.9	123.3	69.7	35.5	38.3	22.8	39.9	26.7	43.1	58.7	19.8	29.4	22.3	31.0	46.9	17.5	25.5	21.7	26.6	42.2	48.0	29.8	49.3	24.7	34.7	83.9	21.7	41.0	34.1	28.2	24.1	30.8	34.5	39.4	31.9	34.4	31.5	61.0	39.3	28.2	17.4	57.1	32.1	44.7	18.0	30.7	29.5	30.3	18.0	13.1	20.4	7.4	15.6	12.3	2.2	11.3	7.7	41.3	28.3	14.7	21.9	19.1	18.0	9.9	10.8	13.4	13.8	20.7	34.9	12.1	10.1	17.4	20.7	15.7	21.9	28.6	23.1	20.2	38.3	13.8	11.2	28.0	28.7	21.5	22.4	12.0	15.7	15.7	23.5	22.9	14.2	11.4	13.3	32.2	23.1	7.1	26.9	11.6	12.4	21.2	19.7	16.7	22.1	9.0	11.7	15.4	15.6	24.7	17.3	10.9	12.8	10.6	15.4	15.9	11.0	32.0	16.4	28.9	12.6	6.9	7.4	6.6	8.6	4.2	8.5	12.0	8.4	6.8	3.3	18.0	12.3	11.8	20.4	15.6	4.8	13.1	7.7	2.2	48.9	49.8	123.3	69.7	46.9	17.5	48.0	29.8	41.0	57.1
PNN	memA	ENSG00000100941	"Pinin, desmosome associated protein"	Q9H307	14	39175183-39183218	"Predicted intracellular proteins, Transporters"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001378	Supported		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA001378: AB_1079648"	"unprognostic (9.28e-3)"	"unprognostic (5.07e-2)"	"unprognostic (5.46e-2)"	"unprognostic (3.91e-1)"	"unprognostic (7.38e-3)"	"unprognostic (7.40e-2)"	"prognostic unfavourable (5.79e-4)"	"unprognostic (1.65e-2)"	"unprognostic (1.67e-3)"	"unprognostic (3.75e-2)"	"unprognostic (3.70e-2)"	"prognostic unfavourable (2.44e-4)"	"unprognostic (1.51e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.00e-1)"	"unprognostic (4.30e-2)"	21.7	25.3	38.9	38.4	50.8	57.5	26.1	54.3	39.3	31.0	30.0	26.4	34.6	27.9	40.4	66.6	29.5	29.6	21.6	19.1	40.1	18.4	27.3	45.7	24.2	40.7	43.9	31.2	36.6	31.3	31.3	61.3	26.7	44.8	33.9	32.0	18.7	26.7	24.5	37.7	27.0	36.0	34.7	49.1	42.6	26.9	21.7	50.4	32.7	37.1	25.9	32.8	28.4	39.9	20.8	15.8	20.4	10.5	10.6	13.5	3.9	32.1	15.4	42.2	20.7	9.8	8.6	31.1	25.7	7.2	17.7	17.1	24.5	50.6	49.7	16.4	11.2	33.9	31.9	17.5	30.9	22.4	22.7	33.0	46.6	54.1	8.1	42.7	24.2	11.8	15.3	16.1	13.4	11.3	31.2	28.0	14.5	26.5	30.2	36.6	28.0	22.7	40.1	31.5	13.3	14.6	49.1	21.0	11.8	26.5	20.4	14.8	25.1	24.7	20.8	25.9	20.5	12.0	30.2	23.0	18.2	42.8	13.0	35.5	15.4	5.1	10.2	15.1	13.2	8.0	12.2	14.8	9.0	8.0	8.3	20.8	13.5	12.3	20.4	10.6	10.5	15.8	9.7	3.9	38.9	50.8	54.3	39.3	40.1	18.4	43.9	31.2	44.8	50.4
POLI	"RAD30B, RAD3OB"	ENSG00000101751	"DNA polymerase iota"	Q9UNA4	18	54269404-54321266	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication, DNA synthesis"	"DNA-binding, DNA-directed DNA polymerase, Mutator protein, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012000, HPA064696"	Enhanced		Supported	"Nuclear speckles,Cytoplasmic bodies"				"Nuclear speckles"	"Cytoplasmic bodies"	"HPA012000: AB_1847786, HPA064696: "	"unprognostic (1.64e-1)"	"unprognostic (5.79e-3)"	"unprognostic (9.72e-3)"	"unprognostic (4.92e-2)"	"unprognostic (3.04e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.05e-2)"	"unprognostic (4.04e-3)"	"unprognostic (2.22e-2)"	"unprognostic (2.07e-3)"	"unprognostic (1.30e-3)"	"unprognostic (1.55e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.52e-2)"	"unprognostic (6.99e-2)"	16.5	11.1	10.2	9.5	14.0	5.2	15.8	9.6	14.7	12.9	9.9	13.4	13.7	6.6	13.2	13.1	6.6	10.3	8.3	9.1	8.7	7.6	12.9	6.4	9.0	7.4	10.9	9.0	16.4	11.8	17.6	21.3	17.4	15.3	12.7	7.7	9.6	11.3	14.7	7.2	8.2	7.6	10.9	12.0	8.2	9.0	30.5	10.9	17.3	27.3	1.5	7.0	12.7	10.5	9.9	10.3	10.9	10.7	7.9	12.7	7.1	7.7	2.8	21.3	12.9	7.2	14.1	6.9	6.4	13.8	7.4	12.4	2.1	7.4	3.7	2.1	9.3	6.4	5.0	7.3	8.3	8.8	2.5	4.6	3.2	5.4	11.8	7.3	3.8	15.2	11.2	6.4	13.4	15.6	3.1	10.5	12.3	6.1	5.2	6.4	7.3	3.1	3.3	4.3	9.1	8.4	10.3	10.0	10.2	4.6	4.1	6.8	14.8	3.3	7.5	13.9	3.8	2.1	5.3	8.5	1.9	5.2	9.9	6.6	10.1	5.4	10.7	10.9	8.3	5.7	7.7	8.6	8.8	8.6	10.3	9.9	12.7	7.6	6.7	7.9	5.8	8.1	9.8	7.1	10.2	14.0	9.6	14.7	8.7	7.6	10.9	9.0	15.3	10.9
POLR2D	RBP4	ENSG00000144231	"RNA polymerase II subunit D"	O15514	2	127843551-127858157	"Plasma proteins, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 46.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034694, HPA046092"	Approved		Supported	"Nucleoplasm,Nuclear speckles"				"Nucleoplasm, Nuclear speckles"		"HPA034694: , HPA046092: AB_10963049"	"unprognostic (3.57e-2)"	"unprognostic (3.76e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.54e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavourable (8.91e-4)"	"unprognostic (2.51e-1)"	"unprognostic (7.95e-3)"	"unprognostic (2.64e-3)"	"unprognostic (1.97e-1)"	"unprognostic (2.51e-1)"	"prognostic unfavourable (2.79e-4)"	"unprognostic (3.66e-2)"	"unprognostic (6.57e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.38e-1)"	8.2	9.4	8.1	8.9	9.1	17.9	7.9	9.3	12.6	6.9	7.7	12.3	6.9	6.3	7.5	6.2	9.8	7.7	7.6	7.3	7.8	6.3	6.3	13.5	7.2	11.8	9.9	7.5	10.3	17.4	7.4	9.4	10.2	8.7	7.2	9.9	7.3	7.6	6.5	21.9	8.9	7.8	9.8	8.8	11.1	7.8	46.4	9.9	16.7	6.3	9.1	16.8	8.0	7.2	16.7	20.6	11.4	22.1	16.7	21.0	14.3	18.2	11.9	22.2	15.5	8.3	9.1	17.8	17.5	8.3	21.1	18.9	26.9	15.1	28.4	15.1	11.7	9.7	31.8	15.1	32.8	16.6	17.3	28.0	11.9	24.7	9.7	30.0	15.6	6.4	11.4	28.2	16.2	13.7	39.0	25.5	12.0	14.5	29.8	13.7	31.1	13.8	28.7	23.5	25.5	7.0	12.5	13.8	18.5	11.8	14.6	14.7	16.3	20.8	13.8	18.3	25.8	10.3	20.1	30.1	48.7	51.0	15.9	15.0	18.0	5.7	15.8	11.4	19.4	21.5	18.1	16.7	15.6	16.9	20.6	15.1	21.0	17.8	5.0	16.7	22.1	13.5	13.9	14.3	8.1	9.1	9.3	12.6	7.8	6.3	9.9	7.5	8.7	9.9
POMP	"C13orf12, HSPC014, UMP1"	ENSG00000132963	"Proteasome maturation protein"	Q9Y244	13	28659104-28678925	"Disease related genes, Predicted intracellular proteins"		Chaperone	"Ichthyosis, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026995	Approved		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA026995: AB_1845546"	"unprognostic (2.00e-1)"	"unprognostic (3.56e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.15e-1)"	"unprognostic (8.58e-2)"	"prognostic unfavourable (2.05e-5)"	"unprognostic (2.71e-3)"	"unprognostic (2.50e-2)"	"unprognostic (9.90e-2)"	"unprognostic (4.35e-2)"	"unprognostic (4.83e-2)"	"unprognostic (4.93e-1)"	"unprognostic (1.39e-3)"	"unprognostic (1.70e-2)"	"unprognostic (9.41e-2)"	"unprognostic (1.03e-2)"	"unprognostic (9.81e-2)"	35.4	31.5	44.5	29.3	37.7	27.4	28.8	21.1	38.2	24.2	32.2	17.7	19.6	27.5	21.1	41.4	30.1	20.3	22.9	52.7	38.4	36.3	38.6	58.4	27.8	28.4	48.2	32.1	18.5	22.9	11.7	21.9	48.4	38.1	23.5	33.9	18.0	20.4	26.7	68.2	20.6	35.0	28.3	40.4	31.5	24.1	32.5	29.2	31.3	30.9	44.7	33.0	29.3	19.9	36.7	62.7	38.5	57.3	24.9	35.9	41.6	23.0	28.5	30.4	35.4	35.1	39.5	28.4	53.0	47.4	53.5	42.8	55.6	52.7	40.9	32.4	41.1	34.5	39.8	41.3	73.1	30.8	30.6	38.4	30.9	42.6	48.8	46.3	32.0	31.7	43.2	38.5	35.9	42.1	48.8	16.8	68.3	40.8	39.0	66.3	52.5	33.8	37.8	46.4	27.4	60.2	36.5	35.7	27.5	23.8	34.2	35.7	23.8	54.2	37.9	25.6	26.1	40.3	43.8	14.4	25.7	57.7	30.5	31.5	55.9	31.8	45.5	27.3	30.2	57.3	26.3	36.5	31.1	33.6	53.9	36.7	22.1	31.5	38.5	24.9	56.1	62.7	35.9	41.6	44.5	37.7	21.1	38.2	38.4	36.3	48.2	32.1	38.1	29.2
PPIE	"CyP-33, MGC111222, MGC3736"	ENSG00000084072	"Peptidylprolyl isomerase E"	Q9UNP9	1	39692182-39763914	"Enzymes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Isomerase, RNA-binding, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA019357, HPA020131"	Approved		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA019357: , HPA020131: AB_1847405"	"unprognostic (2.94e-1)"	"unprognostic (4.32e-2)"	"unprognostic (6.34e-2)"	"unprognostic (6.97e-2)"	"unprognostic (5.99e-2)"	"unprognostic (8.41e-2)"	"prognostic unfavourable (1.76e-4)"	"unprognostic (3.52e-2)"	"unprognostic (2.69e-1)"	"unprognostic (3.88e-3)"	"unprognostic (1.25e-1)"	"unprognostic (9.29e-2)"	"prognostic unfavourable (5.05e-5)"	"unprognostic (5.86e-2)"	"unprognostic (3.95e-1)"	"unprognostic (9.06e-2)"	"unprognostic (1.00e-1)"	19.3	23.8	23.7	24.3	22.5	18.6	25.7	25.9	36.1	25.5	28.1	35.6	22.2	19.7	30.6	26.5	26.0	34.7	21.1	27.1	22.3	22.1	25.2	29.8	20.6	25.9	26.3	20.5	35.5	42.1	27.4	23.6	21.9	24.9	26.1	22.7	26.9	30.7	28.9	29.6	21.7	23.2	34.2	25.6	25.7	23.9	38.8	20.2	22.8	33.7	21.9	33.9	31.5	22.6	43.3	31.6	14.1	27.2	49.0	46.9	44.2	9.6	16.7	15.4	12.3	17.1	15.2	8.1	16.6	16.7	25.4	23.9	20.8	28.5	27.4	23.5	18.6	14.7	21.0	24.7	24.3	17.7	22.6	30.2	19.4	6.3	23.5	27.2	16.6	13.8	22.6	23.8	8.8	22.8	30.6	19.2	18.5	17.3	12.5	22.1	18.4	18.7	18.6	11.6	15.6	19.2	18.0	21.9	17.5	17.4	14.2	12.0	17.8	71.5	14.8	16.0	17.7	19.7	25.5	26.3	26.3	18.9	11.1	35.1	25.0	11.6	27.1	14.1	38.3	27.0	37.0	43.3	39.7	38.2	31.6	39.8	46.9	38.9	2.2	49.0	27.2	28.5	40.0	44.2	23.7	22.5	25.9	36.1	22.3	22.1	26.3	20.5	24.9	20.2
PPIG	"CARS-Cyp, SCAF10, SRCyp"	ENSG00000138398	"Peptidylprolyl isomerase G"	Q13427	2	169584340-169641406	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021788, HPA057469"	Supported		Supported	"Nuclear speckles,Cytosol"				"Nuclear speckles"	Cytosol	"HPA021788: AB_1847408, HPA057469: "	"unprognostic (2.70e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.04e-3)"	"unprognostic (4.17e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.55e-3)"	"unprognostic (3.66e-2)"	"unprognostic (2.15e-3)"	"unprognostic (3.15e-3)"	"unprognostic (2.47e-2)"	"unprognostic (2.28e-1)"	"prognostic unfavourable (4.56e-4)"	"unprognostic (5.23e-2)"	"unprognostic (3.29e-1)"	"unprognostic (3.41e-2)"	"unprognostic (3.39e-2)"	26.2	25.3	28.5	23.8	45.3	39.2	26.7	45.0	40.7	33.1	27.1	14.6	26.0	25.3	27.1	28.1	29.4	24.3	21.2	24.2	30.0	20.3	26.0	41.1	25.5	30.4	27.7	35.9	29.5	22.8	39.4	56.7	26.0	38.0	29.3	23.9	13.8	28.6	28.8	27.8	24.5	30.8	31.9	39.7	29.7	24.1	19.8	33.7	24.1	28.4	22.6	29.9	37.4	27.6	36.4	23.7	41.7	24.7	18.7	29.6	13.3	19.1	9.1	25.8	14.1	14.3	17.6	24.3	21.9	16.5	16.2	16.8	24.9	22.1	33.1	20.2	15.8	18.5	20.2	18.0	24.0	23.0	16.3	49.8	13.6	30.3	13.8	46.8	22.2	14.8	20.4	22.0	24.7	17.8	48.0	27.6	18.5	15.5	34.5	28.7	37.0	9.3	31.8	25.8	32.3	20.1	28.9	22.6	14.9	23.6	17.6	23.8	16.4	27.1	20.4	21.2	16.2	14.1	18.0	16.1	23.1	46.2	15.6	25.1	19.4	20.7	20.0	29.9	20.3	20.1	23.2	27.6	27.0	23.8	14.9	36.4	29.6	23.7	41.7	18.7	24.7	23.7	22.9	13.3	28.5	45.3	45.0	40.7	30.0	20.3	27.7	35.9	38.0	33.7
PPP1R16B	"ANKRD4, KIAA0823, TIMAP"	ENSG00000101445	"Protein phosphatase 1 regulatory subunit 16B"	Q96T49	20	38805705-38923024	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 44.4;lymphoid tissue: 35.0"	"Cell line enhanced"	"Detected in some"		"Daudi: 22.2;HMC-1: 24.0;HUVEC TERT2: 14.1;U-266/70: 39.0;U-266/84: 15.6;U-698: 15.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049571			Supported	"Nuclear speckles,Plasma membrane"				"Plasma membrane"	"Nuclear speckles"	"HPA049571: "	"unprognostic (2.62e-2)"	"prognostic favourable (2.11e-4)"	"unprognostic (2.67e-3)"	"unprognostic (3.35e-3)"	"unprognostic (2.19e-1)"	"prognostic favourable (7.87e-5)"	"unprognostic (1.13e-1)"	"unprognostic (4.17e-2)"	"unprognostic (4.31e-2)"	"unprognostic (6.28e-2)"	"unprognostic (4.09e-3)"	"unprognostic (4.77e-2)"	"unprognostic (3.45e-2)"	"unprognostic (8.53e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.73e-1)"	"unprognostic (7.90e-2)"	11.2	3.2	26.3	15.9	44.4	13.0	4.4	19.7	35.1	3.6	4.5	25.6	0.0	3.6	3.5	1.9	3.3	5.8	5.3	4.9	25.5	9.1	24.4	2.6	7.3	30.1	15.0	18.8	1.6	1.5	1.2	1.8	3.7	10.9	2.1	5.1	1.6	2.3	2.3	3.4	1.8	9.2	6.8	18.6	14.4	4.9	1.2	15.1	5.1	3.2	0.5	35.0	7.5	3.7	8.4	4.9	3.5	1.3	3.9	5.2	1.6	0.0	0.3	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	22.2	0.3	0.0	0.0	0.4	0.0	0.0	0.5	0.1	1.7	0.0	0.0	0.0	0.1	24.0	0.0	0.0	0.0	0.0	14.1	0.3	4.7	0.0	0.0	2.8	3.7	3.1	0.0	1.9	0.0	0.0	0.0	0.0	7.1	8.0	0.0	0.0	0.0	0.0	1.2	2.1	0.0	0.3	0.0	0.0	39.0	15.6	15.3	0.0	0.0	0.0	0.0	0.3	3.5	5.2	0.7	2.8	8.4	3.7	5.1	1.1	5.4	2.2	3.0	0.0	3.9	1.3	4.9	3.7	1.6	26.3	44.4	19.7	35.1	25.5	9.1	15.0	18.8	10.9	15.1
PPP4R3A	"FLFL1, FLJ20707, KIAA2010, MSTP033, PP4R3, SMEK1, smk-1, smk1"	ENSG00000100796	"Protein phosphatase 4 regulatory subunit 3A"	Q6IN85	14	91457611-91510554	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002568, HPA063917"	Approved		Supported	"Nucleoplasm,Nuclear speckles,Cytosol"				Nucleoplasm	"Nuclear speckles, Cytosol"	"HPA002568: AB_1079207, HPA063917: "	"unprognostic (5.51e-2)"	"unprognostic (2.93e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.40e-2)"	"unprognostic (9.95e-3)"	"unprognostic (4.10e-2)"	"unprognostic (5.71e-3)"	"unprognostic (1.05e-1)"	"unprognostic (8.34e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.85e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.57e-1)"	"unprognostic (4.53e-2)"	19.0	14.2	22.1	25.7	19.7	48.5	20.1	33.2	22.6	20.6	22.7	15.0	22.0	19.8	22.0	17.7	22.7	21.0	23.4	15.7	19.4	14.2	20.7	27.8	21.4	29.0	20.8	16.8	23.4	21.7	25.6	24.0	25.1	16.3	21.6	20.9	14.7	20.5	29.1	34.8	25.4	27.1	19.9	18.0	29.1	21.2	25.3	18.3	44.6	19.6	20.3	27.5	19.9	25.6	9.0	7.4	8.5	4.7	12.1	10.0	3.6	14.6	17.5	22.1	15.5	12.1	12.1	30.2	12.6	12.4	14.3	14.2	15.1	19.2	33.0	16.1	11.1	15.9	21.5	16.3	22.5	26.8	8.8	16.9	12.3	12.4	13.7	33.1	18.5	8.4	25.2	11.1	16.9	14.5	15.2	24.5	15.9	23.6	24.9	16.0	16.2	12.4	28.9	23.8	14.1	14.4	23.8	25.9	14.2	18.7	45.8	15.8	24.0	19.2	14.3	12.8	11.5	13.1	16.0	18.9	28.3	38.0	15.3	15.6	19.9	8.5	3.1	3.6	7.2	3.5	10.0	7.1	7.3	6.5	2.9	9.0	9.0	7.3	3.4	12.1	4.7	7.4	9.3	3.6	22.1	19.7	33.2	22.6	19.4	14.2	20.8	16.8	16.3	18.3
PPP4R3B	"FLFL2, FLJ31474, KIAA1387, PSY2, SMEK2"	ENSG00000275052	"Protein phosphatase 4 regulatory subunit 3B"	Q5MIZ7	2	55547292-55618880	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001233, CAB017185"	Approved		Supported	"Nucleoplasm,Nuclear speckles,Centrosome"				"Nucleoplasm, Nuclear speckles"	Centrosome	"CAB017185: , HPA001233: AB_1080033"	"unprognostic (9.60e-2)"	"unprognostic (2.47e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.87e-2)"	"unprognostic (6.34e-2)"	"unprognostic (3.56e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.27e-2)"	"unprognostic (8.27e-3)"	"unprognostic (7.62e-2)"	"unprognostic (1.07e-2)"	"unprognostic (3.69e-1)"	"prognostic unfavourable (6.03e-4)"	"unprognostic (9.73e-2)"	"unprognostic (1.45e-1)"	"unprognostic (6.28e-2)"	"unprognostic (2.77e-1)"	11.9	10.4	12.1	10.6	13.1	8.1	10.9	17.5	13.1	11.2	11.4	8.6	7.4	11.5	8.8	7.8	12.0	12.5	9.1	5.3	12.8		12.7	18.1	8.3	13.0	13.3	7.9	10.8	13.6	10.7	11.7	11.1	11.4	9.5	10.6	7.8	9.6	9.1	6.0	11.0	14.4	10.3	11.1	10.8	11.0	8.0	12.3	18.7	12.6	6.2	14.3	11.3	10.0	17.6	16.9	23.9	19.6	20.0	25.3	21.6	19.7	15.4	17.0	14.3	18.2	19.2	23.4	15.9	17.4	13.8	11.8	18.1	19.1	26.8	32.4	15.7	17.2	19.3	13.1	20.7	38.5	8.1	26.7	14.5	24.2	29.5	30.4	22.2	14.8	31.7	16.8	29.1	21.6	25.3	27.2	18.2	23.1	19.6	20.0	16.7	12.2	18.3	25.7	20.2	19.0	20.7	21.2	12.9	17.3	24.0	25.8	15.1	24.7	16.9	21.2	27.2	10.4	21.9	28.1	21.1	10.3	19.8	29.0	22.5	21.2	15.6	23.9	20.4	19.6	23.0	17.6	21.5	21.2	16.9	16.9	25.3	22.0	18.1	20.0	19.3	9.2	21.5	21.6										
PRKAA1	AMPKa1	ENSG00000132356	"Protein kinase AMP-activated catalytic subunit alpha 1"	Q13131	5	40759379-40798374	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Autophagy, Biological rhythms, Cholesterol biosynthesis, Cholesterol metabolism, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism, Transcription, Transcription regulation, Wnt signaling pathway"	"Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005050, HPA035409, HPA064946"	Supported		Supported	"Nuclear speckles"				"Nuclear speckles"		"CAB005050: AB_562037, HPA035409: , HPA064946: "	"unprognostic (2.07e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.51e-2)"	"unprognostic (3.57e-2)"	"unprognostic (3.97e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.51e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.88e-1)"	"unprognostic (3.34e-3)"	"unprognostic (2.63e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.10e-2)"	40.6	15.7	9.4	15.9	16.1	29.0	26.2	14.3	17.7	30.2	24.0	19.9	18.9	21.7	23.5	20.9	22.5	20.4	21.3	15.0	10.5	11.7	35.9	40.7	24.8	16.7	12.2	8.5	28.8	20.6	25.3	20.0	16.8	35.7	26.1	22.3	20.0	23.2	17.9	18.5	16.6	32.6	20.7	14.1	25.1	22.1	29.3	11.4	21.4	28.0	20.5	22.9	32.5	17.9	8.4	6.5	15.9	8.9	10.8	12.6	6.5	11.3	11.8	9.5	12.6	23.5	24.5	9.0	19.3	19.8	14.5	13.0	11.1	14.7	6.7	9.0	19.8	9.2	8.7	17.6	27.5	19.6	7.9	13.3	27.3	8.8	19.4	12.6	14.0	22.6	8.6	19.4	20.0	21.4	6.2	19.4	21.6	5.4	11.6	9.9	4.1	14.3	9.8	20.3	9.8	22.3	19.3	8.2	8.3	33.9	22.6	11.5	11.9	10.5	22.9	26.2	14.2	15.1	15.7	7.7	6.0	8.0	16.4	27.4	13.9	14.1	6.6	12.7	10.0	8.1	12.6	8.4	9.4	9.4	6.5	7.7	11.5	10.0	15.9	10.8	8.9	2.0	11.3	6.5	9.4	16.1	14.3	17.7	10.5	11.7	12.2	8.5	35.7	11.4
PRKAA2	"AMPK, AMPKa2, PRKAA"	ENSG00000162409	"Protein kinase AMP-activated catalytic subunit alpha 2"	P54646	1	56645322-56715335	"Enzymes, Predicted membrane proteins, Transporters"	"Autophagy, Biological rhythms, Cholesterol biosynthesis, Cholesterol metabolism, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism, Transcription, Transcription regulation, Wnt signaling pathway"	"Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 39.1;skeletal muscle: 40.2"	"Cell line enhanced"	"Detected in many"		"HEK 293: 8.5;RPTEC TERT1: 14.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.0"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044540	Approved		Supported	"Nuclear speckles,Golgi apparatus"				"Nuclear speckles"	"Golgi apparatus"	"HPA044540: "	"unprognostic (4.17e-3)"	"unprognostic (1.62e-2)"	"unprognostic (4.17e-1)"	"prognostic unfavourable (4.80e-4)"	"unprognostic (9.35e-2)"	"unprognostic (1.92e-3)"	"prognostic unfavourable (5.30e-4)"	"unprognostic (7.30e-2)"	"unprognostic (3.94e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.97e-1)"	"unprognostic (8.64e-2)"	"prognostic favourable (4.95e-5)"	"unprognostic (1.30e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.85e-1)"	2.4	2.1	3.7	1.2	6.3	0.7	4.1	7.2	8.1	2.2	5.5	1.2	2.4	1.2	3.0	3.2	6.3	3.5	2.6	39.1	4.2	2.9	14.5	1.4	2.0	0.8	2.4	6.2	2.5	2.6	10.4	2.6	1.2	5.0	4.6	2.2	6.0	4.5	3.5	40.2	1.4	2.1	7.2	1.9	1.9	3.2	1.7	0.8	0.0	4.0	12.3	0.8	4.4	2.1	0.2	0.0	1.0	0.1	0.1	0.1	0.0	0.0	3.7	2.0	0.0	0.7	0.5	2.3	1.8	1.4	2.5	4.3	3.8	4.7	0.0	0.6	0.6	0.0	7.8	0.0	7.1	0.0	8.5	0.0	6.9	5.2	0.0	0.0	0.1	0.6	0.0	3.5	0.3	0.8	0.0	0.0	1.0	0.1	0.0	0.0	5.5	5.4	0.0	0.0	0.0	14.0	1.2	2.0	5.4	5.7	0.1	0.0	3.2	0.0	0.0	1.5	2.3	2.7	6.3	0.0	0.0	0.0	4.5	0.0	1.1	0.5	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	1.0	0.1	0.0	0.0	0.0	0.0	3.7	6.3	7.2	8.1	4.2	2.9	2.4	6.2	5.0	0.8
PRKN	"AR-JP, PARK2, parkin, PDJ"	ENSG00000185345	"Parkin RBR E3 ubiquitin protein ligase"	O60260	6	161347420-162727771	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Autophagy, Transcription, Transcription regulation, Ubl conjugation pathway"	Transferase	"Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 41.8"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 3.6;HEL: 9.0;Karpas-707: 5.7;RPMI-8226: 5.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016257, HPA036012"	Enhanced		Supported	"Nuclear speckles,Cytosol"				"Nuclear speckles"	Cytosol	"CAB016257: AB_628104, HPA036012: "	"unprognostic (9.23e-2)"	"unprognostic (3.29e-2)"	"unprognostic (6.48e-2)"	"unprognostic (2.69e-3)"	"unprognostic (9.85e-2)"	"unprognostic (5.85e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.03e-3)"	"unprognostic (8.16e-2)"	"prognostic favourable (6.75e-12)"	"unprognostic (9.93e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.24e-2)"	"unprognostic (2.50e-1)"	6.8	7.1	7.9	2.3	12.2	1.5	4.2	7.2	13.4	5.3	4.3	6.3	4.6	2.8	7.8	4.4	6.1	3.4	4.3	17.7	9.2	6.2	17.4	3.6	2.6	3.0	5.8	5.2	6.4	3.0	5.6	8.6	2.0	5.5	4.0	2.4	8.3	3.5	4.8	41.8	4.0	3.3	6.6	5.9	2.7	3.5	10.3	6.8	0.6	3.8	4.7	2.7	4.9	2.1	4.6	1.2	4.2	0.8	1.8	4.6	1.3	0.0	0.3	1.2	3.6	0.9	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.4	1.2	0.0	0.0	0.2	0.2	0.0	0.4	0.6	9.0	0.2	0.0	0.8	0.2	0.1	3.1	0.1	0.0	0.5	0.0	0.4	5.7	0.9	0.5	0.1	0.1	0.2	0.8	0.0	0.0	5.7	0.6	0.1	0.9	2.5	0.0	0.0	0.3	0.0	0.6	0.0	0.1	0.3	0.1	0.3	0.8	0.1	0.0	0.1	0.1	2.2	2.8	0.8	4.2	2.1	0.5	3.5	1.5	2.0	2.2	1.2	4.6	4.4	4.6	1.5	1.8	0.4	0.3	0.2	1.3	7.9	12.2	7.2	11.7	9.2	6.2	5.8	5.2	5.5	6.8
PRPF4B	"KIAA0536, PR4H, Prp4"	ENSG00000112739	"Pre-mRNA processing factor 4B"	Q13523	6	4021267-4064983	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020638	Approved		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA020638: AB_1855774"	"unprognostic (1.03e-1)"	"unprognostic (2.66e-1)"	"unprognostic (4.95e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.59e-3)"	"unprognostic (1.21e-2)"	"prognostic unfavourable (2.27e-4)"	"unprognostic (8.68e-3)"	"unprognostic (3.41e-2)"	"unprognostic (4.45e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.50e-3)"	"unprognostic (8.90e-2)"	"unprognostic (2.34e-1)"	"unprognostic (7.63e-3)"	"prognostic favourable (6.82e-5)"	23.2	21.6	19.6	24.0	20.5	8.5	21.4	35.6	26.8	18.3	19.3	6.0	14.7	12.0	22.2	14.2	23.6	14.7	13.6	16.3	16.5	11.7	15.0	14.5	13.0	15.4	14.5	14.1	19.1	14.4	20.9	30.9	17.1	21.0	14.9	15.7	5.3	22.7	20.4	45.7	16.3	16.4	14.9	23.7	19.0	13.6	11.6	20.2	21.8	21.1	11.3	17.4	21.4	22.2	9.7	13.6	7.5	11.9	11.8	9.1	3.9	14.4	12.6	19.8	13.6	11.3	10.5	9.6	14.1	15.5	15.4	15.5	12.0	7.3	23.8	17.8	15.8	13.0	25.0	12.2	22.1	11.1	18.3	26.7	14.4	10.7	8.7	29.4	14.6	9.6	8.1	10.9	6.8	15.3	36.5	8.8	15.0	8.5	21.6	9.9	11.9	11.7	24.5	19.2	23.0	9.8	16.4	15.4	10.1	16.3	10.2	12.4	15.9	14.8	16.3	15.1	8.7	9.9	13.6	10.0	15.6	27.7	8.3	13.5	18.4	7.5	11.9	3.6	7.6	9.9	9.1	9.7	8.6	9.0	10.2	9.3	8.0	8.0	6.1	11.8	8.7	13.6	6.3	3.9	19.6	20.5	35.6	26.8	16.5	11.7	14.5	14.1	21.0	20.2
PRPF6	"ANT-1, bB152O15.1, C20orf14, hPrp6, Prp6, RP60, SNRNP102, TOM, U5-102K"	ENSG00000101161	"Pre-mRNA processing factor 6"	O94906	20	63981135-64033100	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"		"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047106	Supported		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA047106: AB_10963084"	"unprognostic (1.29e-1)"	"unprognostic (9.96e-3)"	"unprognostic (7.02e-2)"	"unprognostic (9.36e-3)"	"unprognostic (1.80e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.66e-3)"	"unprognostic (3.37e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.76e-3)"	"unprognostic (2.18e-1)"	"unprognostic (3.16e-3)"	"unprognostic (6.16e-2)"	"unprognostic (8.04e-2)"	"unprognostic (7.19e-2)"	"unprognostic (5.39e-3)"	31.5	26.3	28.3	25.0	35.2	25.0	31.4	66.3	46.7	30.1	26.9	43.7	20.8	25.9	37.0	28.9	29.3	44.6	30.3	28.8	26.8	27.6	25.7	25.8	27.9	31.6	28.7	31.0	46.5	33.7	40.5	30.8	29.8	30.1	29.5	23.3	32.3	33.0	34.5	49.3	49.1	27.7	34.2	31.4	32.7	27.6	41.5	30.5	43.8	31.2	28.4	34.4	31.6	27.1	30.1	25.0	31.9	30.4	51.7	44.3	33.8	20.0	24.5	18.0	19.0	20.6	14.5	23.7	15.9	18.0	48.9	21.9	65.5	24.6	25.3	38.9	21.0	31.3	29.0	33.0	26.1	12.1	16.8	21.4	32.7	59.1	22.8	28.9	29.8	16.4	23.6	22.5	26.1	18.1	20.8	22.1	16.2	24.7	29.1	36.2	16.0	30.6	32.2	15.4	24.3	18.6	20.3	18.0	21.1	30.8	31.7	20.2	31.1	37.8	25.5	28.2	16.2	22.4	29.2	18.5	18.0	26.8	20.6	17.5	21.8	31.9	25.3	30.1	30.1	26.7	42.1	30.1	37.3	32.4	25.0	26.3	44.3	36.9	21.5	51.7	30.4	23.2	32.7	33.8	28.3	35.2	66.3	46.7	26.8	27.6	28.7	31.0	30.1	30.5
PUS7L	DKFZP434G1415	ENSG00000129317	"Pseudouridylate synthase 7 like"	Q9H0K6	12	43718993-43758817	"Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056203, HPA058750"	Uncertain		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA056203: , HPA058750: "	"unprognostic (3.41e-3)"	"unprognostic (1.03e-1)"	"unprognostic (2.51e-3)"	"unprognostic (1.83e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.79e-1)"	"unprognostic (5.87e-4)"	"unprognostic (1.11e-1)"	"unprognostic (8.11e-3)"	"unprognostic (1.37e-2)"	"unprognostic (3.49e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.80e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.50e-2)"	"unprognostic (9.27e-2)"	8.0	7.0	14.9	9.1	18.5	6.1	10.6	20.3	16.6	9.2	7.3	3.7	8.3	7.3	7.3	7.9	9.7	6.1	7.7	6.9	14.2	9.0	9.3	7.9	5.4	10.4	8.3	12.6	10.2	9.5	12.7	21.7	7.7	11.5	8.3	9.1	2.7	8.4	9.4	6.1	7.2	7.6	6.3	12.1	9.2	7.6	5.6	11.3	13.0	11.6	6.1	11.3	8.6	8.3	6.6	5.2	8.6	4.3	5.1	6.9	3.4	6.4	4.8	4.3	2.4	3.0	10.7	7.6	5.6	4.8	7.5	5.8	17.2	4.6	14.7	7.2	6.9	5.8	6.2	5.7	13.0	4.5	3.8	10.8	5.4	6.4	3.7	17.2	7.0	4.4	4.3	7.8	8.2	5.4	18.7	6.5	17.5	2.6	8.8	4.4	7.8	5.2	8.4	10.1	8.8	3.3	4.9	7.2	2.3	6.9	7.6	3.0	8.9	4.9	3.9	7.7	5.1	8.9	8.8	5.7	9.8	14.9	7.1	28.4	2.5	8.6	4.3	4.8	5.0	3.8	6.2	4.4	5.4	5.3	4.4	6.6	4.8	6.9	3.1	5.1	3.1	5.2	2.1	3.4	14.9	18.5	20.3	16.6	14.2	9.0	8.3	12.6	11.5	11.3
RBM14	"COAA, DKFZp779J0927, SIP, SYTIP1"	ENSG00000239306	"RNA binding motif protein 14"	Q96PK6	11	66616582-66627347	"Predicted intracellular proteins"	"Immunity, Innate immunity, Transcription, Transcription regulation"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006628	Supported		Supported	"Nuclear speckles"			13000	"Nuclear speckles"		"HPA006628: AB_1078546"	"unprognostic (6.96e-2)"	"unprognostic (4.79e-2)"	"unprognostic (4.34e-3)"	"unprognostic (4.45e-2)"	"unprognostic (2.15e-1)"	"unprognostic (9.56e-3)"	"prognostic unfavourable (2.02e-7)"	"unprognostic (4.21e-2)"	"unprognostic (1.54e-3)"	"unprognostic (1.08e-2)"	"prognostic favourable (1.04e-4)"	"unprognostic (9.38e-3)"	"unprognostic (8.59e-3)"	"unprognostic (1.29e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.94e-1)"	23.5	23.2	22.6	28.4	27.3	35.2	20.8	44.3	31.0	24.1	20.8	26.9	28.6	18.7	30.8	24.6	25.7	28.9	25.3	22.0	22.3	19.4	26.6	29.1	21.0	34.7	32.1	20.4	37.7	26.6	24.8	34.0	24.5	22.4	27.8	22.9	28.8	27.6	22.3	24.3	34.8	24.7	28.0	21.7	32.1	22.5	42.9	25.6	47.2	27.7	20.2	34.1	18.5	23.0	18.3	24.7	20.1	19.6	15.7	22.6	20.8	22.7	25.6	16.5	14.1	8.7	6.2	31.3	12.0	6.8	17.8	10.5	26.2	20.0	36.3	13.6	7.8	20.3	22.2	15.6	14.6	16.2	19.7	21.6	20.2	20.8	5.5	20.1	21.4	4.3	5.5	16.4	7.6	13.2	26.3	26.5	14.1	22.3	37.4	25.5	33.4	25.3	34.7	18.6	19.9	11.9	21.1	20.1	17.7	22.3	17.6	9.8	25.9	19.1	14.5	17.5	30.0	12.7	20.6	14.0	19.6	31.7	13.8	21.9	39.1	12.9	16.9	20.1	22.3	19.6	21.7	17.0	19.6	21.5	24.7	18.3	20.5	22.6	7.6	15.7	19.5	16.2	16.6	20.8	22.6	27.3	44.3	31.0	22.3	19.4	32.1	20.4	22.4	25.6
RBM39	"CAPER, CAPERalpha, CC1.3, fSAP59, HCC1, RNPC2"	ENSG00000131051	"RNA binding motif protein 39"	Q14498	20	35701347-35742312	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001591	Supported		Supported	"Nucleoplasm,Nuclear speckles,Microtubules,Centriolar satellite"				"Nucleoplasm, Nuclear speckles"	"Microtubules, Centriolar satellite"	"HPA001591: AB_1079749"	"unprognostic (1.37e-2)"	"unprognostic (4.97e-1)"	"unprognostic (2.72e-2)"	"unprognostic (9.09e-2)"	"unprognostic (3.47e-1)"	"unprognostic (4.99e-2)"	"unprognostic (3.55e-3)"	"unprognostic (4.56e-2)"	"unprognostic (7.83e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.04e-2)"	"unprognostic (7.65e-3)"	"prognostic unfavourable (2.78e-5)"	"unprognostic (1.88e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.64e-1)"	"unprognostic (2.28e-3)"	41.4	44.1	37.5	41.5	41.4	120.8	38.5	57.5	41.8	43.4	35.0	30.7	46.3	29.5	51.9	34.3	42.8	35.3	40.7	40.2	35.8	29.9	39.2	32.4	40.4	41.8	41.1	31.4	52.3	35.6	40.9	71.5	45.2	37.4	39.2	27.0	28.9	37.1	46.0	44.1	32.1	30.6	40.2	43.0	38.4	33.5	22.9	46.4	52.4	40.7	28.2	40.5	39.9	46.1	27.6	32.5	88.9	25.1	24.2	22.5	16.8	28.7	26.7	27.8	24.6	21.9	24.9	30.3	38.6	19.3	25.2	23.8	38.6	26.7	39.7	30.1	14.9	27.2	41.2	24.4	29.1	26.6	29.5	52.8	27.0	44.6	24.8	48.6	33.0	10.1	42.4	21.1	24.0	23.5	54.4	35.4	21.6	24.9	56.5	35.0	33.5	32.0	34.5	44.1	29.9	22.9	20.8	27.1	23.5	30.2	38.5	33.7	25.9	34.3	27.0	32.8	28.1	30.4	34.6	22.8	46.3	58.3	22.5	39.1	24.0	41.2	25.1	38.2	22.5	22.1	22.1	25.3	19.8	20.7	22.4	27.6	18.9	18.0	88.9	24.2	19.4	32.5	22.1	16.8	37.5	41.4	57.5	41.8	35.8	29.9	41.1	31.4	37.4	46.4
RBM8A	"BOV-1A, BOV-1B, BOV-1C, RBM8, RBM8B, Y14, ZNRP"	ENSG00000265241	"RNA binding motif protein 8A"	Q9Y5S9	1	145917714-145927678	"Plasma proteins, Predicted intracellular proteins, Transporters"	"mRNA processing, mRNA splicing, mRNA transport, Nonsense-mediated mRNA decay, Translation regulation, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"blood: 120.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA018403	Supported		Supported	"Nuclear speckles"			120000	"Nuclear speckles"		"HPA018403: AB_1858908"	"unprognostic (3.81e-1)"	"unprognostic (3.99e-3)"	"unprognostic (1.59e-1)"	"unprognostic (6.83e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.16e-1)"	"unprognostic (4.62e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.38e-1)"	"unprognostic (8.79e-3)"	"unprognostic (7.27e-3)"	"prognostic unfavourable (1.55e-4)"	"unprognostic (3.30e-3)"	"unprognostic (2.18e-1)"	"unprognostic (3.77e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.64e-3)"	6.2	6.5	9.1	9.5	9.8	18.7	6.1	6.3	9.8	8.3	6.2	9.6	9.8	6.2	7.4	5.0	15.1	5.7	5.0	6.4	7.3		6.4	6.5	5.5	11.2	7.0	7.1	7.6	5.1	6.9	5.5	7.9	13.5	5.7	5.0	5.7	6.2	6.3	24.6	7.2	6.0	6.8	13.2	6.5	5.8	8.5	9.5	6.8	6.3	4.8	11.7	7.1	3.5	101.9	120.1	118.0	85.5	85.3	89.3	115.9	51.2	42.0	38.4	30.5	13.8	13.6	47.2	31.4	21.3	45.2	33.3	55.4	39.0	47.1	49.7	21.6	35.3	40.8	34.3	37.2	41.7	38.9	36.3	31.8	40.9	19.6	60.5	31.9	14.9	25.9	40.4	43.4	33.5	54.5	44.7	34.7	141.6	60.8	48.0	65.9	73.3	54.0	33.5	46.8	28.9	49.5	39.4	48.3	46.8	24.1	42.6	45.1	73.7	34.5	36.5	46.6	35.8	85.8	50.5	79.6	69.1	32.7	36.5	31.4	89.7	77.6	118.0	86.5	85.5	82.1	101.9	82.5	87.8	76.5	90.1	77.7	86.3	89.3	85.3	79.9	120.1	89.3	115.9										
RMI2	"BLAP18, C16orf75, MGC24665"	ENSG00000175643	"RecQ mediated genome instability 2"	Q96E14	16	11249619-11351762	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"DNA replication"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 31.7;testis: 29.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 6.5"	"Group enriched"	"Detected in many"	5	"B-cells: 6.5;T-cells: 3.0"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA040995	Uncertain		Supported	"Nuclear speckles,Cytosol"				"Nuclear speckles"	Cytosol	"HPA040995: AB_10795531"	"unprognostic (2.76e-1)"	"prognostic favourable (5.69e-5)"	"unprognostic (1.17e-1)"	"unprognostic (3.09e-3)"	"unprognostic (1.69e-2)"	"unprognostic (1.80e-3)"	"prognostic unfavourable (2.77e-5)"	"unprognostic (3.98e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.44e-3)"	"unprognostic (3.89e-1)"	"unprognostic (2.18e-1)"	"unprognostic (5.50e-2)"	"unprognostic (3.68e-2)"	"unprognostic (3.60e-3)"	"unprognostic (1.03e-1)"	1.0	1.8	4.2	18.0	5.1	4.8	2.8	0.7	4.1	2.8	7.3	1.0	0.4	4.3	2.5	3.2	11.8	1.0	2.6	1.9	2.5	1.5	3.1	2.3	2.9	17.9	1.6	5.6	3.6	1.6	0.7	1.1	13.2	1.2	2.6	9.0	0.8	2.9	1.7	1.1	8.7	5.6	1.1	1.4	4.2	4.0	29.6	1.2	31.7	1.4	2.8	20.4	3.6	4.5	6.5	0.6	0.9	0.0	0.3	3.0	0.3	19.0	12.8	25.1	10.7	1.1	5.5	10.5	11.1	8.8	10.5	17.6	4.9	22.7	26.5	9.6	5.2	11.2	10.7	10.6	17.1	5.2	10.0	14.5	7.6	32.4	0.4	5.6	6.5	1.2	2.0	4.5	4.4	5.7	20.0	21.1	5.5	22.0	19.2	26.0	21.1	5.1	23.3	27.1	28.3	6.2	12.4	14.5	11.5	9.4	15.8	8.2	26.7	8.4	1.8	8.5	7.9	16.2	1.6	5.8	9.5	31.4	7.9	18.4	15.5	0.0	0.0	0.9	0.6	0.0	0.0	6.5	0.2	0.0	0.4	2.5	1.8	0.7	0.2	0.3	0.0	0.6	3.0	0.3	4.2	5.1	0.7	4.1	2.5	1.5	1.6	5.6	1.2	1.2
RREB1	HNT	ENSG00000124782	"Ras responsive element binding protein 1"	Q92766	6	7107597-7251980	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA001756, HPA034843"	Approved		Supported	"Nucleoli fibrillar center,Nuclear speckles"				"Nuclear speckles"	"Nucleoli fibrillar center"	"HPA001756: AB_1856477, HPA034843: "	"unprognostic (1.69e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.93e-1)"	"unprognostic (5.05e-2)"	"unprognostic (7.38e-2)"	"unprognostic (1.23e-3)"	"unprognostic (2.53e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.45e-2)"	"unprognostic (6.51e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.16e-1)"	"prognostic favourable (1.41e-4)"	"unprognostic (1.21e-2)"	"unprognostic (1.60e-1)"	"unprognostic (9.54e-2)"	"unprognostic (2.92e-1)"	17.4	13.3	3.4	17.9	3.6	24.1	15.9	1.4	3.3	15.8	16.8	3.6	13.5	9.7	18.5	16.3	26.6	9.4	19.1	8.5	3.8	2.1	12.7	18.5	14.4	15.9	4.2	1.8	12.5	26.4	14.6	11.2	15.9	4.6	13.7	8.3	15.2	23.6	18.5	30.5	16.5	20.3	14.5	5.2	20.0	9.6	10.6	4.4	12.8	15.9	17.1	24.9	12.5	17.5	3.0	7.8	8.6	3.6	5.2	2.3	2.0	6.8	6.6	5.5	6.4	5.2	3.3	22.7	2.7	3.8	3.1	4.2	10.2	5.4	3.2	5.8	5.1	5.0	7.9	8.5	3.4	4.6	6.4	12.9	4.6	12.8	7.1	7.1	9.8	5.7	7.0	4.9	7.5	4.1	22.6	0.0	3.5	8.3	4.2	19.8	2.5	5.8	6.7	6.8	5.2	5.2	13.2	1.5	1.3	6.0	8.8	5.7	6.6	16.6	6.4	6.1	3.9	4.3	3.5	2.2	2.4	5.0	1.7	5.9	4.9	6.0	3.6	8.6	2.2	3.1	1.7	3.0	1.3	1.4	2.4	1.6	2.3	2.1	2.8	5.2	3.2	7.8	0.8	2.0	3.4	3.6	1.4	3.3	3.8	2.1	4.2	1.8	4.6	4.4
RSBN1L	"FLJ42526, FLJ45813, MGC71764"	ENSG00000187257	"Round spermatid basic protein 1 like"	Q6PCB5	7	77696443-77783022	"Cancer-related genes, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 31.5"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 31.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020406, HPA020413"	Approved		Supported	"Nuclear speckles,Plasma membrane"				"Nuclear speckles"	"Plasma membrane"	"HPA020406: AB_1856488, HPA020413: AB_2253910"	"unprognostic (2.02e-1)"	"unprognostic (2.61e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.62e-2)"	"unprognostic (2.43e-2)"	"prognostic favourable (3.74e-4)"	"unprognostic (1.27e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.25e-1)"	"unprognostic (9.02e-2)"	"unprognostic (7.30e-3)"	"unprognostic (1.93e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.25e-3)"	"unprognostic (1.53e-3)"	12.9	10.6	15.0	22.1	14.6	9.5	15.5	28.7	17.0	22.8	23.5	8.9	12.1	11.1	17.2	13.6	15.0	14.2	13.4	10.6	12.4	10.3	12.0	14.9	15.7	18.2	11.1	11.0	19.2	14.9	19.5	16.2	12.2	11.8	18.8	15.1	13.9	14.0	15.4	13.6	11.7	14.9	18.0	11.0	20.7	14.3	29.8	13.8	34.5	21.1	6.7	18.0	23.6	28.2	7.2	7.0	31.5	4.0	3.0	5.2	1.2	8.8	6.8	11.4	20.0	8.0	10.3	5.6	6.6	7.1	9.4	10.8	8.4	15.9	18.2	2.6	6.8	7.7	15.5	8.5	13.5	9.8	8.3	14.5	10.8	8.3	6.8	17.8	13.7	7.3	6.2	8.6	9.5	7.7	19.6	19.2	9.7	10.2	15.2	17.9	8.1	6.1	15.9	11.4	19.1	5.9	11.7	13.5	14.1	10.0	18.2	7.2	11.1	9.5	7.4	14.1	13.0	8.4	10.0	8.6	9.1	29.3	6.7	16.5	9.2	9.1	4.0	6.4	5.2	2.9	3.9	5.4	4.5	3.8	2.2	7.2	4.3	4.7	31.5	3.0	3.2	7.0	4.5	1.2	15.0	14.6	28.7	17.0	12.4	10.3	11.1	11.0	11.8	13.8
S100PBP	"FLJ12903, S100PBPR"	ENSG00000116497	"S100P binding protein"	Q96BU1	1	32816767-32858879	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027242, HPA027328"	Approved		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA027242: , HPA027328: "	"unprognostic (4.29e-2)"	"unprognostic (8.54e-2)"	"unprognostic (3.54e-1)"	"unprognostic (2.52e-3)"	"unprognostic (2.44e-2)"	"prognostic favourable (5.22e-5)"	"prognostic unfavourable (1.26e-6)"	"unprognostic (1.61e-1)"	"unprognostic (2.52e-3)"	"unprognostic (3.71e-1)"	"unprognostic (6.79e-2)"	"unprognostic (1.83e-2)"	"prognostic unfavourable (9.03e-4)"	"unprognostic (2.87e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.48e-1)"	8.5	11.0	9.6	13.2	15.9	13.9	10.5	18.1	12.4	13.0	9.0	18.9	12.2	6.8	19.8	11.9	8.5	11.1	11.4	6.5	9.0	12.0	7.2	7.5	8.7	15.6	14.9	8.7	20.1	6.5	8.7	13.4	12.1	12.0	12.6	8.9	11.0	8.6	10.3	6.3	9.2	10.0	13.7	11.0	14.6	7.7	35.2	16.1	14.2	11.3	6.5	15.9	10.2	12.1	7.7	10.3	5.7	3.5	16.9	8.3	3.4	6.2	7.6	18.3	9.0	8.6	12.3	9.1	12.4	8.7	11.9	13.0	4.8	9.9	18.8	9.6	8.2	9.9	18.3	7.6	14.4	10.4	4.7	25.1	14.4	6.4	10.3	10.9	9.9	8.7	7.2	11.5	13.9	12.3	14.1	14.6	14.1	2.9	17.4	9.5	20.1	5.9	14.3	18.9	16.7	5.2	4.0	7.4	7.2	12.2	3.5	13.6	7.0	6.9	6.0	14.8	10.9	13.3	7.6	22.7	20.3	19.3	7.4	12.2	7.5	5.4	3.5	5.7	6.3	1.9	8.3	7.7	5.3	6.9	3.7	4.9	3.6	5.1	3.9	16.9	1.6	10.3	5.1	3.4	9.6	15.9	18.1	12.4	9.0	12.0	14.9	8.7	12.0	16.1
SAP130	FLJ12761	ENSG00000136715	"Sin3A associated protein 130"	Q9H0E3	2	127941217-128028120	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 50.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034664			Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA034664: AB_10603238"	"unprognostic (2.17e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.65e-1)"	"prognostic unfavourable (7.89e-4)"	"unprognostic (2.75e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.92e-2)"	"unprognostic (6.77e-2)"	"unprognostic (3.75e-2)"	"unprognostic (5.26e-2)"	"unprognostic (4.41e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.13e-1)"	9.3	8.7	8.9	10.4	11.3	18.0	7.8	12.2	14.1	9.7	9.3	13.8	6.6	8.2	11.7	9.5	9.9	9.4	8.2	8.0	9.6	8.5	6.8	7.8	7.9	9.1	9.7	9.0	11.6	8.4	16.3	13.8	10.4	9.6	9.1	9.8	8.8	11.3	8.5	10.5	11.6	8.9	10.3	8.9	8.3	9.0	50.3	9.9	17.1	8.8	6.9	11.9	9.9	9.5	5.8	6.8	15.6	8.5	3.5	6.2	3.5	20.3	11.3	21.2	17.1	14.1	9.8	23.3	13.0	12.8	20.2	16.0	26.7	8.5	17.0	11.8	14.7	14.3	23.4	13.4	21.1	9.4	15.0	16.9	10.1	20.7	17.0	14.6	13.4	9.1	10.1	26.7	16.8	16.1	20.4	12.7	16.8	22.7	20.3	11.5	21.9	12.6	14.0	17.5	11.4	10.8	18.1	11.2	13.5	13.7	13.0	8.1	9.8	10.1	13.7	19.6	21.3	18.1	13.7	17.8	17.5	20.4	16.1	9.9	12.5	2.4	4.2	4.8	6.2	3.0	4.8	2.4	4.4	4.0	3.7	5.8	3.2	3.5	15.6	3.5	8.5	6.8	3.0	3.5	8.9	11.3	12.2	14.1	9.6	8.5	9.7	9.0	9.6	9.9
SARNP	"CIP29, Hcc-1, THO1"	ENSG00000205323	"SAP domain containing ribonucleoprotein"	P82979	12	55752463-55817756	"Plasma proteins, Predicted intracellular proteins"	"mRNA transport, Transcription, Transcription regulation, Translation regulation, Transport"	"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA030902, HPA030903"	Supported		Supported	"Nuclear speckles"			120000	"Nuclear speckles"		"HPA030902: AB_10669872, HPA030903: AB_10964180"	"unprognostic (1.83e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.36e-4)"	"unprognostic (2.02e-2)"	"unprognostic (4.29e-3)"	"unprognostic (1.21e-2)"	"unprognostic (5.03e-2)"	"unprognostic (6.48e-2)"	"unprognostic (2.31e-6)"	"unprognostic (8.50e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.29e-3)"	"unprognostic (1.19e-1)"	24.3	31.5	32.3	22.8	32.6	40.2	30.8	34.8	29.6	28.8	29.2	22.3	19.9	16.0	26.0	30.8	30.4	22.7	18.2	39.5	27.1	33.5	30.9	25.1	26.3	31.3	35.9	23.6	28.0	31.1	19.4	27.4	28.4	29.4	26.0	28.9	19.8	20.5	26.6	44.4	20.3	25.7	27.9	31.3	30.6	22.1	26.4	28.9	34.6	25.8	20.8	41.8	31.4	23.4	39.7	50.1	68.1	50.2	40.6	53.1	43.7	26.9	23.6	59.7	25.1	27.6	39.9	28.3	38.7	29.3	46.5	39.1	33.1	29.9	43.9	26.0	30.2	15.3	52.3	36.4	50.3	34.4	30.1	44.2	39.0	28.2	39.5	36.9	33.2	29.4	27.0	30.5	22.9	49.0	31.6	32.4	46.4	21.6	45.8	58.1	52.0	21.0	42.2	31.1	35.9	62.4	29.8	25.4	20.8	32.1	20.6	32.1	31.3	49.2	33.9	18.8	18.8	24.1	29.3	20.6	27.5	60.1	22.6	37.7	23.5	63.7	46.2	68.1	38.2	50.2	34.7	39.7	40.7	40.7	50.1	34.6	32.6	36.5	35.7	40.6	42.3	48.0	53.1	43.7	32.3	32.6	34.8	29.6	27.1	33.5	35.9	23.6	29.4	28.9
SETD1A	"KIAA0339, KMT2F, Set1"	ENSG00000099381	"SET domain containing 1A"	O15047	16	30957294-30984664	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA020646, HPA058376"	Enhanced		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA020646: AB_1856752, HPA058376: AB_2683695"	"unprognostic (8.62e-2)"	"unprognostic (1.93e-2)"	"unprognostic (3.96e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.40e-2)"	"prognostic unfavourable (8.47e-4)"	"unprognostic (5.01e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.18e-1)"	"unprognostic (5.77e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.94e-1)"	11.0	10.5	10.0	12.4	10.2	25.6	10.3	23.0	14.5	11.1	12.1	14.1	7.6	10.2	15.3	6.7	9.4	11.2	9.7	7.6	8.8	6.7	9.3	10.5	9.0	12.6	9.3	9.8	15.3	14.8	15.6	12.9	11.3	9.5	10.9	5.7	13.5	12.7	10.5	15.2	12.3	11.4	11.7	8.0	14.5	10.3	22.3	10.0	15.5	12.7	5.4	14.1	10.6	9.9	2.0	2.6	2.5	1.4	1.3	1.6	0.9	6.4	12.5	8.6	10.0	4.9	3.5	9.3	7.3	5.5	6.3	5.3	10.6	6.6	17.3	8.1	6.7	8.5	7.7	7.4	5.2	9.2	30.0	8.0	21.6	11.8	4.7	13.6	13.8	5.9	5.9	8.8	5.6	4.8	16.1	9.8	3.4	13.5	16.1	13.8	12.2	8.3	24.5	8.5	10.9	3.9	7.1	9.3	9.5	9.8	8.1	5.4	8.4	11.0	6.5	9.5	9.2	6.0	7.6	14.9	18.0	16.9	7.6	11.8	7.2	0.0	0.8	2.5	1.2	1.4	1.6	0.2	1.0	0.8	0.6	2.0	0.7	1.5	0.5	1.3	0.4	2.6	0.4	0.9	10.0	10.2	23.0	14.5	8.8	6.7	9.3	9.8	9.5	10.0
SF3A3	"PRP9, PRPF9, SAP61, SF3a60"	ENSG00000183431	"Splicing factor 3a subunit 3"	Q12874	1	37956975-37990921	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032054, HPA032055"	Supported		Supported	"Nucleoplasm,Nuclear speckles"				"Nuclear speckles"	Nucleoplasm	"HPA032054: AB_10602184, HPA032055: "	"unprognostic (1.56e-1)"	"unprognostic (1.21e-1)"	"unprognostic (7.08e-3)"	"unprognostic (6.19e-3)"	"unprognostic (1.06e-1)"	"unprognostic (5.68e-2)"	"prognostic unfavourable (2.11e-8)"	"unprognostic (1.34e-1)"	"unprognostic (2.74e-2)"	"unprognostic (5.74e-3)"	"unprognostic (9.18e-2)"	"unprognostic (4.79e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.52e-3)"	"unprognostic (8.39e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.68e-2)"	7.0	6.4	5.3	6.3	5.9	13.6	7.6	7.4	5.5	6.3	6.5			4.3	9.4	8.7	6.8	7.7	4.1	4.3	4.8	4.9	5.9	6.2	6.1	8.4	5.3		8.7	6.7	6.4	5.7	5.6		6.1	7.2		5.9	7.2	15.3	7.7	5.9	7.7	4.3	7.9	6.2	5.8			6.3		10.3	6.2	6.1	23.6	19.0	10.6	20.6	18.7	27.8	20.6	15.7	12.0	21.7	18.5	13.6	12.6	26.3	15.4	14.1	27.0	21.9	19.7	16.7	29.9	13.5	14.9	13.6	27.6	22.4	33.2	13.6	26.9	38.0	19.2	17.0	12.5	46.2	18.4	11.9	15.7	28.0	18.5	18.7	33.4	11.8	19.5	10.5	24.3	26.7	53.6	18.7	29.1	37.3	21.5	12.4	16.4	19.0	14.1	19.7	9.2	16.2	10.9	18.3	16.8	14.2	15.6	13.0	30.5	11.4	16.1	30.5	13.6	42.6	17.6	10.6	15.3	9.8	21.8	18.9	21.2	20.4	25.8	22.0	19.0	23.6	27.8	23.6	2.0	18.7	20.6	11.8	26.3	20.6										
SFMBT2	KIAA1617	ENSG00000198879	"Scm like with four mbt domains 2"	Q5VUG0	10	7158624-7411486	"Predicted intracellular proteins"		Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 26.7"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 16.2;REH: 14.5;RPMI-8226: 13.5;THP-1: 17.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 7.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035447, HPA035448, HPA070388"	Uncertain		Supported	"Nucleoplasm,Nuclear speckles"				"Nucleoplasm, Nuclear speckles"		"HPA035447: , HPA035448: AB_10669904, HPA070388: "	"unprognostic (4.36e-2)"	"unprognostic (2.29e-2)"	"unprognostic (4.36e-2)"	"unprognostic (1.42e-3)"	"unprognostic (3.23e-2)"	"unprognostic (2.05e-3)"	"unprognostic (4.65e-1)"	"unprognostic (4.56e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.51e-2)"	"unprognostic (5.57e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.26e-1)"	"unprognostic (9.17e-3)"	"unprognostic (5.37e-3)"	"unprognostic (7.29e-2)"	3.0	4.2	9.6	5.9	11.7	6.1	6.2	6.6	13.7	2.5	2.8	26.7	1.1	2.0	4.3	3.7	2.3	3.7	3.6	3.9	12.6	6.9	2.7	1.1	4.1	7.2	14.6	7.4	11.2	3.8	10.1	6.6	3.7	10.8	6.5	3.4	3.9	4.6	3.6	3.9	1.2	3.5	3.4	10.6	9.0	2.9	1.5	9.7	2.0	7.8	1.1	6.2	3.7	4.1	0.1	5.4	1.7	7.4	1.3	1.8	0.4	0.0	3.4	0.2	0.0	0.0	0.2	3.1	0.1	0.0	0.0	0.0	0.0	0.8	5.3	0.0	0.1	1.5	5.9	0.0	0.0	0.3	5.3	0.0	8.8	0.0	0.4	5.7	0.7	0.8	0.2	0.0	0.1	0.0	8.9	16.2	0.0	2.3	4.5	9.0	1.0	0.0	14.5	1.7	13.5	0.0	0.4	1.3	11.1	0.0	0.0	0.0	0.8	17.4	0.0	0.0	1.8	0.2	0.1	6.9	9.9	0.0	0.7	10.9	0.1	0.1	0.4	1.7	1.4	3.8	0.8	0.1	0.5	0.9	0.7	0.1	1.8	1.1	0.2	1.3	7.4	5.4	0.0	0.4	9.6	11.7	6.6	13.7	12.6	6.9	14.6	7.4	10.8	9.7
SMC4	"CAP-C, hCAP-C, SMC4L1"	ENSG00000113810	"Structural maintenance of chromosomes 4"	Q9NTJ3	3	160399274-160434962	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA condensation, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 70.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA029449, CAB055509"	Approved		Supported	"Nuclear speckles,Cytosol"				"Nuclear speckles, Cytosol"		"CAB055509: , HPA029449: AB_10603891"	"unprognostic (2.63e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.45e-2)"	"prognostic unfavourable (7.63e-4)"	"unprognostic (2.22e-1)"	"unprognostic (1.28e-2)"	"prognostic unfavourable (2.94e-4)"	"unprognostic (9.54e-2)"	"unprognostic (2.18e-2)"	"unprognostic (5.47e-2)"	"prognostic unfavourable (4.20e-5)"	"prognostic unfavourable (9.00e-4)"	"prognostic unfavourable (8.05e-7)"	"unprognostic (3.03e-2)"	"unprognostic (4.46e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.98e-2)"	4.8	5.5	3.0	25.4	4.4	15.1	4.0	3.1	3.2	5.3	10.1	1.7	5.3	6.5	5.2	4.9	19.3	4.6	7.0	5.7	2.4	1.7	4.4	6.3	7.9	16.5	3.1	1.3	4.7	4.2	1.7	10.8	7.4	2.6	4.4	6.9	2.7	5.7	6.9	5.9	4.6	7.0	6.2	3.1	13.1	5.7	20.7	3.2	70.2	5.1	7.6	14.3	7.8	6.3	8.8	6.1	30.5	7.6	7.8	15.8	4.8	62.1	11.5	26.2	12.1	5.0	5.1	12.1	31.0	14.7	35.9	31.2	14.5	35.8	39.4	18.1	12.7	36.0	29.8	15.0	57.8	52.2	20.8	38.1	19.7	4.7	2.8	25.2	31.2	2.6	2.2	19.0	15.5	15.2	21.9	45.8	21.4	11.2	30.9	6.2	15.4	27.1	31.4	41.2	28.6	6.7	7.7	15.8	16.4	23.7	21.9	10.8	26.3	18.9	14.4	23.0	19.2	20.9	56.5	30.6	31.3	71.9	16.4	25.9	25.5	30.5	3.2	12.1	6.7	4.7	6.5	8.8	10.5	8.0	3.5	7.2	6.7	6.0	5.7	7.8	7.6	6.1	15.8	4.8	3.0	4.4	3.1	3.2	2.4	1.7	3.1	1.3	2.6	3.2
SMC5	"KIAA0594, SMC5L1"	ENSG00000198887	"Structural maintenance of chromosomes 5"	Q8IY18	9	70258962-70354888	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054900	Supported		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA054900: "	"unprognostic (2.55e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.72e-1)"	"unprognostic (8.04e-3)"	"unprognostic (2.15e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.80e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.36e-2)"	"unprognostic (7.30e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.73e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.80e-1)"	12.8	9.0	11.5	21.6	13.7	20.8	15.3	34.2	14.7	15.3	14.2	6.9	16.7	12.2	14.4	12.8	14.3	15.5	12.9	13.1	10.7	7.3	10.1	13.3	14.3	15.6	15.0	9.5	33.2	19.9	10.7	30.0	15.9	12.2	15.6	15.9	5.5	17.5	24.3	36.9	11.3	16.9	18.8	13.3	13.9	13.1	11.7	14.6	20.2	13.5	11.1	14.2	14.9	22.9	11.5	11.3	14.7	9.4	9.8	11.9	5.2	22.4	5.6	14.2	8.6	8.3	15.6	11.2	15.6	13.6	8.6	9.4	2.1	12.3	22.6	5.1	11.7	20.7	15.3	10.4	17.2	10.1	5.5	13.1	9.3	6.7	10.6	21.3	13.6	10.9	7.3	11.5	13.3	8.9	9.6	9.1	15.8	3.4	28.0	7.5	10.9	7.9	16.6	23.4	7.0	8.7	11.1	10.2	7.6	15.5	10.0	4.3	6.0	9.1	9.7	11.6	12.2	15.6	21.3	11.3	15.0	15.7	9.7	11.2	13.7	14.7	7.7	12.8	11.9	8.4	11.1	10.1	10.2	11.0	5.9	11.5	11.5	10.4	5.1	9.8	9.4	11.3	10.5	5.2	11.5	13.7	34.2	14.7	10.7	7.3	15.0	9.5	12.2	14.6
SMURF2		ENSG00000108854	"SMAD specific E3 ubiquitin protein ligase 2"	Q9HAU4	17	64542295-64662068	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ: 54.0;HBF TERT88: 41.5;LHCN-M2: 41.5;TIME: 47.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071508	Enhanced		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA071508: "	"unprognostic (1.21e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.24e-1)"	"unprognostic (6.19e-2)"	"unprognostic (7.33e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.50e-1)"	"unprognostic (7.94e-2)"	"unprognostic (1.09e-2)"	"unprognostic (5.46e-3)"	"unprognostic (2.54e-1)"	"unprognostic (5.55e-2)"	"unprognostic (1.98e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.41e-1)"	12.3	9.2	10.5	9.0	15.0	11.5	10.2	16.7	10.0	9.2	9.1	11.5	8.1	9.3	7.9	6.9	7.6	7.8	10.5	8.2	12.6	4.6	9.4	5.7	19.0	8.6	9.5	4.8	8.5	9.0	8.2	10.7	15.3	10.1	10.6	8.2	9.6	9.9	7.6	7.5	11.0	13.7	8.9	6.6	9.9	9.8	21.6	10.6	8.9	11.4	4.1	9.6	9.4	11.7	3.0	3.0	4.8	2.2	7.3	3.5	1.7	15.6	4.3	3.7	2.8	2.6	10.0	1.8	54.0	24.6	21.1	18.4	2.4	12.0	2.1	3.4	9.2	3.5	3.5	9.3	41.5	1.1	2.3	2.2	2.6	2.9	2.3	2.9	1.4	2.7	3.6	29.3	11.2	24.3	3.2	2.1	41.5	3.4	6.7	1.3	2.2	5.7	1.5	9.0	1.3	5.8	2.8	3.5	3.1	3.3	1.7	2.5	2.8	2.3	47.8	24.0	13.0	9.2	35.8	2.4	2.8	3.8	5.9	1.7	7.2	2.8	2.2	4.8	3.3	2.0	2.8	2.0	2.4	3.5	3.0	3.0	2.3	2.6	4.4	7.3	1.0	2.6	1.1	1.7	10.5	15.0	16.7	10.0	12.6	4.6	9.5	4.8	10.1	10.6
SNRNP40	"HPRP8BP, PRP8BP, PRPF8BP, SPF38, WDR57"	ENSG00000060688	"Small nuclear ribonucleoprotein U5 subunit 40"	Q96DI7	1	31259568-31296782	"Predicted intracellular proteins, Predicted membrane proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026527, HPA027345"	Supported		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA026527: AB_1858814, HPA027345: AB_2239703"	"unprognostic (2.31e-3)"	"unprognostic (5.63e-2)"	"unprognostic (5.24e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.14e-3)"	"unprognostic (1.28e-2)"	"prognostic unfavourable (4.73e-6)"	"unprognostic (2.14e-2)"	"unprognostic (2.43e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.57e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.78e-2)"	"unprognostic (5.93e-2)"	"unprognostic (4.31e-2)"	"unprognostic (6.24e-2)"	20.2	23.1	13.2	19.6	20.2	25.2	21.2	24.1	21.8	20.9	20.1	30.0	20.9	16.2	25.6	23.0	23.4	23.0	15.4	17.8	14.3	15.4	18.8	19.1	17.4	31.6	31.5	14.0	26.7	15.8	15.0	20.2	21.9	23.5	20.8	22.8	20.2	17.9	22.4	22.6	20.8	19.9	22.0	22.3	27.3	18.7	31.3	21.3	44.0	24.4	17.0	38.2	20.0	19.4	33.7	32.8	27.5	33.8	36.7	44.3	47.8	20.6	15.6	29.2	24.0	14.7	12.1	20.0	17.4	17.3	31.9	31.7	22.4	21.1	27.0	17.2	13.7	19.9	44.0	20.8	33.1	28.7	32.4	39.8	22.5	24.4	18.1	43.6	18.2	11.3	16.7	31.1	23.5	25.8	37.0	16.1	18.4	14.8	32.1	25.7	52.3	22.6	25.6	41.2	20.8	13.6	17.1	20.0	19.5	27.7	14.5	32.8	14.4	28.0	17.8	18.0	26.3	24.8	33.0	13.1	16.1	37.3	14.6	41.0	29.2	26.0	26.7	27.5	37.2	33.8	42.6	33.7	36.4	36.6	32.8	30.9	39.2	44.3	5.9	36.7	30.3	27.9	37.4	47.8	13.2	20.2	24.1	21.8	14.3	15.4	31.5	14.0	23.5	21.3
SNRPA1	Lea1	ENSG00000131876	"Small nuclear ribonucleoprotein polypeptide A'"	P09661	15	101281510-101295282	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045622, HPA048499"	Supported		Supported	"Nucleoplasm,Nuclear speckles,Nuclear bodies"				Nucleoplasm	"Nuclear speckles, Nuclear bodies"	"HPA045622: , HPA048499: "	"unprognostic (2.73e-1)"	"unprognostic (1.48e-1)"	"unprognostic (8.09e-2)"	"unprognostic (2.20e-1)"	"unprognostic (8.08e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavourable (8.56e-5)"	"unprognostic (5.80e-2)"	"unprognostic (1.66e-3)"	"prognostic favourable (8.83e-5)"	"unprognostic (4.74e-2)"	"unprognostic (6.77e-3)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (3.06e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.37e-2)"	11.9	13.3	12.4	26.1	19.6	35.2	17.7	9.7	17.2	9.9	18.0	10.2	10.4	14.6	14.3	21.1	24.6	12.4	11.8	17.3	17.9	9.8	16.1	19.7	14.1	29.2	11.2	12.2	10.8	16.3	9.1	10.7	29.3	14.1	10.3	19.3	11.3	17.2	9.1	13.4	12.1	22.5	11.7	9.4	26.4	15.9	24.3	7.0	33.4	11.6	18.1	30.0	12.3	12.2	21.7	23.5	8.4	18.2	18.3	26.9	15.3	31.2	21.9	21.1	10.7	6.0	4.9	20.8	29.1	13.5	26.2	20.0	46.7	28.0	34.8	16.7	19.7	18.7	31.5	20.8	28.1	17.6	48.7	27.3	35.6	24.6	4.6	31.2	19.6	4.0	15.6	16.7	21.1	16.8	37.9	32.8	16.0	34.6	31.4	33.2	27.0	18.6	31.4	22.8	35.0	19.1	82.2	16.5	17.3	17.7	20.3	21.9	19.6	24.7	12.1	14.0	26.6	16.3	29.0	27.1	80.2	67.6	11.3	29.5	16.5	1.4	15.0	8.4	24.6	18.2	24.1	21.7	25.4	24.2	23.5	19.1	21.2	26.3	2.9	18.3	16.6	22.3	26.9	15.3	12.4	19.6	9.7	17.2	17.9	9.8	11.2	12.2	14.1	7.0
SNURF		ENSG00000273173	"SNRPN upstream reading frame"	Q9Y675	15	24954986-24977850	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 140.9"	"Cell line enhanced"	"Detected in many"		"NTERA-2: 58.0;U-698: 30.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA065733			Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA065733: "	"unprognostic (2.08e-1)"	"unprognostic (2.88e-2)"	"unprognostic (6.82e-2)"	"unprognostic (4.59e-3)"	"unprognostic (4.03e-2)"	"unprognostic (1.40e-3)"	"unprognostic (4.39e-2)"	"unprognostic (6.89e-3)"	"unprognostic (1.56e-2)"	"unprognostic (6.74e-2)"	"unprognostic (8.91e-4)"	"unprognostic (3.77e-1)"	"unprognostic (1.77e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.12e-2)"	11.9	20.8	47.6	10.9	50.2	16.7	9.7	59.3	140.9	8.1	19.1	16.7	13.7	5.5	13.2	72.6	9.9	8.1	20.4	32.1	47.7	47.8	23.6	20.1	15.5	14.8	45.6	40.9	15.4	19.4	23.9	40.9	6.4	44.4	21.8	6.3	16.0	12.3	13.9	69.6	7.6	10.8	7.9	28.4	23.9	17.8	7.3	18.9	9.5	40.4	6.5	11.3	9.7	6.7	13.4	11.8	6.1	1.4	10.1	22.0	9.5	0.0	3.6	19.3	13.2	0.9	1.2	0.0	11.1	1.0	1.2	0.8	1.9	10.5	0.1	6.1	0.7	4.2	0.0	2.4	1.0	3.8	0.0	20.0	14.5	0.5	3.4	21.0	7.4	3.0	0.6	2.2	0.0	1.4	2.0	0.0	2.1	0.0	15.1	0.1	58.0	0.5	15.3	23.9	0.2	0.8	24.1	11.3	8.7	0.0	1.0	5.5	11.4	2.0	20.6	8.4	8.9	0.2	2.4	16.9	20.7	30.7	12.7	9.3	7.0	6.1	0.8	3.0	8.3	0.4	16.2	11.1	17.3	14.9	1.5	13.4	22.0	20.0	0.9	10.1	1.4	11.8	17.1	9.5	47.6	50.2	59.3	65.9	47.7	47.8	45.6	40.9	44.4	18.9
SRSF11	"NET2, p54, SFRS11"	ENSG00000116754	"Serine and arginine rich splicing factor 11"	Q05519	1	70205682-70253052	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008762	Supported		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA008762: AB_1856782"	"unprognostic (7.82e-3)"	"unprognostic (1.69e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.85e-1)"	"unprognostic (5.32e-3)"	"unprognostic (1.30e-3)"	"prognostic unfavourable (3.91e-4)"	"unprognostic (2.23e-3)"	"unprognostic (5.65e-3)"	"unprognostic (3.18e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.25e-3)"	"prognostic unfavourable (6.53e-6)"	"unprognostic (7.79e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.43e-2)"	36.1	42.7	38.3	36.9	41.3	80.1	42.2	68.2	43.6	38.6	32.6	34.8	38.4	30.7	41.4	51.2	31.2	39.0	31.6	25.9	33.4	26.6	30.7	42.5	33.9	47.6	47.7	34.4	51.1	42.5	39.0	53.4	38.4	39.9	37.1	32.4	32.3	34.4	41.8	31.3	51.8	40.6	36.8	37.8	45.9	34.5	35.1	41.7	46.6	44.6	25.5	43.3	32.8	36.7	34.7	42.1	45.4	29.7	36.0	36.4	22.2	24.6	12.5	33.0	21.0	17.0	22.9	45.4	30.5	15.8	24.9	22.7	22.0	18.6	42.0	20.9	15.3	21.1	41.6	16.7	34.1	28.1	32.5	42.5	28.2	26.3	20.3	58.4	17.7	18.3	21.2	23.0	23.5	22.1	41.8	26.6	24.5	9.6	34.9	43.4	53.0	21.2	41.6	36.5	26.6	29.0	17.8	27.8	23.0	25.8	28.0	36.4	22.4	26.3	26.1	27.6	19.8	19.8	27.4	30.8	24.6	46.2	19.8	43.5	24.1	39.6	29.7	45.4	32.6	23.1	36.4	34.7	32.9	31.4	30.1	34.1	36.1	33.4	15.0	36.0	27.1	42.1	35.5	22.2	38.3	41.3	68.2	43.6	33.4	26.6	47.7	34.4	39.9	41.7
SRSF4	"SFRS4, SRP75"	ENSG00000116350	"Serine and arginine rich splicing factor 4"	Q08170	1	29147743-29181987	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050975	Supported		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA050975: "	"unprognostic (3.26e-3)"	"unprognostic (8.08e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.57e-3)"	"unprognostic (1.37e-1)"	"unprognostic (5.89e-2)"	"unprognostic (1.89e-3)"	"unprognostic (1.63e-1)"	"prognostic unfavourable (3.27e-4)"	"unprognostic (2.36e-1)"	"unprognostic (1.75e-1)"	"prognostic unfavourable (4.26e-4)"	"prognostic unfavourable (4.30e-4)"	"unprognostic (6.25e-3)"	"unprognostic (2.80e-1)"	"unprognostic (7.75e-3)"	"unprognostic (1.60e-2)"	42.5	26.5	26.8	31.7	34.6	46.6	38.7	37.5	28.3	33.9	35.8	27.9	30.7	35.1	39.0	29.1	35.9	30.7	26.3	28.7	26.0	22.3	27.8	40.7	36.7	37.1	35.0	24.1	43.0	30.4	28.5	27.0	40.7	27.9	35.2	26.2	27.8	33.6	34.8	47.0	38.0	34.0	52.6	30.7	38.7	29.9	23.4	33.8	46.9	35.1	23.6	30.0	55.6	70.2	23.8	25.6	44.8	26.1	20.0	35.0	20.7	31.0	18.6	34.9	12.7	25.5	19.4	21.8	26.2	19.3	31.0	26.6	17.0	19.1	35.7	24.6	21.6	29.2	29.4	23.8	31.5	43.3	35.2	54.5	27.4	26.5	26.7	36.4	34.6	15.6	30.3	26.2	33.7	25.5	44.1	28.4	21.0	15.4	46.5	31.5	37.6	17.7	43.4	38.4	24.0	21.0	31.9	21.4	24.6	32.3	18.3	29.9	12.1	22.0	24.8	25.1	20.2	27.3	42.6	26.8	20.1	39.5	24.1	46.9	27.2	26.2	20.8	44.8	31.8	24.7	30.9	23.4	29.3	34.0	25.6	23.8	25.6	27.1	41.2	20.0	26.1	19.7	35.0	20.7	26.8	34.6	37.5	28.3	26.0	22.3	35.0	24.1	27.9	33.8
SRSF6	"B52, SFRS6, SRP55"	ENSG00000124193	"Serine and arginine rich splicing factor 6"	Q13247	20	43457928-43464247	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029005, CAB034889"	Supported		Supported	"Nuclear speckles"				"Nuclear speckles"		"CAB034889: AB_785899, HPA029005: AB_10610424"	"unprognostic (1.51e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.25e-2)"	"unprognostic (6.41e-2)"	"unprognostic (3.91e-2)"	"prognostic unfavourable (3.86e-4)"	"unprognostic (3.99e-3)"	"unprognostic (4.39e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.27e-3)"	"unprognostic (6.03e-3)"	"prognostic unfavourable (2.82e-4)"	"unprognostic (1.73e-1)"	"unprognostic (2.70e-1)"	"unprognostic (4.31e-1)"	"unprognostic (1.18e-2)"	24.9	35.9	21.7	29.3	31.5	57.0	34.7	30.6	23.0	26.7	21.4	29.5	44.4	20.3	32.1	36.9	23.3	35.6	26.7	18.3	21.4	18.5	30.3	41.4	25.5	26.3	33.9	17.0	41.4	48.3	30.4	47.8	29.0	24.2	30.3	26.7	26.3	32.0	30.2	25.6	27.9	30.0	24.5	17.8	38.8	29.3	27.0	30.5	49.4	36.7	38.6	34.4	21.3	20.7	12.3	17.3	14.7	24.2	15.3	22.1	14.6	15.1	10.9	31.4	20.4	18.1	25.0	23.5	21.3	13.5	19.3	16.3	22.7	19.2	30.0	16.0	25.2	21.3	32.4	40.6	26.0	8.8	17.8	25.2	21.6	25.8	22.4	29.7	19.5	42.3	21.8	17.2	15.8	18.0	18.2	19.0	18.3	18.1	38.2	35.4	18.4	16.2	22.2	19.6	24.2	22.6	25.4	24.2	31.4	26.7	38.9	34.8	21.9	34.9	18.8	19.5	14.4	16.7	22.0	24.7	15.1	39.8	24.5	22.5	13.6	14.7	14.5	6.7	15.8	24.2	17.5	12.3	16.6	15.0	17.3	12.2	22.1	20.7	7.2	15.3	19.0	14.8	13.2	14.6	21.7	31.5	30.6	23.0	21.4	18.5	33.9	17.0	24.2	30.5
STK17A	DRAK1	ENSG00000164543	"Serine/threonine kinase 17a"	Q9UEE5	7	43582758-43626786	"Enzymes, Plasma proteins, Predicted membrane proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 43.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											"HPA018138, HPA037979"	Uncertain		Approved	"Nuclear speckles,Plasma membrane"				"Nuclear speckles"	"Plasma membrane"	"HPA018138: , HPA037979: AB_10795247"	"unprognostic (1.81e-3)"	"unprognostic (1.08e-2)"	"unprognostic (2.67e-1)"	"unprognostic (5.41e-2)"	"unprognostic (5.11e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.03e-2)"	"unprognostic (9.15e-3)"	"unprognostic (2.07e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.36e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.99e-3)"	"unprognostic (3.76e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.97e-3)"	"unprognostic (3.66e-1)"	7.1	10.1	6.1	43.3	8.2	20.2	8.4	7.9	7.2	4.8	9.3	3.7	2.0	6.1	5.3	4.2	10.1	4.7	8.6	17.7	5.7	5.6	6.7	8.1	15.2	36.6	6.6	2.6	7.3	14.3	1.5	6.3	37.2	5.7	6.2	5.3	3.6	8.6	3.4	10.7	4.8	12.3	5.8	5.3	27.8	11.0	9.0	2.8	30.1	7.3	6.8	37.7	10.3	8.1	10.8	1.4	11.5	0.9	12.7	11.4	2.9	4.5	5.7	5.2	3.5	6.5	8.6	2.1	16.5	17.8	9.0	9.2	4.9	3.3	7.3	26.0	13.7	9.4	3.9	21.9	12.6	18.0	4.4	6.5	4.3	6.1	4.8	11.2	4.4	7.0	25.8	11.9	10.9	16.8	7.6	25.2	10.3	2.1	18.2	5.2	8.0	18.7	6.3	3.3	14.5	15.7	3.4	2.8	6.3	7.4	3.4	4.8	4.0	5.7	16.8	19.6	7.5	11.6	18.4	15.3	7.6	10.6	19.9	9.9	31.2	0.7	0.4	11.5	5.8	0.2	5.8	10.8	6.1	9.7	0.3	10.1	11.4	10.2	6.4	12.7	0.9	1.4	3.2	2.9	6.1	8.2	7.9	5.9	5.7	5.6	6.6	2.6	5.7	2.8
STK19	"D6S60, G11, RP1"	ENSG00000204344	"Serine/threonine kinase 19"	P49842	6	31971091-31982821	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 4.8;REH: 4.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031510, HPA031511, HPA068559"	Uncertain		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA031510: AB_10603119, HPA031511: AB_2673915, HPA068559: "	"unprognostic (1.65e-1)"	"unprognostic (2.30e-1)"	"unprognostic (3.31e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.15e-2)"	"unprognostic (4.26e-2)"	"prognostic unfavourable (1.18e-4)"	"unprognostic (3.95e-2)"	"unprognostic (2.76e-3)"	"unprognostic (2.25e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.40e-1)"	"unprognostic (4.10e-1)"	6.4	8.2	3.8	4.3	6.5	2.9	4.0	9.9	6.3	5.7	6.6	5.5	4.2	2.2	6.0	5.5	5.3	3.5	5.3	3.6	5.0	3.5	3.9	6.6	4.1	2.5	4.3	7.5	5.7	12.4	4.7	4.6	6.3	4.0	6.2	2.7	5.6	2.9	6.7	6.1	6.8	2.6	5.9	3.7	7.0	6.3	7.9	4.2	2.6	4.7	4.1	3.8	4.4	4.2	2.1	2.7	0.4	3.8	0.9	1.1	0.5	0.0	0.3	0.0	1.1	2.9	1.7	0.0	2.3	0.3	0.5	1.1	0.0	1.9	1.5	0.6	1.2	2.0	0.0	0.6	0.9	4.8	0.9	3.6	0.9	0.2	1.4	3.7	0.0	1.5	0.1	0.8	0.3	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.6	0.0	4.4	2.4	1.1	0.0	0.0	1.0	0.9	0.3	0.6	0.2	1.7	0.0	0.0	0.0	1.1	1.1	0.0	0.1	2.3	0.1	1.9	0.6	0.1	0.0	3.8	0.1	0.6	1.4	0.7	2.1	0.9	0.1	2.7	1.0	1.1	0.5	0.4	0.9	1.4	1.5	0.1	0.5	3.8	6.5	9.9	6.3	5.0	3.5	4.3	7.5	4.0	4.2
SYF2	"CBPIN, DKFZp564O2082, fSAP29, NTC31, p29"	ENSG00000117614	"SYF2 pre-mRNA splicing factor"	O95926	1	25222679-25232502	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018265, HPA070710"	Approved		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA018265: AB_10962002, HPA070710: "	"unprognostic (4.19e-3)"	"unprognostic (1.58e-2)"	"unprognostic (9.98e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.76e-2)"	"unprognostic (6.76e-3)"	"unprognostic (7.40e-3)"	"unprognostic (2.36e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.33e-2)"	"unprognostic (7.58e-2)"	"unprognostic (4.89e-2)"	"unprognostic (2.27e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.45e-3)"	"prognostic favourable (5.72e-4)"	37.5	30.4	31.6	30.8	35.4	67.3	34.4	34.7	30.1	38.2	36.0	15.1	29.3	28.7	34.1	37.8	36.3	28.5	24.5	28.6	30.1	22.0	35.5	24.7	27.7	30.1	30.7	25.3	57.8	32.2	29.5	29.8	37.7	32.9	36.6	31.1	16.3	28.2	31.1	69.8	29.9	40.7	46.8	41.0	34.3	31.3	20.7	32.4	37.2	39.3	28.2	37.1	54.5	50.6	31.5	16.9	85.5	26.5	25.8	29.5	20.1	18.9	8.2	19.7	15.7	31.9	38.9	15.3	20.8	31.5	18.4	17.7	5.4	25.4	17.8	27.5	22.9	17.0	16.9	15.5	26.3	28.4	17.4	21.4	19.6	13.6	31.4	27.1	19.6	29.0	40.8	20.0	26.4	26.5	16.1	25.5	25.5	7.7	26.8	35.1	26.7	13.2	17.5	17.7	27.5	29.9	9.5	16.9	24.7	19.2	15.7	51.0	13.8	31.3	24.5	16.3	14.5	30.9	16.1	30.8	29.3	17.1	24.3	28.3	15.7	39.4	21.0	51.4	20.9	22.5	24.3	31.5	26.4	25.5	16.9	28.1	28.7	26.3	85.5	25.8	26.5	16.7	29.5	20.1	31.6	35.4	34.7	30.1	30.1	22.0	30.7	25.3	32.9	32.4
TAF5L	PAF65B	ENSG00000135801	"TATA-box binding protein associated factor 5 like"	O75529	1	229593111-229626047	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067941			Supported	"Nuclear speckles,Cytoplasmic bodies"				"Nuclear speckles"	"Cytoplasmic bodies"	"HPA067941: "	"unprognostic (3.41e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.39e-2)"	"unprognostic (1.93e-1)"	"unprognostic (7.46e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.63e-1)"	"unprognostic (6.84e-2)"	"unprognostic (5.17e-3)"	"unprognostic (8.16e-3)"	"unprognostic (1.91e-3)"	"unprognostic (3.21e-1)"	"unprognostic (2.99e-1)"	"unprognostic (4.99e-2)"	"unprognostic (3.11e-1)"	19.5	8.3	13.0	14.4	12.8	23.0	25.6	13.5	14.7	12.1	15.3	14.7	9.9	12.7	15.8	10.6	15.0	14.1	16.3	12.9	10.5	9.0	9.5	18.6	13.6	15.7	12.1	8.0	12.2	10.4	12.7	11.6	25.0	12.9	15.7	15.8	9.2	13.3	12.3	24.9	10.1	17.0	16.5	12.8	15.6	13.8	8.5	10.5	15.9	13.5	11.9	15.3	17.1	13.2	1.1	1.6	0.2	1.3	2.1	2.6	0.8	16.7	9.7	14.0	11.6	9.7	10.2	36.3	11.4	13.7	14.3	13.4	13.0	13.8	18.9	12.2	12.3	14.4	15.4	14.0	13.8	14.1	22.1	14.8	9.9	8.3	10.9	19.6	17.2	11.2	13.6	14.1	12.1	13.9	19.7	17.6	13.4	8.1	22.1	10.6	19.8	7.7	19.7	15.7	19.5	10.0	15.6	14.1	17.2	9.8	13.5	15.7	16.0	20.5	12.0	11.9	14.6	15.8	24.0	9.4	7.1	21.7	9.1	11.9	18.7	0.0	1.1	0.2	2.1	1.2	2.6	1.1	2.2	1.7	1.6	1.0	2.2	1.9	0.2	2.1	1.3	0.7	1.9	0.8	13.0	12.8	13.5	14.7	10.5	9.0	12.1	8.0	12.9	10.5
TCF12	"bHLHb20, HEB, HsT17266, HTF4"	ENSG00000140262	"Transcription factor 12"	Q99081	15	56918623-57299281	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes, Craniosynostosis, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 89.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004432, HPA065827"	Approved		Supported	"Nucleoplasm,Nuclear speckles"				"Nucleoplasm, Nuclear speckles"		"CAB004432: AB_671267, HPA065827: "	"unprognostic (1.19e-1)"	"unprognostic (1.11e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.07e-3)"	"unprognostic (1.11e-1)"	"unprognostic (6.63e-2)"	"unprognostic (1.85e-1)"	"prognostic unfavourable (8.89e-4)"	"unprognostic (7.83e-2)"	"unprognostic (7.26e-3)"	"unprognostic (5.57e-3)"	"prognostic unfavourable (5.24e-5)"	"unprognostic (2.03e-1)"	"unprognostic (2.93e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.41e-1)"	20.9	14.3	24.9	12.6	37.5	10.9	18.4	32.7	41.8	48.2	16.5	33.6	14.0	16.0	28.1	15.0	14.8	28.2	21.4	15.7	28.4	16.4	17.0	14.4	17.3	13.7	33.9	15.3	26.2	12.5	29.2	15.7	19.1	27.9	26.3	17.9	14.7	20.1	17.5	18.1	16.0	15.8	25.8	25.3	13.6	17.3	14.7	41.3	89.4	17.0	9.6	15.8	23.3	21.2	11.8	15.9	16.0	19.3	12.2	17.6	10.2	6.5	12.3	54.2	17.5	24.7	21.7	9.5	13.5	23.8	12.0	16.0	8.0	5.3	9.0	11.1	20.4	7.9	21.2	9.7	15.4	11.8	7.9	18.1	13.4	9.5	17.1	11.3	9.5	19.1	17.6	11.0	29.2	21.4	20.2	11.4	16.3	2.2	26.7	6.3	14.6	5.3	36.6	63.0	8.4	16.5	12.2	11.1	32.1	14.6	5.3	13.1	8.2	22.3	16.5	19.4	14.8	8.2	19.7	6.5	11.6	15.0	10.8	22.1	23.1	16.0	11.2	8.7	15.0	14.3	12.4	10.8	12.2	13.6	15.9	11.8	14.1	12.7	1.3	12.2	19.3	6.6	17.6	10.2	24.9	37.5	32.7	26.9	28.4	16.4	33.9	15.3	27.9	41.3
TCF15	"bHLHa40, EC2, PARAXIS"	ENSG00000125878	"Transcription factor 15"	Q12870	20	603797-610398	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"breast: 11.4;heart muscle: 19.4;skeletal muscle: 18.0"	"Cell line enhanced"	"Detected in some"		"HEL: 10.7;HMC-1: 17.6;U-2 OS: 3.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA050998, HPA060221"	Approved		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA050998: , HPA060221: "	"unprognostic (2.12e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.58e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.29e-1)"	"unprognostic (4.62e-2)"	"unprognostic (5.57e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.81e-1)"	"prognostic unfavourable (3.25e-4)"	"unprognostic (1.52e-1)"	"unprognostic (9.43e-2)"	"unprognostic (1.27e-3)"	"unprognostic (7.21e-2)"	"unprognostic (8.56e-2)"	"unprognostic (5.11e-1)"	"unprognostic (6.99e-2)"	8.4	0.3	0.9	0.4	1.0	0.2	11.4	0.1	1.1	0.6	1.3	0.1	0.0	0.4	0.8	0.3	1.7	0.4	0.7	19.4	1.2	0.7	0.5	0.3	0.9	0.3	1.0	0.0	0.2	0.1	0.4	0.3	8.2	0.7	1.0	0.3	0.3	0.8	0.3	18.0	0.2	0.4	1.3	1.1	0.2	0.4	1.6	0.6	0.2	1.3	6.0	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	1.5	0.0	0.0	0.0	3.0	10.7	0.0	0.0	0.0	0.0	17.6	0.0	0.0	0.0	0.0	0.5	1.7	0.0	0.0	0.0	0.0	0.0	3.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	1.6	0.0	1.4	0.0	0.0	1.4	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.0	0.1	1.1	1.2	0.7	1.0	0.0	0.7	0.6
TCP11L2	MGC40368	ENSG00000166046	"T-complex 11 like 2"	Q8N4U5	12	106301929-106347015	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 32.1"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 32.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039483, HPA042188"	Uncertain		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA039483: AB_10795291, HPA042188: AB_10794415"	"unprognostic (1.41e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.15e-2)"	"unprognostic (1.97e-1)"	"prognostic favourable (9.52e-4)"	"unprognostic (3.87e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.11e-1)"	"unprognostic (9.05e-3)"	"unprognostic (5.44e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.02e-2)"	"unprognostic (3.67e-1)"	9.1	12.0	8.1	6.2	18.2	22.3	9.0	10.4	13.0	9.7	8.6	31.5	3.3	6.2	10.3	7.1	20.1	11.6	8.1	18.9	8.3	5.8	6.1	5.6	14.4	12.9	22.2	9.4	9.7	8.6	11.1	7.2	12.3	16.2	7.5	7.9	9.5	15.9	5.9	18.0	14.0	10.3	10.2	14.6	10.2	10.2	8.7	18.4	16.4	12.2	6.3	14.0	11.3	11.8	6.2	0.8	32.1	3.2	1.9	6.3	1.7	2.6	6.6	1.0	1.9	9.2	10.7	4.2	1.7	8.6	1.1	2.8	1.0	3.6	0.9	2.7	6.7	12.6	0.8	3.7	2.0	1.4	2.8	0.5	2.5	4.0	9.0	0.3	1.8	13.4	8.7	1.3	6.5	6.2	1.6	1.3	1.5	1.9	1.6	1.4	1.2	4.2	0.8	0.2	3.0	8.7	12.5	4.2	3.1	4.5	1.4	5.2	3.9	0.3	4.7	1.6	1.4	2.4	0.4	8.4	0.6	3.2	4.6	0.2	0.8	10.8	3.2	4.9	2.4	1.4	1.8	6.2	4.9	2.7	0.8	5.7	6.3	4.1	32.1	1.9	2.2	0.6	5.6	1.7	8.1	18.2	10.4	13.0	8.3	5.8	22.2	9.4	16.2	18.4
TERT	"EST2, hEST2, TCS1, TP2, TRT"	ENSG00000164362	"Telomerase reverse transcriptase"	O14746	5	1253147-1295069	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"DNA-binding, Nucleotidyltransferase, Ribonucleoprotein, RNA-directed DNA polymerase, Transferase"	"Cancer-related genes, Disease mutation, Dyskeratosis congenita"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"bone marrow: 3.4;lymphoid tissue: 12.0;testis: 5.0"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 61.2;fHDF/TERT166: 58.1;HBEC3-KT: 118.1;hTEC/SVTERT24-B: 74.6;LHCN-M2: 33.7;TIME: 96.1"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA054641, HPA065897"	Supported		Supported	"Nucleoplasm,Nuclear speckles,Cytosol"				Nucleoplasm	"Nuclear speckles, Cytosol"	"HPA054641: , HPA065897: "	"unprognostic (1.21e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.24e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.43e-3)"	"unprognostic (6.42e-3)"	"unprognostic (1.85e-2)"	"unprognostic (2.21e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.59e-1)"	"unprognostic (9.16e-4)"	"unprognostic (8.84e-11)"	"unprognostic (1.92e-1)"	"unprognostic (2.15e-1)"		"unprognostic (3.35e-1)"	0.0	0.0	0.0	7.1	0.9	3.4	0.0	0.0	0.2	0.1	1.1	0.0	0.0	1.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	2.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	1.0	0.4	5.0	0.0	12.0	0.0	0.0	2.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	30.6	61.2	0.5	0.0	23.3	4.2	7.9	0.1	0.1	0.7	0.0	58.1	0.0	0.2	118.1	5.0	0.0	0.3	0.0	0.0	0.1	0.0	0.3	0.2	0.0	3.0	74.6	0.8	0.2	0.6	0.1	33.7	0.0	0.2	1.6	0.4	0.2	0.8	0.0	0.8	3.4	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.2	96.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.0
THOC6	"fSAP35, MGC2655, WDR58"	ENSG00000131652	"THO complex 6"	Q86W42	16	3024027-3027755	"Disease related genes, Predicted intracellular proteins"	"Apoptosis, mRNA processing, mRNA splicing, mRNA transport, Transport"	"Developmental protein, RNA-binding"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052953	Uncertain		Supported	"Nucleoplasm,Nuclear speckles"				"Nucleoplasm, Nuclear speckles"		"HPA052953: "	"unprognostic (2.07e-2)"	"unprognostic (4.13e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.91e-1)"	"unprognostic (7.82e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.20e-2)"	"unprognostic (5.15e-2)"	"unprognostic (3.44e-2)"	"prognostic unfavourable (4.40e-4)"	"unprognostic (3.59e-1)"	"unprognostic (1.43e-1)"	"unprognostic (6.17e-2)"	"unprognostic (9.43e-2)"	10.5	12.0	7.8	14.6	8.2	16.7	12.8	7.0	9.8	10.0	13.7	9.1	11.9	15.5	15.7	8.6	13.7	10.4	19.3	9.5	7.0	5.6	12.9	17.5	12.4	15.5	11.0	4.8	13.2	20.7	11.8	13.2	28.0	9.0	15.1	8.6	7.2	16.6	11.0	17.0	20.6	17.6	10.5	6.5	16.9	10.5	9.0	6.8	27.3	12.7	19.4	17.9	10.0	11.6	17.8	34.5	5.0	24.4	14.3	16.4	16.3	12.6	20.7	15.1	15.8	7.7	8.9	26.6	3.9	9.1	9.2	13.7	13.7	15.0	24.1	12.9	6.5	17.5	16.4	12.5	5.1	21.2	21.0	13.0	19.1	19.9	13.2	19.0	28.7	8.9	15.1	11.2	28.0	8.5	18.9	13.0	4.5	29.7	10.7	35.3	27.0	8.9	29.0	11.3	28.1	9.6	6.4	31.0	14.7	11.1	17.7	7.2	12.7	20.8	7.0	9.6	22.3	10.8	14.1	9.4	8.0	29.1	2.5	13.1	9.6	0.8	24.4	5.0	14.8	23.7	14.9	15.3	13.7	14.3	34.5	17.8	16.0	16.4	1.8	14.3	13.1	29.1	14.2	16.3	7.8	8.2	7.0	9.8	7.0	5.6	11.0	4.8	9.0	6.8
THOC7	"FLJ23445, fSAP24, NIF3L1BP1"	ENSG00000163634	"THO complex 7"	Q6I9Y2	3	63833870-63863903	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, mRNA transport, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 144.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044143	Approved		Supported	"Nuclear speckles,Cytosol"				"Nuclear speckles, Cytosol"		"HPA044143: AB_10794892"	"unprognostic (4.33e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.26e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.20e-3)"	"unprognostic (3.53e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.86e-2)"	"unprognostic (9.90e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.51e-2)"	"unprognostic (5.18e-2)"	"unprognostic (4.25e-2)"	"unprognostic (2.31e-1)"	24.3	28.5	41.1	19.7	34.7	29.0	33.3	20.6	37.6	24.6	29.6	14.8	24.1	27.7	22.2	24.6	43.6	18.7	27.2	36.1	38.5	28.3	30.5	32.5	17.2	25.9	33.9	35.2	21.1	35.6	18.0	23.8	42.0	33.7	24.6	30.4	14.8	30.4	22.8	52.9	27.0	34.9	31.1	27.2	20.4	21.5	24.6	15.5	34.4	21.3	43.0	27.6	28.4	22.8	25.4	31.4	32.2	24.8	27.6	32.1	17.7	19.5	12.0	13.8	3.4	18.5	25.4	13.2	17.3	17.9	20.3	20.4	14.4	21.7	23.4	7.3	22.2	11.5	15.5	27.2	28.4	23.9	11.3	20.9	15.7	16.6	19.5	29.1	10.3	18.3	22.9	17.4	30.8	22.2	16.0	22.8	24.6	144.9	25.5	26.4	17.5	9.7	18.6	13.0	31.9	35.1	18.7	6.9	16.0	15.0	21.1	23.4	13.5	40.5	16.0	14.8	15.8	18.3	30.5	15.0	22.0	28.4	18.4	37.3	19.2	32.2	21.9	17.1	22.2	24.8	30.7	25.4	27.6	30.0	31.4	17.4	23.8	24.8	13.1	27.6	20.7	28.9	32.1	17.7	41.1	34.7	20.6	37.6	38.5	28.3	33.9	35.2	33.7	15.5
UBE4A	"E4, KIAA0126, UBOX2, UFD2"	ENSG00000110344	"Ubiquitination factor E4A"	Q14139	11	118359585-118399211	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055035, HPA064010"	Approved		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA055035: , HPA064010: "	"unprognostic (1.32e-2)"	"unprognostic (8.15e-2)"	"unprognostic (5.23e-3)"	"unprognostic (3.34e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.97e-1)"	"unprognostic (7.67e-3)"	"unprognostic (3.31e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.67e-2)"	"unprognostic (6.01e-2)"	"unprognostic (5.83e-2)"	"unprognostic (7.73e-3)"	"unprognostic (4.74e-2)"	"unprognostic (5.94e-2)"	"unprognostic (2.72e-1)"	"unprognostic (8.86e-2)"	19.3	18.5	17.7	20.5	30.1	16.6	19.7	49.4	36.6	19.0	18.5	33.0	16.1	20.3	23.2	21.2	21.2	19.8	17.0	20.3	17.7	18.8	20.3	29.5	18.4	22.2	25.7	25.7	24.2	26.7	31.1	24.2	18.6	35.5	21.5	23.1	21.2	20.3	17.2	32.5	25.6	23.7	19.9	25.5	24.0	25.5	21.8	27.5	22.1	22.1	15.1	22.6	21.6	20.4	5.7	11.0	14.6	13.2	7.1	9.0	5.2	9.1	8.9	11.4	11.4	19.8	18.4	11.4	13.6	14.2	10.1	12.4	24.5	22.6	19.3	26.3	17.0	20.3	16.1	12.8	16.8	10.8	7.5	31.6	8.0	12.6	17.1	17.8	24.3	18.5	9.3	20.6	20.3	16.8	17.9	18.2	14.5	17.3	15.2	17.8	10.6	11.4	9.7	16.6	19.7	11.1	21.4	10.4	10.8	19.6	17.0	6.0	22.7	8.2	17.2	15.0	9.9	12.8	11.2	5.4	6.5	18.4	8.3	20.7	15.3	14.6	10.9	10.5	9.0	12.0	6.9	5.7	6.9	6.4	11.0	4.3	7.4	6.6	11.0	7.1	13.2	6.5	7.7	5.2	17.7	30.1	49.4	36.6	17.7	18.8	25.7	25.7	35.5	27.5
UNC45A	"GC-UNC45, SMAP-1"	ENSG00000140553	"Unc-45 myosin chaperone A"	Q9H3U1	15	90930180-90954093	"Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Myogenesis"	"Chaperone, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039228	Approved		Supported	"Nuclear speckles,Cytosol"			21000000	"Nuclear speckles"	Cytosol	"HPA039228: "	"unprognostic (1.46e-1)"	"unprognostic (3.83e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.70e-3)"	"prognostic unfavourable (7.72e-4)"	"unprognostic (2.27e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.98e-1)"	"unprognostic (9.85e-2)"	"prognostic favourable (7.46e-7)"	"unprognostic (9.30e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.28e-2)"	19.1	21.0	10.1	14.4	10.1	11.9	20.6	21.8	14.6	20.3	27.6	10.7	23.2	13.0	29.7	15.5	24.9	20.4	24.8	12.8	9.5	7.3	16.2	15.9	15.2	13.2	11.9	12.3	22.1	19.4	25.8	14.1	22.8	11.5	23.8	10.9	15.3	20.2	29.6	6.9	26.6	16.9	35.8	9.7	15.7	22.4	18.4	10.8	18.0	20.8	12.6	16.9	33.2	30.4	10.1	12.0	12.1	11.9	10.8	14.5	9.8	15.1	30.9	12.8	11.1	35.1	16.3	11.4	17.2	14.9	23.5	18.9	24.6	20.1	17.9	23.2	21.7	33.7	21.7	22.2	11.1	19.8	31.6	34.5	32.3	17.6	19.9	8.5	23.5	20.1	27.2	23.0	16.9	31.8	15.2	14.7	17.6	24.4	10.9	7.3	17.3	15.7	21.8	19.5	19.0	16.0	36.1	18.1	16.4	23.2	23.2	21.5	21.0	17.7	31.3	20.1	14.5	16.9	18.0	14.1	19.5	8.4	19.7	20.0	20.4	12.1	9.0	5.4	14.5	8.3	14.0	10.1	11.9	11.2	12.0	8.3	10.0	9.1	1.8	10.8	11.9	10.7	10.5	9.8	10.1	10.1	21.8	14.6	9.5	7.3	11.9	12.3	11.5	10.8
USP36	"FLJ12851, KIAA1453"	ENSG00000055483	"Ubiquitin specific peptidase 36"	Q9P275	17	78787381-78841441	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012082, HPA012395, HPA052860"	Uncertain	Supported	Enhanced	"Nucleoli,Nuclear speckles"				Nucleoli	"Nuclear speckles"	"HPA012082: AB_1858682, HPA012395: , HPA052860: "	"unprognostic (1.94e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavourable (5.18e-5)"	"unprognostic (9.35e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.50e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.81e-1)"	"unprognostic (4.03e-3)"	"unprognostic (1.78e-1)"	26.3	23.4	12.9	21.3	16.0	36.5	28.1	28.3	17.4	17.2	16.4	25.4	19.2	12.3	25.1	22.2	14.6	18.0	21.9	17.4	10.4	11.2	15.9	16.4	20.0	17.2	17.5	16.0	41.3	33.6	19.6	30.0	23.4	14.6	21.0	15.1	20.4	21.8	45.5	19.5	29.3	15.1	25.2	14.5	18.2	17.3	20.8	13.7	12.8	19.3	11.2	22.2	24.6	18.1	6.7	12.4	8.9	5.3	5.6	8.8	2.5	15.7	19.1	5.6	10.4	12.1	13.5	10.8	13.0	13.2	12.5	8.4	18.5	8.0	20.2	6.6	11.5	11.6	13.2	9.6	22.4	4.8	20.0	18.4	27.8	19.2	12.4	20.1	10.1	11.7	16.0	17.8	39.9	10.8	14.6	21.3	10.3	12.1	18.3	20.4	8.7	15.3	14.1	12.3	13.5	7.9	16.6	16.6	10.1	9.3	43.5	23.6	11.2	12.8	9.2	29.5	13.7	17.1	22.9	15.8	6.2	24.8	11.6	15.8	9.2	8.9	3.9	3.1	7.6	5.3	8.8	6.4	7.2	6.4	2.3	6.7	8.0	7.7	5.7	5.6	3.3	12.4	4.8	2.5	12.9	16.0	28.3	17.4	10.4	11.2	17.5	16.0	14.6	13.7
WRN	"RECQ3, RECQL2"	ENSG00000165392	"Werner syndrome RecQ like helicase"	Q14191	8	31033801-31173769	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Exonuclease, Helicase, Hydrolase, Multifunctional enzyme, Nuclease"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028661	Approved		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA028661: AB_10602255"	"unprognostic (8.73e-2)"	"unprognostic (9.33e-2)"	"unprognostic (1.51e-3)"	"unprognostic (3.85e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.21e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.27e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.53e-2)"	"unprognostic (6.51e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.00e-2)"	"unprognostic (2.66e-1)"	10.1	9.2	5.6	8.5	6.6	15.6	11.1	10.7	7.3	14.2	8.0	7.7	7.7	5.5	24.4	8.8	7.6	9.7	6.9	7.0	5.9	4.0	5.1	7.7	7.2	6.7	8.2	5.3	12.0	9.9	7.8	28.1	8.5	7.0	8.6	7.8	8.3	10.8	7.8	7.7	10.2	7.0	12.1	14.9	8.9	8.3	10.4	7.3	11.8	7.9	6.3	9.3	10.8	8.7	3.9	2.7	1.3	1.9	2.9	6.2	1.6	6.4	6.3	13.1	8.3	7.8	12.5	8.3	7.3	7.1	8.9	9.3	4.0	3.9	15.1	6.7	7.3	3.3	8.1	5.2	13.4	4.2	6.9	15.4	6.0	3.3	9.8	9.1	5.7	9.1	5.8	8.5	10.2	8.6	24.3	9.6	8.2	4.1	18.9	4.4	11.2	4.6	10.9	9.9	6.0	3.7	7.0	2.8	7.5	8.8	5.0	6.9	3.5	4.5	13.7	9.7	6.0	5.0	6.1	2.5	2.7	19.0	7.2	7.2	6.6	1.2	1.9	1.3	3.3	1.9	6.2	3.9	3.8	3.3	2.7	3.5	2.5	3.2	0.5	2.9	0.8	2.0	2.8	1.6	5.6	6.6	10.7	7.3	5.9	4.0	8.2	5.3	7.0	7.3
YLPM1	"C14orf170, PPP1R169, ZAP"	ENSG00000119596	"YLP motif containing 1"	P49750	14	74763366-74859435	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048070, HPA061123"	Uncertain		Supported	"Nucleoplasm,Nuclear speckles"				"Nucleoplasm, Nuclear speckles"		"HPA048070: , HPA061123: AB_2684435"	"unprognostic (2.17e-1)"	"unprognostic (3.32e-2)"	"unprognostic (3.95e-1)"	"unprognostic (2.98e-1)"	"unprognostic (3.79e-2)"	"unprognostic (7.64e-2)"	"unprognostic (3.22e-3)"	"unprognostic (8.74e-2)"	"unprognostic (3.60e-2)"	"unprognostic (2.56e-1)"	"unprognostic (7.83e-3)"	"unprognostic (6.63e-2)"	"prognostic favourable (6.08e-7)"	"unprognostic (1.09e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.60e-1)"	17.2	19.0	28.9	21.7	33.4	26.1	21.0	51.4	32.6	18.6	15.4	24.9	18.8	13.1	23.8	20.6	17.4	20.6	15.9	15.8	24.2	18.2	15.7	14.0	16.4	20.8	24.1	24.8	31.3	21.0	30.9	30.5	19.8	22.5	20.0	17.2	18.8	20.6	22.8	20.7	23.0	16.5	17.7	21.2	18.9	16.2	28.8	27.6	24.7	22.5	8.7	20.6	22.4	18.7	5.5	7.8	3.3	3.9	5.4	4.6	3.0	18.9	21.1	23.1	4.4	16.6	16.2	12.5	13.2	13.5	13.4	13.5	18.5	13.7	28.5	9.9	14.8	17.2	20.0	13.7	21.3	17.1	11.5	20.6	13.4	12.6	9.0	15.7	15.7	14.2	9.1	15.1	11.4	18.2	16.3	13.6	16.5	19.5	18.1	12.7	13.8	17.7	27.3	23.0	9.9	10.7	27.4	17.0	16.7	21.2	13.1	5.0	15.6	10.4	27.3	16.2	20.8	11.6	16.5	16.7	16.0	31.4	14.1	11.5	12.1	0.7	3.4	3.3	3.8	3.9	4.2	4.4	3.2	3.2	3.1	5.5	4.6	4.6	2.7	5.4	3.1	7.8	2.7	3.0	28.9	33.4	51.4	32.6	24.2	18.2	24.1	24.8	22.5	27.6
ZBTB18	"C2H2-171, RP58, TAZ-1, ZNF238"	ENSG00000179456	"Zinc finger and BTB domain containing 18"	Q99592	1	244048939-244057476	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"brain: 114.4;skeletal muscle: 40.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 114.4"	"Cell type enhanced"	"Detected in many"		"neutrophil: 5.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024656			Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA024656: "	"unprognostic (3.48e-3)"	"unprognostic (9.17e-3)"	"unprognostic (3.69e-3)"	"prognostic favourable (1.34e-4)"	"unprognostic (6.83e-2)"	"unprognostic (4.52e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.15e-2)"	"unprognostic (8.43e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.60e-1)"	"unprognostic (6.28e-2)"	"unprognostic (9.37e-2)"	"unprognostic (2.07e-2)"	"unprognostic (6.54e-3)"	"prognostic favourable (6.78e-6)"	4.1	3.4	20.1	7.3	14.7	13.4	4.7	114.4	26.0	4.1	4.7	5.4	8.1	6.9	3.5	10.3	3.0	4.6	3.8	7.4	24.8	6.3	6.4	10.0	5.1	8.8	7.1	19.1	4.0	13.0	3.1	2.7	4.9	11.7	5.5	5.8	4.6	5.2	6.7	40.3	4.1	6.2	5.9	7.5	10.0	5.8	11.4	4.6	16.4	4.4	2.8	8.1	6.5	9.3	2.4	2.2	5.8	1.5	0.3	1.4	0.2	11.5	4.1	15.9	0.6	2.1	2.2	11.1	6.5	4.8	10.5	6.4	3.1	9.4	8.8	0.6	12.5	1.2	10.1	3.2	13.2	3.1	8.9	1.5	1.4	1.5	3.3	1.8	4.7	1.8	2.7	6.3	3.9	11.3	1.1	3.8	12.4	0.1	15.1	7.4	8.2	1.8	4.4	10.8	2.5	6.6	4.0	23.5	23.0	2.7	0.1	7.1	0.2	13.4	16.8	5.4	6.6	3.3	13.7	1.6	0.2	3.5	5.5	5.7	10.9	0.2	0.7	2.9	0.3	0.7	0.4	1.6	0.7	0.5	0.9	2.4	1.4	0.9	5.8	0.3	1.5	2.2	0.5	0.2	20.1	14.7	114.4	24.1	24.8	6.3	7.1	19.1	11.7	4.6
ZNF250	"MGC9718, ZFP647, ZNF647"	ENSG00000196150	"Zinc finger protein 250"	P15622	8	144876497-144902168	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA020853	Uncertain		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA020853: AB_1859152"	"unprognostic (1.16e-3)"	"unprognostic (9.56e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.60e-3)"	"unprognostic (1.03e-1)"	"unprognostic (5.95e-3)"	"unprognostic (3.73e-3)"	"unprognostic (2.72e-2)"	"unprognostic (6.27e-2)"	"unprognostic (7.37e-2)"	"unprognostic (4.94e-2)"	"unprognostic (1.06e-1)"	"prognostic favourable (2.43e-7)"	"unprognostic (2.23e-1)"	"unprognostic (6.79e-2)"	"unprognostic (5.82e-2)"	"prognostic favourable (8.26e-4)"	6.5	7.0	8.4	9.4	10.0	4.5	21.2	33.0	11.1	13.8	9.0	8.6	7.3	9.2	15.8	11.4	9.1	10.7	7.2	7.1	6.3	7.6	10.5	5.6	9.3	5.9	9.3	9.5	16.4	8.6	12.5	14.7	10.0	10.0	10.6	6.8	10.4	8.8	12.4	10.6	14.8	9.1	12.2	6.5	8.3	6.9	6.1	9.2	9.7	19.9	6.0	8.8	12.7	12.0	12.2	7.5	6.4	5.9	6.1	12.7	5.0	4.7	3.6	12.9	10.9	7.4	5.3	4.6	5.6	6.2	8.8	7.8	2.3	3.4	12.7	9.7	6.5	6.2	6.4	6.7	6.4	3.6	7.9	10.3	13.2	3.5	3.6	2.0	3.8	4.0	9.1	6.8	8.1	4.8	8.3	10.8	8.0	8.7	12.3	4.7	3.6	10.7	14.9	5.9	5.5	9.0	3.8	12.8	10.2	11.0	4.0	4.9	5.8	5.6	4.9	9.8	8.8	7.9	5.0	5.6	4.3	7.5	4.8	6.9	4.1	4.6	5.9	6.4	12.7	3.3	9.8	12.2	9.4	7.3	7.5	11.0	11.1	9.2	3.3	6.1	4.2	3.2	12.4	5.0	8.4	10.0	33.0	11.1	6.3	7.6	9.3	9.5	10.0	9.2
ZNF821		ENSG00000102984	"Zinc finger protein 821"	O75541	16	71859680-71895336	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.9;testis: 23.7"	"Cell line enhanced"	"Detected in many"		"AF22: 13.8;SCLC-21H: 13.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 9.3;naive B-cell: 11.5"	"Group enriched"	"Detected in many"	8	"B-cells: 11.5;T-cells: 5.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036372, HPA042742"	Enhanced		Supported	"Nucleoplasm,Nuclear speckles"				"Nucleoplasm, Nuclear speckles"		"HPA036372: AB_10669790, HPA042742: "	"unprognostic (3.16e-1)"	"unprognostic (1.77e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.12e-2)"	"prognostic favourable (1.20e-4)"	"unprognostic (1.69e-2)"	"unprognostic (2.28e-2)"	"unprognostic (7.72e-2)"	"unprognostic (5.25e-2)"	"unprognostic (3.04e-2)"	"prognostic favourable (4.27e-5)"	"unprognostic (2.83e-2)"	"prognostic favourable (6.32e-10)"	"unprognostic (1.82e-2)"	"unprognostic (1.79e-1)"	"unprognostic (7.97e-2)"	"unprognostic (1.02e-1)"	2.0	4.2	6.3	3.7	7.5	3.1	4.8	26.9	13.4	4.3	3.8	5.1	2.3	2.1	5.8	11.1	2.5	3.5	3.9	2.9	5.7	7.6	5.9	2.6	3.4	6.0	5.2	6.0	7.3	2.4	5.6	9.2	2.5	7.1	4.4	5.0	5.2	5.2	5.1	4.0	6.0	4.3	3.0	4.8	3.7	3.3	23.7	3.4	2.2	6.1	0.7	7.3	2.4	4.0	11.5	0.9	0.4	0.5	1.0	5.1	0.7	1.1	0.9	13.8	6.7	2.8	3.6	2.4	1.4	3.1	3.1	4.9	1.9	0.8	2.6	2.4	2.7	1.9	4.6	2.0	3.8	3.9	5.2	0.5	1.0	0.7	1.7	0.9	3.0	3.1	3.5	2.1	1.3	2.3	1.6	1.9	3.3	3.3	1.4	0.9	5.5	0.6	6.0	2.9	4.5	3.5	0.4	13.9	6.6	1.8	1.2	1.5	4.7	3.0	4.6	3.3	3.4	1.2	0.9	4.7	2.3	10.5	1.1	2.6	3.1	0.0	0.5	0.4	2.2	0.0	1.9	9.3	2.3	1.6	0.9	11.5	1.4	0.5	0.4	1.0	0.5	0.0	5.1	0.7	6.3	7.5	26.9	13.4	5.7	7.6	5.2	6.0	7.1	3.4